PTC has received the Enzyme Targeting Therapeutics Innovation of the Year in the 6th annual BioTech Breakthrough Awards for our treatment for PKU. We're proud to have recognition of our therapy designed to expand options for patients living with this lifelong metabolic condition.
PTC Therapeutics
PTC Therapeutics, Inc. is an U.S.-based pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapies that alter gene expression via post-transcriptional control (PTC) mechanisms in orphan diseases. More on Wikipedia
-
PTC Therapeutics
@PTCBio
-
PTC Therapeutics
@PTCBio
PTC's President & CEO Matthew Klein, MD and CFO Pierre Gravier will speak at two upcoming investor conferences to close out the year. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we announced our Q3 2026 financial results where we highlighted our continued commercial momentum and raised full-year revenue guidance. Read the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… | Webcast: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
PTC will host a web conference to report our third quarter 2026 financial results and provide an update on the company’s business on Thursday, Oct. 29, 2026, at 4:30 p.m. ET. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Hello, #fabrydisease community. We're honored to introduce ourselves as we advance the investigational gene therapy ST-920 with an FDA submission planned before the end of 2026. Read our letter to the community: www.ptcbio.com/wp-content/uploads/sites/2/2026/09/PTC-The…
-
PTC Therapeutics
@PTCBio
PTC will participate in three upcoming investor conferences in September. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
#ssiem2026 is a meaningful moment for the PKU community. At the meeting multiple scientific data presentations spanning research, clinical outcomes & real-world case studies will be featured. ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics was selected as the winning bidder to acquire ST-920 – a BLA-stage one-time administered AAV gene therapy for Fabry disease – from Sangamo Therapeutics in a competitive bankruptcy auction. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-expa…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics welcomes Hege Sollie-Zetlmayer to its Board of Directors. With 30 years experience in biopharma and medical devices, including eight at PTC as CHRO, she brings deep global leadership to advance our mission for patients with rare diseases.
-
PTC Therapeutics
@PTCBio
Today we announced our Q2 2026 financial results, highlighting strong commercial momentum with accelerating global uptake of our treatment for PKU. Learn more in our press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… | Webcast: edge.media-server.com/mmc/p/ytf73gp6
-
PTC Therapeutics
@PTCBio
PTC will host a web conference to report our second quarter 2026 financial results and provide an update on the company’s business on Thursday, July 30, 2026, at 4:30 p.m. ET. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Every day, the #pku community faces unseen challenges. This #internationalpkuday, PTC is making a #pledgeforpku: to listen, learn and support everyone this journey. Join us in championing hope, access and a future without limits. www.ptcbio.com/posts/sharing-our-pledge-for-pku/
-
PTC Therapeutics
@PTCBio
Ahead of International PKU Day, we’re spotlighting mental health in the PKU community. Kevin, Signe & Regina share their journeys with stigma, anxiety & resilience. Learn more about their stories: www.ptcbio.com/posts/international-pku-day-making-space-f…
-
PTC Therapeutics
@PTCBio
Our 2025 Corporate Social Responsibility Report highlights a year of focus, execution and measurable progress delivering differentiated medicines for people with rare disorders. See how we're driving impact across access, innovation, people & our planet: www.ptcbio.com/posts/ptc-2025-corporate-social-responsibi…
-
PTC Therapeutics
@PTCBio
On #clinicaltrialsday, we honor patients, families, and clinical teams advancing rare disease research. This year's #researchrising theme reminds us that progress comes from partnership and trust. Learn more: www.ptcbio.com/posts/international-clinical-trials-day-pa…
-
PTC Therapeutics
@PTCBio
May is Friedreich’s ataxia (FA) Awareness Month and we're proud to honor the strength of those living with this rare condition. Kailey’s journey reflects the challenges many face, from recognizing symptoms to finding support. Learn more: www.ptcbio.com/posts/finding-strength-in-the-giant-family…
-
PTC Therapeutics
@PTCBio
Some days, the hardest part of living with a rare disorder isn’t what others can see—it’s the uncertainty: navigating genetic testing barriers and painful life changes. During #hdawarenessmonth, PTC is proud to share stories like April's. Learn more: www.ptcbio.com/posts/taking-time-to-breathe/
-
PTC Therapeutics
@PTCBio
Today, we announced our Q1 2026 financial results, highlighting record performance and continued momentum across the business—led by the global launch of our treatment for #pku. See the release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… and webcast recording: edge.media-server.com/mmc/p/ysmfx4tx
-
PTC Therapeutics
@PTCBio
PTC will participate in three upcoming investor conferences in May and June. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
This #nationalpkuawarenessmonth, we’re honoring the resilience of the PKU community. Living with PKU is more than a diet—it takes constant planning, advocacy and support. Amanda’s story, alongside her mom Jill, helps make the invisible visible. Learn more: www.ptcbio.com/posts/never-ending-support/
-
PTC Therapeutics
@PTCBio
On Rare Disease Day, we recognize the millions living with rare conditions. At PTC, we know that progress starts with listening to those impacted. Together, we can make a difference. Learn more: www.ptcbio.com/posts/listening-first-what-weve-learned-fr…
-
PTC Therapeutics
@PTCBio
PTC will participate in three upcoming investor conferences in March, including TD Cowen 46th Annual Health Care Conference, Leerink 2026 Global Healthcare Conference and the Barclays Global Healthcare Conference. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PKU is rare—but the PKU community’s strength is extraordinary. Living with PKU means daily planning, monitoring, and resilience. This Rare Disease Day, we’re amplifying their voices. Watch, listen, and share their stories: www.ptcbio.com/posts/raise-your-voice-for-pku/
-
PTC Therapeutics
@PTCBio
Today, we announced our Q4 and full-year 2025 financial results, highlighting strong revenue performance that sets the stage for continued growth and innovation in the coming year. Learn more in our release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… and webcast recording: edge.media-server.com/mmc/p/mvj9b5fa
-
PTC Therapeutics
@PTCBio
Proud to stand with the global #raredisease community and families impacted by AADC deficiency (#aadcd). As Dr. Marcus Wheeler notes, symptoms can overlap with other disorders—so awareness matters. We’re committed to providing education, support, and earlier recognition.
-
PTC Therapeutics
@PTCBio
PTC was honored to receive BioNJ's 2026 Innovator Award for the FDA approval of our treatment for PKU. Thank you, BioNJ, and congrats to everyone advancing the future of medicine.
-
PTC Therapeutics
@PTCBio
Sometimes, the right opportunity finds you. Luke Millington turned his internship at PTC into a career supporting the #dmd community. Read his inspiring story: www.ptcbio.com/posts/25-remarkable-stories-where-experien…
-
PTC Therapeutics
@PTCBio
PTC will host a web conference call to report our fourth-quarter and full-year 2025 financial results and provide an update on the company’s business on Thursday, Feb. 19, 2026, at 4:30 p.m. ET. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
At PTC, our commitment to those with significant unmet medical needs drives us every day. In honor of Rare Disease Day this month, we're sharing the story of Tiffany, a mother of two living with #fa, a rare, neuromuscular disorder. Learn more: www.ptcbio.com/posts/looking-for-lifes-small-miracles/.
-
PTC Therapeutics
@PTCBio
Pam and Kelsey are helping to raise awareness of phenylketonuria (PKU) by sharing their inspiring story. Read more: people.com/woman-rare-metabolic-disorder-adopts-girl-with…
-
PTC Therapeutics
@PTCBio
#icymi: At the J.P. Morgan 2026 Healthcare Conference, PTC Therapeutics shared key updates on our strong positioning for success in 2026 and beyond. Learn more: jpmorgan.metameetings.net/events/healthcare26/sessions/31…
-
PTC Therapeutics
@PTCBio
Today, our CEO Dr. Matthew Klein, shared highlights from a successful 2025 and an outlook for what we expect to be an exciting 2026 at the J.P. Morgan Healthcare Conference. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Our CEO Matthew Klein, M.D., will present at the annual J.P. Morgan 2026 Healthcare Conference on Monday, Jan. 12 at 9 a.m. PST/12 p.m. EST. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
#breakingnews: Japan has approved our treatment for children and adults living with phenylketonuria (#pku), marking a meaningful step forward for the PKU community. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
ICYMI: Our CEO Matthew Klein, MD, participated in the Citi 2025 Global Healthcare Conference yesterday to share insights on how PTC's strong Q3 performance has set the stage for a successful future. Listen for more: kvgo.com/global-healthcare-conference-2025/ptc-therapeuti…
-
PTC Therapeutics
@PTCBio
Tracy's PKU journey shows why awareness and support matter. On #pkuawarenessday, we're proud to share her story and highlight the daily discipline behind living with this rare disease. Learn more: youtu.be/_XO6w44ca7A
-
PTC Therapeutics
@PTCBio
Miss PTC’s R&D Day? Catch up on the latest updates on our science, pipeline progress, and insights in the full replay: ir.ptcbio.com/events/event-details/rd-day
-
PTC Therapeutics
@PTCBio
PTC announced that it will host an R&D Day on Dec. 2 in New York City to discuss the company's pipeline. The event will also be webcast. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We're honored that our #genetherapy treatment for #aadcdeficiency received the Therapeutics Innovation of the Year by BioTech Breakthrough Awards, a milestone in advancing care for patients with a rare disease.
-
PTC Therapeutics
@PTCBio
Yesterday, we shared our Q3 2025 financial results and provided a corporate update. Learn more in our release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… and webcast recording: edge.media-server.com/mmc/p/dazmefwy
-
PTC Therapeutics
@PTCBio
PTC will participate in three upcoming investor conferences. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
AADC deficiency is a rare condition with complex physical and emotional challenges. This AADC Awareness Day, we're honored to share stories from families like the Licciardello’s and their journey to diagnosis for their son Simone. www.ptcbio.com/posts/a-familys-path-to-hope/
-
PTC Therapeutics
@PTCBio
PTC Therapeutics is sponsoring a virtual symposium with international experts on Nov. 7. We invite all HCPs to join us for a discussion on clinical perspectives on a novel treatment for #phenylketonuria (PKU). Register now: webapp.spotme.com/login/ptc/redefining-pku-management
-
PTC Therapeutics
@PTCBio
On Tuesday, Nov. 4, PTC Therapeutics will report its third quarter 2025 financial results and provide an update on the company's business and outlook. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today our leaders participated in the Cantor Global Healthcare Conference 2025 to share the latest updates on PTC Therapeutics. Listen to the webcast to learn more: ir.ptcbio.com/events/event-details/cantor-global-healthca…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics is sponsoring a scientific symposium at #iciem2025 in Kyoto, Japan. We invite all HCPs at the conference to join us for a discussion on advancing research and care for children and adults living with #phenylketonuria (PKU).
-
PTC Therapeutics
@PTCBio
PTC will participate at the Cantor Global Healthcare Conference, the Wells Fargo 2025 Healthcare Conference, and the Morgan Stanley 23rd Annual Global Healthcare Conference this September. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
 -
PTC Therapeutics
@PTCBio
#breakingnews for #investors and #media: We are proud to announce the U.S. FDA has approved our treatment for children and adults living with phenylketonuria (#pku). Read the press release for more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
On Thursday, August 7, our leaders will report our second quarter 2025 financial results and provide an update on the company's business and outlook. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we proudly recognize International PKU Day, led by @official_espku to spread awareness and education about living with #pku. Learn how the dietary challenges of this rare condition can impact the quality of life for both children and adults: www.youtube.com/watch?v=itnlGE_SwsY
-
PTC Therapeutics
@PTCBio
We are proud to announce the European Commission has granted marketing authorization for our medicine to treat children and adults living with phenylketonuria (PKU). Learn more: ir.ptcbio.com/news-releases/news-release-details/sephienc…
-
PTC Therapeutics
@PTCBio
Our CEO, Dr. Matthew Klein and CFO, Pierre Gravier will participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 today June 10 at 9:20 a.m. ET. Tune in to our fireside chat to hear our latest updates: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
Our leaders will participate in the William Blair 45th Annual Growth Stock Conference 2025 today June 3 at 10:20 a.m. ET. Tune in to our fireside chat to hear our latest updates: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
Our leaders will be participating in the RBC Capital Markets Global Healthcare Conference 2025 today, May 20 at 2:05 p.m. ET. Tune in to our fireside chat to hear our latest updates: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
We invite you to hear from PTC's leaders at the Bank of America Securities 2025 Health Care Conference today, May 13. Tune in to our live webcast at 1 p.m. ET (10 a.m. PT) to learn more about the company's latest updates: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
Today we announced our first quarter 2025 earnings, highlighting a promising start thanks to strong revenue performance and a steady progression of global launch activities following the recent positive CHMP opinion for our potential PKU treatment. ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion on PTC's treatment option Sephience (sepiapterin) for adults and children with phenylketonuria (PKU). Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC's leaders will present at four upcoming investor conferences this May and June. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we announced that our leaders will report the company's first-quarter 2025 financial results and provide an update on the company's business and outlook on Tuesday, May 6 at 4:30 p.m. ET. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We are pioneering innovative treatments for patients around the world and are proud to share that our #genetherapy for AADC deficiency (#aadcd) has received approval in Hong Kong.
-
PTC Therapeutics
@PTCBio
Our teams were thrilled to connect with the #friedreichsataxia (FA) community at the 2025 #mdaconference and share data from our #fa program. We're proud to be developing a potential treatment for children and adults living with this rare disorder.
-
PTC Therapeutics
@PTCBio
It's been a productive week for us at #acmgmtg25. We presented new data from our sepiapterin Phase 3 APHENITY trial and open-label extension study demonstrating the potential to treat children and adults living with #pku. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We're excited to be onsite at this year's #acmgmtg25 in Los Angeles to to share data on our #pku and #aadcd programs.
-
PTC Therapeutics
@PTCBio
We're honored to be named one of Gallup's 2025 Exceptional Workplace Award winners for Strengths Development for the fourth time! Learn more: www.ptcbio.com/posts/ptc-earns-gallups-2025-exceptional-w…
-
PTC Therapeutics
@PTCBio
PTC will be participating in the Barclays 27th Annual Global Healthcare Conference today, March 11 at 12:30 p.m. ET. Tune in to our fireside chat to hear our latest updates: ir.ptcbio.com/events/event-details/barclays-27th-annual-g…
-
PTC Therapeutics
@PTCBio
PTC will be participating in the TD Cowen 45th Annual Health Care 2025 Conference today, March 4 at 11:10 a.m. ET. Tune in to our fireside chat to hear our latest updates: ir.ptcbio.com/events/event-details/td-cowen-45th-annual-h…
-
PTC Therapeutics
@PTCBio
On this #rarediseaseday, we celebrate the inspiring rare disease community who motivate us to excel. We’re proud to raise awareness of the 6,000+ identified rare diseases and more than 300 million people worldwide living with a rare condition.
-
PTC Therapeutics
@PTCBio
Today, our CEO Matthew B. Klein, M.D. shared an update about PTC’s outstanding year of execution in 2024. From record revenue to key regulatory milestones, we achieved remarkable success across all areas of the business last year. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
The FDA has accepted our NDA for vatiquinone to treat Friedreich's ataxia. Our application has been granted Priority Review and assigned a PDUFA date of Aug. 19, 2025. This is our 4th NDA submitted and accepted for review within the last year. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC will announce fourth quarter and full year 2024 financial results and provide an update on the company's business and outlook on Thursday, Feb. 27. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We're incredibly proud to be named one of @BioNJ_Org's 2025 Innovator Award Honorees in recognition of the first and only FDA-approved gene therapy for treating children and adults with #aadcdeficiency.
BioNJ
@BioNJ_Org
Announcing the #bionj 2025 Innovator Award Honorees!
myemail.constantcontact.com/subject.html?soid=11020611505… -
PTC Therapeutics
@PTCBio
At this week’s 43rd Annual J.P. Morgan Healthcare Conference, our CEO Matthew Klein, M.D., shared insights on how PTC’s successful execution in 2024 has set the stage for a bright and successful future in 2025 and beyond. Hear the full story: ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
Today we provided an update on the company's progress and outlook for 2025 at the J.P. Morgan Healthcare Conference. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, we announced our submission of the vatiquinone NDA for the treatment of children and adults living with Friedreich ataxia FA to the U.S. FDA. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we are pleased to announce that PTC has entered into a Global License and Collaboration Agreement with Novartis for the PTC518 Huntington’s disease program. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150 million upon the closing of the transaction. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Caregiving is a profound act of love and commitment, but it can also be an incredibly challenging journey when caring for those living with rare diseases. This National Family Caregivers Month, we're sharing their stories to shine a light on their impact: www.ptcbio.com/2024/11/21/celebrating-those-who-care-for-…
-
PTC Therapeutics
@PTCBio
PTC set forth ambitious goals for 2024 and as CEO Matthew Klein, MD, shared at the Jefferies Global Healthcare Conference, we’re proud to be executing on all of our plans and upcoming milestones. Learn more: wsw.com/webcast/jeff315/register.aspx?conf=jeff315&page=p…
-
PTC Therapeutics
@PTCBio
We're thrilled to share that PTC has won the 2024 BioTech Breakthrough Award for 'Biotech AI Solution of the Year'! Learn more about the enterprise tool we developed that's helping us operate more efficiently and drive innovation: www.ptcbio.com/posts/ptc-wins-biotech-ai-solution-of-the-…
-
PTC Therapeutics
@PTCBio
We're excited to present at the upcoming #isporeurope 2024 Conference in Barcelona, Spain from Nov. 17-20. Learn more below about our poster presentations across three therapeutic areas. We look forward to seeing you there!
-
PTC Therapeutics
@PTCBio
#breakingnews: Today, we are proud to announce that the FDA has approved our #genetherapy for treating adults and children with #aadcdeficiency. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
This media couldn't be displayed. See it on the original post. -
PTC Therapeutics
@PTCBio
Today, our leaders provided a corporate update and reported our third-quarter 2024 financial results. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We are pleased to announce that we will present a company overview at three upcoming investor conferences in November and December. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
CEO Matthew Klein, MD was pleased to join our regional CIS team at the Commonwealth Without Borders Conference in Tashkent, Uzbekistan to meet with leading medical experts and discuss diagnosis and innovative treatments for children & adults living with #rarediseases. #innovation
-
PTC Therapeutics
@PTCBio
Today we announced that the U.S. FDA has accepted for review the resubmission of the NDA for Translarna for the treatment of nmDMD. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC is proud to sponsor a new E.S.PKU metabolic passport, designed to make traveling with #pku easier for people living with this rare disorder. Visit us at our exhibition booth at the E.S.PKU Conference in Porto this week for your copy. #espku2024
-
PTC Therapeutics
@PTCBio
Today we announced that we will host a conference call to report our third quarter 2024 financial results and provide an update on the company's business outlook on Thursday, Nov. 7 at 4:30 p.m. ET. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We are pioneering innovative treatments for patients around the world and are proud to share that our gene therapy for AADC deficiency has received approval in Brazil and Taiwan.
-
PTC Therapeutics
@PTCBio
PTC is proud to participate in the upcoming E.S.PKU Conference (#espku2024) on October 24-27 in Porto, Portugal. Join us as we discuss our latest research and developments in #pku.
-
PTC Therapeutics
@PTCBio
This week we celebrated the grand opening of our new office in Dublin. The international headquarters will continue to play a key role in PTC’s expanding commercial portfolio and pipeline, ensuring PTC’s innovative medicines reach more rare disease patients worldwide.
-
PTC Therapeutics
@PTCBio
Today we're thrilled to share several positive updated on the vatiquinone Friedreich ataxia (#fa) program. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We are looking forward to participating in the upcoming 29th Annual Congress of the World Muscle Society from October 8-12 in Prague. Learn more about the data we’ll be sharing through our poster presentations below.
-
PTC Therapeutics
@PTCBio
When it comes to rare disease, every story is a journey that deserves to be told. PTC is proud to introduce its new Rare Journeys Hub: a collection of the stories elevating the voices of adults and children living with rare conditions around the world. www.ptcbio.com/rare-journeys/
-
PTC Therapeutics
@PTCBio
Today, we announced the FDA has accepted our filing for the NDA of sepiapterin for treating pediatric and adult patients living with phenylketonuria (#pku). Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC is committed to advancing research and treatment options for neurologic conditions like #aadc deficiency. Meet our team at the #mdscongress in Philadelphia this weekend to learn more.
-
PTC Therapeutics
@PTCBio
We’re proud to push the boundaries of innovation by leveraging cutting-edge science to address serious unmet medical needs. See how our #ferroptosis and inflammation platform is opening new approaches to fight neurodegenerative diseases, like #parkinsons. journals.plos.org/plosone/article?id=10.1371/journal.pone…
-
PTC Therapeutics
@PTCBio
Today we announced that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Learn more: ir.ptcbio.com/news-releases/news-release-details/fda-gran…
-
PTC Therapeutics
@PTCBio
In honor of Newborn Screening Awareness Month, we're raising awareness about the importance of testing newborns for rare genetic conditions, like #pku, a topic often discussed in our My VIBE podcast. Listen for more: insightful-moments-my-vibe.simplecast.com
-
PTC Therapeutics
@PTCBio
Today is World Duchenne Awareness Day. We're honoring this year's theme to "Raise Your Voice for Duchenne" by highlighting remarkable stories from the #duchenne community: www.ptcbio.com/posts/raising-voices-for-duchenne/
-
PTC Therapeutics reposted
HR Awards
@HRAwardsIRL
🏆The finalists for the Best Leadership Development category have been announced!
Avolon, Depaul, Lidl, Primeline Group, PTC Therapeutics, RCSI, and The Doyle Collection are leading the way in building future leaders.
www.hrawards.ie/shortlist -
PTC Therapeutics
@PTCBio
PTC supported a research project that explored the experience of teenagers and young adults living with #duchenne as they transition from pediatric care to adult care. Learn more about the study and its impact: www.ptcbio.com/posts/improving-the-transition-from-pediat…
-
PTC Therapeutics
@PTCBio
Join us at #ssiem 2024 where we'll be discussing #aadcdeficiency and #pku. Learn more about our poster presentations below and visit us at booth #s12/S13! #exploringnewhorizons #porto
-
PTC Therapeutics
@PTCBio
We’re proud to be attending #ssiem 2024 in Porto, Portugal. We invite healthcare professionals attending the conference to join us for our sponsored symposium sessions focused on #aadcdeficiency and #pku. #exploringnewhorizons #porto
-
PTC Therapeutics
@PTCBio
As we approach World Duchenne Awareness Day on Sept. 7, we are honoring this year’s theme of “Raise Your Voice for Duchenne” by highlighting remarkable individuals from our #duchennecan series who are doing just that. #wdad2024 #duchennemusculardystrophy
-
PTC Therapeutics
@PTCBio
Today, PTC announced that the company will present a company overview at upcoming investor conferences. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
In a recent article for pharmaphorum, PTC's Edouard Dumont Saint Priest discusses the importance of intercultural intelligence to help pharma and biotech companies grow effectively in emerging markets worldwide. Read more: pharmaphorum.com/market-access/applying-intercultural-int…
-
PTC Therapeutics
@PTCBio
Today, our leaders provided a corporate update and reported our second quarter 2024 financial results. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we announced the submission of the sepiapterin NDA to the U.S. FDA for the treatment of pediatric and adult patients with PKU. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we announced that the company will host a webcast to report its second quarter 2024 financial results on Thursday, August 8. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Early diagnosis of #als can be challenging. On this global #alsawarenessday, learn more about the signs and symptoms.
-
PTC Therapeutics
@PTCBio
Today we shared interim 12-month results from the Phase 2 PIVOT-HD study of PTC518 in Huntington’s disease (HD) patients. Read more: ir.ptcbio.com/news-releases/news-release-details/interim-…
-
PTC Therapeutics reposted
RARE Revolution Magazine®
@RareRevolutionM
For #huntingtonsdisease (#hd) awareness month, Jenna Woodard shares how her anger and fear towards her diagnosis changed to positivity and a determination to help others—through her connection with incredible medical staff and the beautiful HD community.
rarerevolutionmagazine.com/huntingtons-disease-hd-was-not… -
PTC Therapeutics
@PTCBio
As #alsawarenessmonth comes to an end in the U.S, we know the work doesn’t stop here. We applaud the Live Like Lou Foundation and many others in the community for their continued efforts. Through collaboration, compassion, and partnership, we can go further together.
Live Like Lou
@LiveLikeLou4
May is #alsawarenessmonth 💙
Did you know that Lou Gehrig inspired the colors in the #als ribbon? The navy blue and white pinstripe ribbons honor Lou's Yankees uniform. Join us as we help leave ALS better than we found it by spreading ALS awareness! #onward -
PTC Therapeutics
@PTCBio
A reminder that PTC will be presenting a company overview at William Blair's 44th Annual Growth Stock Conference today, June 4. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics announced that we will present a company overview at an upcoming investor conference. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today we announced that the sepiapterin MAA for PKU has been validated and accepted for review by the EMA. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We’re proud to support this year’s @CureDuchenne FUTURES National Conference in Orlando, FL from May 23-26 and engage with the #dmd community. See you at booth #12! Learn more: web.cvent.com/event/8ff259d6-8470-4bcf-8fc4-ff32faf3bd51/…
-
PTC Therapeutics
@PTCBio
Today we announced that the EC has decided not to adopt the CHMP's negative opinion of Translarna™ (ataluren) and has returned the opinion to the CHMP for re-evaluation. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We recently sat down with Jonathan Cherry, Global Project Leader, to learn more about PTC’s ferroptosis and inflammation scientific platform and how it relates to #friedreichataxia (FA). Read more: www.ptcbio.com/posts/what-you-need-to-know-about-ferropto…
-
PTC Therapeutics reposted
BiotechTV
@BiotechTV
RBC Global Healthcare Conference: @PTCBio's CEO summarizes a busy year ahead of regulatory decisions and data. $PTCT
Full video: www.biotechtv.com/post/ptc-therapeutics-may-14-2024 -
PTC Therapeutics
@PTCBio
Today we announced that the FDA has accepted our filing of the BLA for Upstaza™, a gene therapy for the treatment of AADC deficiency. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Our 2023 Corporate Sustainability Report is now available. It was a transformational year for PTC, but our commitment to environmental stewardship, social responsibility and corporate governance remained a key focus. Read more: ir.ptcbio.com/static-files/ee74083c-52dd-41da-b0a4-1a1a74…
-
PTC Therapeutics
@PTCBio
PTC is proud to announce that we have been granted @Gallup’s Don Clifton Strengths-Based Culture Award for 2024! Congratulations to all our employees for making PTC an engaging and innovative place to work. Learn more: www.ptcbio.com/posts/ptc-wins-gallups-2024-don-clifton-st…
-
PTC Therapeutics
@PTCBio
Expanding insights and knowledge about #rarediseases is essential to improving patient outcomes. At the ISPOR 2024 Annual Meeting, we’ll share six poster presentations focused on the latest health economics research across four of our key therapeutic areas. #isporannual
-
PTC Therapeutics
@PTCBio
We’re pleased to share that our 2023 annual report is now available. Read our full report for more on PTC's transformative year and how we're positioning the company for future success. ir.ptcbio.com/static-files/7ebbd7d5-7dd7-46df-ab49-7068c1…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics announced that we will present a company overview at two upcoming investor conferences. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, our leaders provided a corporate update and reported our first quarter 2024 financial results. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Are you a U.S. healthcare professional interested in learning more about our opt-in program for PKU? Visit reimaginepku.com to connect with our team.
-
PTC Therapeutics
@PTCBio
Raising awareness for rare diseases empowers patients and drives progress. Learn how to advocate for yourself and others in this article! www.ptcbio.com/posts/advocacy-in-action-diagnosis-disease… #raredisease #patientadvocacy
-
PTC Therapeutics
@PTCBio
We applaud this important research to help advance the understanding of Friedreich ataxia and the progression of the condition in children.
Rare Disease Advisor
@RareDisease_Adv
The Friedreich Ataxia Rating Scale balance and gait subscore, also called the upright stability score, may be a better outcome measure in pediatric patients with Friedreich ataxia. Annals of Clinical and Translational Neurology
Read more: www.rarediseaseadvisor.com/news/upright-stability-score-b…
#raredisease -
PTC Therapeutics
@PTCBio
Join PTC tomorrow at 4 p.m. ET for a sponsored educational symposium for #healthcare professionals attending the #simd2024 Annual Meeting. This symposium will review results from the Phase 3 APHENITY trial in #pku. Learn more and register: survey.sogolytics.com/survey/form?k=RQsQPPVXYsQUXWsPsPsP&…
-
PTC Therapeutics
@PTCBio
Join PTC on April 16 for a sponsored educational symposium for #healthcareprofessionals attending the #simd2024 Annual Meeting. This symposium will discuss unmet needs in #pku and review results from the Phase 3 APHENITY trial. Learn more and register: survey.sogolytics.com/survey/form?k=RQsQPPVXYsQUXWsPsPsP&…
-
PTC Therapeutics
@PTCBio
Don't miss our presentations at #aanam2024 for updates on our innovative therapies for rare neurological disorders.
-
PTC Therapeutics
@PTCBio
Today, PTC announced that it will host a conference call to discuss its first quarter 2024 financial results on Thursday, April 25 at 4:30 p.m. ET. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, PTC announced the submission of a marketing authorization application to the EMA for our investigational therapy for the treatment of PKU. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-anno…
-
PTC Therapeutics
@PTCBio
Angela Minnella, Director of Neuroscience at PTC, is moderating a panel discussion and speaking on the role of ferroptosis in the development and progression of neurodegenerative disease at the 6th Annual Neuroimmunology Drug Development Summit. Hope to see you there!
-
PTC Therapeutics
@PTCBio
We recently sat down with Jeff Trimmer @JKTrim, Senior VP, Research Site Head, to learn more about PTC’s ferroptosis and inflammation scientific platform and the team at PTC working on this program. Read more: www.ptcbio.com/posts/what-you-need-to-know-about-ferropto…
-
PTC Therapeutics
@PTCBio
Are you a U.S. healthcare professional interested in learning more about our opt-in program for PKU? Visit reimaginepku.com to connect with our team.
-
PTC Therapeutics
@PTCBio
We’re onsite at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting discussing phenylketonuria (PKU). Stop by booth 807 to meet our team and visit reimaginepku.com to learn more about our opt-in program for the PKU community. #acmg #acmgmtg24
-
PTC Therapeutics
@PTCBio
Please join us at 4:05 p.m. EDT today for our company overview at the Barclays 26th Annual Healthcare Conference. Register for the webcast here: ir.ptcbio.com/events-presentations #ptct
-
PTC Therapeutics
@PTCBio
Today, our leaders will present a company overview at 2:40 p.m. EDT at the Leerink Partners Global Biopharma Conference 2024. Register for the webcast here: ir.ptcbio.com/events-presentations #ptct
-
PTC Therapeutics
@PTCBio
Join us at 1:30 p.m. EST today for our presentation at the @TDCowen 44th Annual Health Care Conference. Register for the webcast here: ir.ptcbio.com/events-presentations #ptct
-
PTC Therapeutics
@PTCBio
We're looking forward to the 2024 @MDAorg Clinical & Scientific Conference, March 3-6, in Orlando. Stop by booth 315 to meet our team and check out our oral and poster presentations. View the agenda: www.mdaconference.org/wp-content/uploads/2024/02/2024-MDA…
-
PTC Therapeutics
@PTCBio
Today, our leaders provided a corporate update and reported our fourth quarter and full year 2023 financial results. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
Patient advocacy groups work tirelessly for those living with rare diseases and their families. We’re proud to stand alongside them. #rarediseaseday #rarediseaseday2024
-
PTC Therapeutics
@PTCBio
PTC Therapeutics leaders will present a company overview at three upcoming investor conferences. The presentations will be webcast live on our website. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
Kevin Alexander's latest podcast, Owning Your Rare Disease, dropped just in time for #rarediseaseday. Hear his story about living with phenylketonuria (PKU), a rare, inherited metabolic condition, on Apple Podcasts, Spotify, or by clicking here: protect-us.mimecast.com/s/kgxrCn5Y8AIrG51Bf9XkpN?domain=p…
-
PTC Therapeutics
@PTCBio
Ely Marçal experienced a long road to his diagnosis of transthyretin-related familial amyloidotic polyneuropathy. As we approach #rarediseaseday, let's learn about PAF-TTR and hereditary transthyretin amyloidosis (hATTR) through the words of his neurologist.
-
PTC Therapeutics
@PTCBio
We’re proud to support the #raredisease community on #rarediseaseday and every day, because at PTC, we’re in it together. Read more on our newsroom: www.ptcbio.com/posts/in-it-together-rare-disease-day-2024/
-
PTC Therapeutics
@PTCBio
To highlight #rarediseaseday, let’s learn about familial chylomicronemia syndrome (FCS), a rare, genetic disease that prevents the body from breaking down fats. Learn the 7 Cs of resilience and how they help those living with FCS and other rare disorders: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
Today, PTC Therapeutics shared we will host a webcast conference call on Thursday, Feb. 29 to report our fourth quarter and full year 2023 financial results and provide an update on the company's business and outlook. #ptct Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
This #rarediseaseday, we highlight amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects motor neurons in the brain and spinal cord. We invite families facing ALS and other rare diseases to explore our Discovering Wellness series: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
Throughout February, we’re spreading awareness about the therapeutic areas our employees work to treat, including familial chylomicronemia syndrome (FCS), in honor of #rarediseaseday. FCS is a serious disease that prevents the body from breaking down fats: www.ptcbio.com/therapeutic-areas/familial-chylomicronemia…
-
PTC Therapeutics
@PTCBio
For Jean and others living with Friedreich ataxia (FA), difficulties with communication can be isolating. With #rarediseaseday later this month, please listen to Season 2, Episode 5 to learn from Jean and others in the rare disease community: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
-
PTC Therapeutics
@PTCBio
#duchennecan celebrates individuals living with Duchenne muscular dystrophy. With #rarediseaseday approaching, we invite you to visit www.duchennecan.com to read their stories, watch a panel discussion and listen to the Take on Duchenne North America podcast.
-
PTC Therapeutics
@PTCBio
#rarediseaseday will be here soon! Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder that affects the brain. Hear from Judy and Richard Poulin about early experiences with their daughter Rylae-Ann, a child living with AADC deficiency. @edu4rare
-
PTC Therapeutics
@PTCBio
The #rarediseaseday official video illustrates the diverse experiences of the rare disease community. Thank you to EURORDIS-Rare Diseases Europe and its partners for creating such a powerful video to represent the patient voice. Watch here: www.youtube.com/watch?v=zEQ828Lkxac
-
PTC Therapeutics
@PTCBio
This #rarediseaseday, we're looking forward to supporting members of the rare disease community like Jenna, a Huntington’s disease patient and advocate. The story of her diagnosis is a bit different, and she has grown to feel grateful for it: www.ptcbio.com/2023/05/08/jenna-woodard-the-hd-community-…
-
PTC Therapeutics
@PTCBio
We’re proud to be a part of the collective efforts to advance research and knowledge about #aadcdeficiency. Congratulations to all on this important publication.
Teach RARE
@edu4rare
We are proud to help publish this paper with passionate healthcare professionals. #raredisease patients are benefiting from #genetherapy. We will support others in their journey to care for their children, access resources, support research, and advocate for awareness:
-
PTC Therapeutics
@PTCBio
Congrats to our partner Almighty Tree! They helped plant 20K trees in Switzerland in 2023.
For 2 years, our colleagues planted 100 trees w/ Almighty Tree. Read about our sustainability efforts: ir.ptcbio.com/annual-reports-and-proxy/sustainability-rep… #socialimpact #socialresponsibility #committedtodoingourpart -
PTC Therapeutics
@PTCBio
ICYMI: The recording of our presentation at the 42nd Annual J.P. Morgan Healthcare Conference is now available. Please visit our website to listen and view the presentation slides: ir.ptcbio.com/events/event-details/42nd-annual-jp-morgan-… #jpm2024 #jpm24 #ptct
-
PTC Therapeutics
@PTCBio
This morning, PTC shared key points its CEO Matthew Klein will cover in the company presentation at the 42nd Annual J.P. Morgan Healthcare Conference. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…… #jpm2024 #jpm24 #ptct
-
PTC Therapeutics
@PTCBio
We’re looking forward to presenting a company overview tomorrow morning at the 42nd Annual J.P. Morgan Healthcare Conference. Please join us in-person and online: ir.ptcbio.com/events/event-details/42nd-annual-jp-morgan-… #jpm2024 #jpm24 #ptct
-
PTC Therapeutics
@PTCBio
Our approach to corporate social responsibility is rooted in commitment to patient advocacy, access to treatments and advancing science. Here are a few of these moments from 2023. Learn more: ir.ptcbio.com/sustainability-reports #socialimpact #socialresponsibility #committedtodoingourpart
This media couldn't be displayed. See it on the original post. -
PTC Therapeutics
@PTCBio
This morning, PTC shared that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8 at 7:30 a.m. PST/10:30 a.m. EST. Read the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #jpm2024 #jpm24 #ptct
-
PTC Therapeutics
@PTCBio
What a remarkable #duchennecan year it has been! We met a number of individuals living with #duchenne who prove to the world that anything is achievable, despite the initial circumstances or condition. Help us share these inspiring journeys at www.duchenne.com.
-
PTC Therapeutics
@PTCBio
PTC is proud to support patient advocacy organizations like Finn's Friends. Finn's Friends provides family assistance to those affected by #duchenne muscular dystrophy. Check out the nonprofit's recently launched website, finnsfriends.net.
-
PTC Therapeutics
@PTCBio
Check out our newest episode of #takeonduchenne where dietitian and #dmd caregiver Dr. Kindann Fawcett explores the importance of healthy nutrition, weight management, and advocacy for people with #duchenne.
Listen here: www.ptcbio.com/podcast-take-on-duchenne-north-america/ -
PTC Therapeutics
@PTCBio
Mark Boulding and Tyler Bryk were honored to attend today's press conference where plans were announced to establish an #artificialintelligence hub in New Jersey. Learn more about this #ai news: nj.gov/governor/news/news/562023/approved/20231218a.shtml
-
PTC Therapeutics
@PTCBio
There are many things that make PTC Therapeutics truly unique, and the splicing platform is one of them. Read about the splicing platform and the passionate research team employing this technology: www.ptcbio.com/posts/a-whole-team-in-one-molecule-ptcs-sp…
-
PTC Therapeutics
@PTCBio
We partnered with the SMA Foundation and Roche to deliver innovative treatment options for young people with #sma and their families. Read more about this unique partnership and collaboration: www.roche.com/stories/navigating-a-historic-alliance-for-sma
-
PTC Therapeutics
@PTCBio
We’re excited to recognize Lakshmi Sreekumar, Patrice Thorton and Heidi Eliana Mateus for working toward a more inclusive, equal and empowered future with the announcement of our Women’s International Network (W+IN) WOW Women Award recipients. #equity #diversity #inclusion
-
PTC Therapeutics
@PTCBio
In 2023, PTC opened its affiliate office in Kazakhstan and hired its first employees. Today, the team is well positioned to continue improving the lives of patients with rare diseases and their families. Read more: www.ptcbio.com/posts/ptcs-new-horizons-in-kazakhstan/
-
PTC Therapeutics
@PTCBio
We’re looking forward to PKUGLOBE23 December 13-19. Join us and the PKU community through online chats and programs live and on demand. Participants can select preferred time zones and pick and choose which days to attend. To register, visit www.pkuglobe.org.
-
PTC Therapeutics
@PTCBio
PTC’s Dr. Jens Gruenert and Kristina Kempf recently authored an article about the differential diagnosis of #epilepsy and #aadcd. Learn more in the latest publication of epiKurier, a magazine in Germany: www.epikurier.de/aktuelle-ausgabe/wenn-der-schein-truegt/ Use translation to read in your preferred language.
-
PTC Therapeutics
@PTCBio
#newbornscreening holds tremendous promise to propel breakthroughs in disease genes discovery and can positively impact the #raredisease diagnostic journey. We're proud to be involved in this project.
Please read more below about the @Screen4Care approach.
Screen4Care
@Screen4Care
🎉New #screen4care publication in the PLoS ONE journal!
✍ Genetic Newborn Screening and Digital Technologies: A Project Protocol Based on a Dual Approach to Shorten the Rare Diseases Diagnostic Path in Europe
#raredisease #newbornscreening #openaccess
journals.plos.org/plosone/article?id=10.1371/journal.pone… -
PTC Therapeutics
@PTCBio
Luke and Elliott share a special bond to #duchenne and a great friendship. Their shared experiences have led the two young men to great new paths and careers. Read more in this interview with #duchennecan: www.ptcbio.com/posts/luke-elliott-two-paths-to-duchenne/
-
PTC Therapeutics
@PTCBio
At PTC, patients are our priority and so is their safety. In this article, we highlight the important role our Pharmacovigilance team plays in ensuring patient safety is a top health priority. Read more: www.ptcbio.com/posts/an-important-job-and-rewarding-career/
-
PTC Therapeutics
@PTCBio
Last night, our Talent Pipeline Program was recognized with the Avenica Early Careers Pioneer Award. The program was highlighted as a leading example of nurturing early careers talent with a callout to support during the year and a focus on DE&I. #tiara2023
-
PTC Therapeutics
@PTCBio
Helping patient communities is a core part of our mission at PTC. Ahead of Sunday, which is #pkuawareness Day, we're excited to share Neil Smith’s motivation and trust in science that help him stay focused and work to improve peoples’ lives. Read more: www.ptcbio.com/posts/25-remarkable-stories-improving-the-…
-
PTC Therapeutics
@PTCBio
The United Nations has officially designated September 7 as World Duchenne Awareness Day. Congratulations to the dedicated patients, caregivers, advocacy organizations and community partners for reaching this incredible milestone! Read more: www.prnewswire.com/news-releases/united-nations-officiall…
-
PTC Therapeutics
@PTCBio
We partnered with the Universidad de La Sabana to offer "Corporate Communication and Organizational Assertiveness: The Basics of Leadership" for ~20 patient associations from the SAM region. We're honored to be in Bogotá, Colombia this week for the in-person closing session.
-
PTC Therapeutics
@PTCBio
Healthcare professionals are invited to a free webinar at 18:00 CET (12pm EST) on December 7 to explore the totality of evidence for a treatment for nonsense mutation #duchenne muscular dystrophy (nmDMD). Live translation will be available. Register here: ptcwebinars.com/dmd/q4/
-
PTC Therapeutics
@PTCBio
Please join us this Thursday, Nov. 30 for a discussion about the totality of evidence for an nmDMD treatment option and the transition of care for patients with nmDMD. Register for #icnmdigital: icnmd.org/registration-icnmdigital-2023/ #dmd #nmdmd #duchenne
-
PTC Therapeutics
@PTCBio
PTC is proud of its efforts to foster intercultural diversity and inclusion. Our Multicultural Alliance Group of Inclusive Communities employee resource group was recognized for its Intercultural Intelligence Academy Program at the #diversityandwellbeingawards last week.
-
PTC Therapeutics
@PTCBio
Jessica Fabus Cheng takes the DuchenneCan crown! A woman of extraordinary strength and resilience shares her personal #duchenne story and how she is empowering others to reveal their powers. Read more: www.ptcbio.com/posts/jessica-fabus-cheng-takes-the-duchen…
#duchennecan -
PTC Therapeutics
@PTCBio
Join us for a virtual symposium on November 30 as Profs Alexandra Prufer, Luca Bello, and Rosaline Quinlivan discuss the totality of evidence for an nmDMD treatment option and the transition of care for patients with nmDMD. Register for ICNMDigital: icnmd.org/registration-icnmdigital-2023/ #dmd
-
PTC Therapeutics
@PTCBio
Congratulations to our colleagues in Brazil for their work on three creative and impactful projects recently recognized for raising awareness of rare diseases! Learn more in our newsroom: www.ptcbio.com/posts/ptc-team-in-brazil-earns-three-awards/
-
PTC Therapeutics
@PTCBio
Stop by booths 529 and 531 to meet our team at the @AmEpilepsySoc Annual Meeting! Learn about #genetictesting for patients with suspected neurotransmitter disorders, as well as #aadcdeficiency as a potential underlying diagnosis in patients with suspected seizures. #aadcd
-
PTC Therapeutics
@PTCBio
This #nationalfamilycaregiversmonth, we'd like to highlight our PTC Cares™ team. They are honored to support #raredisease families and provide the expertise needed to help make the process of getting treatment easier. Learn more: ptccares.com
-
PTC Therapeutics
@PTCBio
We were honored to join the @JeffFoundation Saturday in Columbia, MO for its family workshop! These events empower patients and families to be their own best advocates, spread awareness about #duchenne in the medical field, and help accelerate R&D. #fightdmdtogether
-
PTC Therapeutics
@PTCBio
HCPs are invited to explore the totality of evidence for a treatment for nonsense mutation #duchenne muscular dystrophy (nmDMD) on December 7 in a webinar beginning at 18:00 CET (12pm EST). Live translation available. Register today: ptcwebinars.com/dmd/q4/
-
PTC Therapeutics
@PTCBio
Meet Áine Hopkins, Stephen Keane, Sian O’Neill and Calum Sinclair, who work in different areas of the business but make a positive difference for #raredisease patients and their families around the globe. Read more in this article from The @IrishTimes: www.irishtimes.com/advertising-feature/2023/09/27/bringin….
-
PTC Therapeutics
@PTCBio
Members of our Patient Engagement team grabbed a moment with Lisa Milberg, Executive Director of the @NPKUA_Info, during the Lifting the Limits gala in Houston this weekend. Frank and Anne were honored to meet several families in attendance and members of the NPKUA team. #pku
-
PTC Therapeutics
@PTCBio
Nearly 200 colleagues came together in New Jersey offices last week to celebrate the start of Diwali, India's biggest holiday of the year. Organized by the Asian Pacific Islander employee group, this was an opportunity to learn about different cultures and bring people together.
-
PTC Therapeutics
@PTCBio
Our colleagues in Switzerland partnered with Almighty Tree to give back to the environment by planting 100 trees. Tree planting is one way the PTC team is working to create a sustainable future. Read more: www.ptcbio.com/2023/11/10/ptc-gives-back-to-the-environment/
-
PTC Therapeutics
@PTCBio
Here are the top 3 considerations our multicultural alliance group considered when initiating a new equity, diversity and inclusion program at PTC: insights.citeline.com/IV148597/Global-Pharma-Companies-Mu… #edi #interculturalintelligence #culture @INVIVOnow @JesseSibarium
-
PTC Therapeutics
@PTCBio
Thank you @SmileyNews for featuring Sebastien and his son! They are a great example of what people with #duchennecan do. Their commitment to helping improve accessibility is about giving people with disabilities the choice, freedom, and opportunity to live independently.
Smiley News
@SmileyNews
This dad wants his son to be able to travel the world - wheelchair or no wheelchair 👨🦼
Meet Sebastien, whose son has Duchenne Muscular Dystrophy, and wants to make the world more accessible #ungoals #goal10 #reducedinequalities
@PTCBio
smileymovement.org/news/the-tool-making-travel-more-acces… -
PTC Therapeutics
@PTCBio
There were many high points for the PTC team throughout #hsg2023, but perhaps the favorite was the opportunity to meet with HD investigators, researchers, patients and families from across the globe. Thank you, @HuntingtonSG! #huntingtonsdisease
-
PTC Therapeutics
@PTCBio
Join us at 7 p.m. EST on Wednesday, Nov. 29 for “Going to College with a Personal Care Attendant,” part of our Accessible College Series, with guest speakers Annie Tulkin, MS and Adrienne Frumberg, M.A. Register today: ptcbio.zoom.us/webinar/register/WN_uW849gkIShuLhP8DVToqdw
-
PTC Therapeutics
@PTCBio
Gabe Holdsman and Ashley Lynam of @MMWR_Law will present “The Future of Restrictive Covenants: Legal Updates & Corporate Strategies." For more info about the @ACCinhouse Greater Philadelphia Litigation Conference, visit www.acc.com/education-events/2023/november-9-2023-person-….
-
PTC Therapeutics
@PTCBio
Felix Wu is a PhD student living with #duchenne who is improving workplace outcomes for people with disabilities and breaking down barriers. Learn more about @IOFelixWu's inspiring research: www.ptcbio.com/posts/felix-can-improve-workplace-outcomes…
#duchennecan -
PTC Therapeutics
@PTCBio
The Government Affairs team recently welcomed colleagues to Washington, D.C. to champion policies that improve patient access, spur innovation, and reduce barriers to rare disease drug development.
-
PTC Therapeutics
@PTCBio
Join our employees for a panel on Wednesday, Nov. 8 at Montclair State University’s Feliciano School of Business to learn about career paths and opportunities that can lead to a STEM-related job and much more!
-
PTC Therapeutics
@PTCBio
Posters highlighting Phase 2 data from our Huntington’s disease program will be showcased at the upcoming 30th Annual Meeting of the Huntington Study Group in Phoenix. #hsg2023 #huntingtonsdisease
-
PTC Therapeutics
@PTCBio
PTC’s U.S. Patient Engagement team has worked hard to support patients and their families in the Spanish-speaking #raredisease community. Read more about the team’s efforts and Spanish-language resources: www.ptcbio.com/posts/supporting-the-spanish-speaking-comm… #nationalfamilycaregiversmonth
-
PTC Therapeutics
@PTCBio
What happens when you tell a mother of a child with a rare disease that something is “too complicated for her to understand”? Jessica Fein interviews Kelly Heger, mother of four, including Jillian who lives with #aadcdeficiency, to learn more: www.idontknowhowyoudoit.com/2121591/episodes/13822337
-
PTC Therapeutics
@PTCBio
We’re looking forward to attending and sponsoring the @ctosociety meeting. Here are our poster presentation titles, which will include updated data from the phase 1b study of our investigational treatment for patients with advanced leiomyosarcoma (LMS). #ctos2023
-
PTC Therapeutics
@PTCBio
We were grateful to attend @TheAkarifoundat's Spanish Conference on Saturday at Valley Children’s Hospital in Fresno, CA. It was so nice to spend time with the families and to share our educational materials, all in Spanish, at the PTC Momentos de Claridad booth. #duchenne
-
PTC Therapeutics
@PTCBio
This afternoon, PTC shared a corporate update and financial results for the third quarter ending September 30, 2023. Read the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
HCPs are invited to attend Session 12 in Shed 2A on Friday entitled "From Advanced Translational Studies to Approved Therapies," where Prof. Hwu will present his findings from long-term clinical trials for #aadcdeficiency at the @ESGCT 30th Annual Congress.
-
PTC Therapeutics
@PTCBio
#icymi France defeated England in a thrilling Final to take the #fipfaworldcup2023! In media coverage, #powerchairfootball is said to help shift the way people living with disabilities are viewed. Learn more: www.ptcbio.com/posts/france-takes-the-2023-fipfa-powercha… #fipfapowerchairworldcup2023
-
PTC Therapeutics
@PTCBio
Our teammates pause for a moment at our booth (No 40 & 42) at the #esgct2023 Annual Congress. Yesterday, @_RafaelSierra presented during a symposium for healthcare professionals entitled, “Breaking Down Barriers: Bringing the Benefits of Gene Therapies to Patients.”
-
PTC Therapeutics
@PTCBio
PTC leaders will hold a webcast this Thursday, Oct. 26 to report our Q3 2023 financial results and provide an update on the company's business and outlook. Read more and register for the dial-in details: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
The PTC team recently attended the FARA Energy Ball for the @CureFA_org. In 14 years, this event has spread awareness of FA and raised $17M+. #curefa
-
PTC Therapeutics
@PTCBio
As “REBEL in a wheelchair,” Juan transformed from a defiant teen living with SMA to an established author, life coach and more, helping teens with #duchenne find their path. Read how Juan turned himself into the ultimate rebel WITH a cause: www.ptcbio.com/posts/juan-morales-the-rebel-in-a-wheelchair/ #duchennecan
-
PTC Therapeutics
@PTCBio
Congratulations to France's Momo Ghalami. You were amazing!
FIPFA
@OfficialFIPFA
The incredible Momo Ghalami was the deserved recipient of the @PTCBio Players’ Player Award of the 2023 FIPFA Powerchair Football World Cup! 👏🇫🇷
📸: @sgphotos1
#powerchairfootball #fipfapowerchairworldcup2023 -
PTC Therapeutics
@PTCBio
Darrel Nicklow has followed every #powerchairfootball game this week and brings us highlights from the #fipfapowerchairworldcup2023, where France was crowned the champion. #fipfaworldcup2023 Watch here: www.youtube.com/watch?v=2ZEhFI7oYCY
-
PTC Therapeutics
@PTCBio
You’re invited to participate in the AADC Family Network's #aadcdeficiency Awareness Day online event at 11 a.m. EDT on Monday, Oct. 23. #aadcd RSVP: www.facebook.com/events/308473441666963
-
PTC Therapeutics
@PTCBio
Darrel Nicklow shares his favorite moments from Wednesday, including a rebound goal from France, precise passes from Denmark and unstoppable corner plays from the USA. Watch the highlights: youtu.be/gL56Lq_2WNM #fipfaworldcup2023 #fipfapowerchairworldcup2023 @OfficialFIPFA
-
PTC Therapeutics
@PTCBio
Yanni Tomazos, Neil Smith and others are in Birmingham for the 37th #espku2023 Conference to learn and share the latest clinical advancements in #pku. In addition to our booth and Silver level sponsorship, PTC will present three posters. @official_espku
-
PTC Therapeutics
@PTCBio
This morning, the company announced an agreement with Royalty Pharma plc. to monetize up to $1.5 billion of the Evrysdi® royalty stream to fund planned operations. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
The #fipfaworldcup2023 kicked off with an impressive match between Australia and the United States. We're pleased to bring you the highlights, prepared by Darrel Nicklow: www.youtube.com/watch?v=d67d2kvzo-0 #powerchairfootball
-
PTC Therapeutics
@PTCBio
This afternoon, the company shared that our leaders would host a webcast conference call at 4:30 p.m. ET on Oct. 26 to discuss our third quarter 2023 financial results and provide an update on our business. Learn more in this press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
With #aadcdeficiency Awareness Day around the corner, @_RafaelSierra shares his perspective on why disease registries are a valuable tool in understanding the disease progression and the natural history of rare conditions, like AADCd, in the real world: www.ptcbio.com/posts/aadcaware-registry-an-example-of-the…
-
PTC Therapeutics
@PTCBio
PTC #powerchairfootball fans are cheering their teams to the #fipfaworldcup2023. There are only 2 days left, and the excitement is growing! Who will you be supporting? Comment below.
-
PTC Therapeutics
@PTCBio
Juan Bautista D’Angelo is getting ready for his first #fifaworldcup2023, playing for the Argentinian national #powerchairfootball team. Coach Sebastián reveals the team is ready to challenge the world’s best. Learn more about Argentina's fighting spirit: www.ptcbio.com/posts/argentina-powerchair-football-nation…
-
PTC Therapeutics
@PTCBio
Scott Hilland and Sean McKinney are ready to score some goals for Northern Ireland at the #fifaworldcup2023! The two young men bring a total of 19 years of #powerchairfootball experience to the game and are poised to achieve the “unexpected”! Read more: www.ptcbio.com/posts/introducing-northern-ireland-the-ris…
-
PTC Therapeutics
@PTCBio
After just the first try at #powerchairfootball (soccer), Tyler Hernandez "fell in love" with the sport, leading to a 20-year career. Listen as Darrel Nicklow and Tyler share some valuable insider tips! www.youtube.com/watch?v=G3Z87Q72f2U #fipfaworldcup2023
-
PTC Therapeutics
@PTCBio
#hsg2023 is set for November 2-4 in Phoenix. Dr. Amy-Lee Bredlau will present during the Clinical Trial Round-Up on Friday, and during the Research Blitz: New & Upcoming Studies with Q&A on Saturday. Register by October 17 and join us! huntingtonstudygroup.org/annual-meeting/hsg-2023/ #huntingtonsdisease
-
PTC Therapeutics
@PTCBio
There are many ways that people living with #rarediseases and their loved ones can be advocates! Learn more about advocating on behalf of a diagnosis and disease awareness: www.ptcbio.com/posts/advocacy-in-action-diagnosis-disease…
-
PTC Therapeutics
@PTCBio
In this interview, Juan shares his experience playing #powerchairfootball. The young men, both living with #duchenne muscular dystrophy, have a message for those considering joining the sport. Watch now and subscribe to Darrel's channel: www.youtube.com/watch?v=QJTgUxVHQ_E #fipfaworldcup2023
-
PTC Therapeutics
@PTCBio
The Republic of Ireland is one of the nations competing at this year’s #fifaworldcup2023. Our PTC colleagues had the pleasure to attend one of their training sessions and witness firsthand extraordinary #powerchairfootball. Read more: www.ptcbio.com/posts/climbing-the-ranks-in-powerchair-foo…
-
PTC Therapeutics
@PTCBio
Thanks for sharing this information on our #als clinical trial, @ALSTDI.
ALS TDI
@ALSTDI
Welcome to the latest episode of Endpoints Shorts, presented by ALS TDI. Our guide for this series will be Dr. Nadia Sethi, ALS TDI’s Director of Community Outreach and Engagement. Today, Nadia talks about @ptctherapeutics' phase 2 trial for PTC 857. www.als.net/endpoints/500029/
-
PTC Therapeutics
@PTCBio
The countdown is ON! Join us on October 15 for #powerchairfootball at its best.
FIPFA
@OfficialFIPFA
𝟏𝟎 𝐃𝐀𝐘𝐒 𝐓𝐎 𝐆𝐎! 💥
#powerchairfootball #fipfapowerchairworldcup2023 -
PTC Therapeutics
@PTCBio
The @HopeforGus Foundation just hiked to Mount Everest Base Camp! “Everest to End Duchenne” raises funds for #duchenne muscular dystrophy research. Congrats to this group for honoring boys with Duchenne who couldn’t trek themselves due to this disease. everesttoendduchenne.org
-
PTC Therapeutics
@PTCBio
The PTC LATAM team has made an incredible impact on the #raredisease community in SAM and Brazil. Read more: www.ptcbio.com/posts/managing-complexity-with-passion/
-
PTC Therapeutics
@PTCBio
We are in Vancouver for the 52nd Child Neurology Society Annual Meeting, October 4-7. Please join us for poster presentations 12:30-2 p.m. PDT and 5:30-7 p.m. PDT on Thursday, Oct. 5. #cnsam #cns @ChildNeuroSoc
-
PTC Therapeutics
@PTCBio
Pat Furlong is the driving force behind @ParentProjectMD, a patient advocacy organization that has had an immense impact on the #duchenne community. Read more about Pat’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-the-primary-ca…
-
PTC Therapeutics
@PTCBio
Talking to Jonathan Bolding, England’s #powerchairfootball captain, we understand why the sport is so attractive. Jonathan’s 21-year career is filled with memories. #fifaworldcup2023 @jbolding8 Check out this Q&A to learn about his journey: www.ptcbio.com/posts/introducing-jonathan-bolding-england…
-
PTC Therapeutics
@PTCBio
We're looking forward #wms2023, Oct. 3-7, for our sponsored symposium as well as our poster presentations. We will share the latest data from our STRIDE Registry, the first and largest real-world study of patients with nonsense mutation #duchenne muscular dystrophy, on Oct. 6.
-
PTC Therapeutics
@PTCBio
We connected with Judit Illes, Director, Government Affairs & Public Policy, PTC to learn more about #newbornscreening and key takeaways from the new white paper, “Pioneering the New Era of Newborn Screening.” Read more: www.ptcbio.com/posts/roadmap-to-newborn-screening-changes…
#newbornscreeningawarenessmonth -
PTC Therapeutics
@PTCBio
4,000 people are diagnosed with #leiomyosarcoma (#lms) each year in the U.S. For #rarecancerday, we connected with Mark Rance in Clinical Development to learn more about this #rarecancer and his motivation for helping those impacted by it. Read more: www.ptcbio.com/posts/qa-with-mark-rance-on-ptcs-work-in-l…
-
PTC Therapeutics
@PTCBio
Insightful Moments My VIBE shares experiences from patients like Lauren, Abigail and Sam. Hear from these individuals and others about the importance of #newbornscreening in #pku in Season 1 Episodes 5-7: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
#newbornscreeningawarenessmonth #raredisease -
PTC Therapeutics
@PTCBio
.@BioNJ_Org's Patient Advocacy Summit will be held on Thursday, Nov. 16 in Princeton, NJ and virtually. Patients, caregivers, clinicians and R&D professionals are encouraged to attend. For more information and to register, visit bionj.org/event/2023-bionj-patient-advocacy-summit/. #patientadvocacy
-
PTC Therapeutics reposted
National Ataxia Foundation
@NAF_Ataxia
Today is #internationalataxiaawarenessday! Share and like this post to create #ataxiaawareness. We'll be posting all day so follow along.
-
PTC Therapeutics
@PTCBio
Kyle Bryant's Friedreich ataxia diagnosis at age 17 first drove him to a recumbent trike. Today, on International Ataxia Awareness Day, we stand with patient advocacy groups to raise awareness about this rare neurological disease. #iaad23 Learn about Kyle: www.ptcbio.com/posts/25-remarkable-stories-riding-through…
-
PTC Therapeutics
@PTCBio
Learn how trauma can affect a family after a #raredisease diagnosis and which strategies to use to help take back your life during our free webinar at 7 p.m. EDT this Monday, Sept. 25. Register today: ptcbio.zoom.us/webinar/register/WN_XwRfhHySQSe8OyFw_xI96w. We look forward to seeing you there!
-
PTC Therapeutics
@PTCBio
Join us on LinkedIn next week to test your knowledge about #powerchairfootball and the #fipfaworldcup2023. Luke Millington, PTC employee and wheelchair football player, will deliver a question - and answer - every day of the week! Follow us here: www.linkedin.com/company/ptc-therapeutics/
-
PTC Therapeutics
@PTCBio
At PTC, we are passionate about improving the lives of people affected by rare diseases. Our global leaders share why this collaboration holds tremendous potential to make a positive impact in the community. Read more here: www.ptcbio.com/posts/ptcs-top-3-goals-for-the-fipfa-power… #fipfaworldcup2023
-
PTC Therapeutics
@PTCBio
Inspired by the incredible impact patient advocacy groups make on the #duchenne community, we launched the STRIVE Awards Program in 2015. Read more about the Remarkable Story of STRIVE: www.ptcbio.com/posts/25-remarkable-stories-supporting-the… #committedtodoingourpart
-
PTC Therapeutics
@PTCBio
We’ll be in Houston to support the National Leiomyosarcoma Foundation's Research Roundtable. We look forward to being a part of the discussions and helping to advance knowledge and awareness about this rare cancer. @NationalLMSF #lms
-
PTC Therapeutics
@PTCBio
We’re excited to be named a finalist in the “Biotech Company of the Year” category by Scrip Awards! Scrip Awards recognize achievements in improving human health.
Congrats to the other finalists! We look forward to seeing you at the awards ceremony on November 16 in London. -
PTC Therapeutics
@PTCBio
T-23 days: Join us on October 15 for the #fipfaworldcup2023! (Great photos, Scot)
FIPFA
@OfficialFIPFA
𝟏 𝐌𝐎𝐍𝐓𝐇 𝐓𝐎 𝐆𝐎! 🤩
In just 30 days, ten powerhouse nations will gather in Sydney to compete for the sport's ultimate prize; the 2023 FIPFA Powerchair Football World Cup! 🏆🌏
📸: Scot Goodman
#powerchairfootball -
PTC Therapeutics
@PTCBio
Six of our teammates logged in this morning for Day 1 of the 2023 @NDC_Diversity Latino Leadership Conference, hosted by the Council for Latino Workplace Equity. They are all members of PTC's Organization of Hispanic/LatinX Allies (OHLA) Employee Resource Group.
-
PTC Therapeutics
@PTCBio
We’re proud of Chetuan Shaffer, Director, Trademark Counsel at PTC, who will be serving as a moderator at the WIPR Trademarks North America 2023 conference, September 19-20, in San Diego, CA. For more information, visit www.trademarksnorthamerica.com. #wiprtrademarkna @WorldIPReview
-
PTC Therapeutics
@PTCBio
You're invited to a free webinar one week from today with Jill Castle, M.ED. Join us at 7 p.m. EDT on September 25 for this Insightful Moments™ program and learn how trauma can affect a family after a #raredisease diagnosis. Register here: ptcbio.zoom.us/webinar/register/WN_XwRfhHySQSe8OyFw_xI96w
-
PTC Therapeutics
@PTCBio
Our teammates can’t wait for the @NPKUA_Info's “Lifting the Limits” Gala. It's an honor to be a part of this event to celebrate the work of patients and families in the #pku community and the ongoing advancements in research.
-
PTC Therapeutics
@PTCBio
Let's unite for the Midwest's largest #als gathering on Saturday, Sept. 23, where we'll walk two miles along the lakefront and around Soldier Field in Chicago. For more information about this event, visit lesturnerals.org/events/walk-for-life/. @LesTurnerALS
-
PTC Therapeutics
@PTCBio
This #wdad2023 was all about ‘Breaking Barriers’ and #duchennecan is pleased to present a number of remarkable individuals who are doing just that! Click to read their stories: duchennecan.com.
-
PTC Therapeutics
@PTCBio
We are inspired by Arzu Mulayim, Senior Director, Medical Affairs at PTC and her dedication to helping those affected by the earthquake in Turkey this year. Learn more about her efforts: www.ptcbio.com/posts/arzus-dedication-to-a-cause-professi…
-
PTC Therapeutics
@PTCBio
Our team is headed to San Diego for @GlobalGenes’ 2023 RARE Advocacy Summit, Sept. 19-21. They’re excited to meet #raredisease families at the Insightful Moments booth and help share their stories in our My VIBE podcast. Listen to current episodes: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
-
PTC Therapeutics
@PTCBio
We're pleased to share our featured article with Professor Thomas Sejersen discussing #duchenne transition of care. Professor Sejersen is a pediatric neurologist focusing on neuromuscular diseases in children. Read the article below to learn more:
RARE Revolution Magazine®
@RareRevolutionM
Increasing numbers of boys with #duchennemusculardystrophy (#dmd) are reaching adulthood. Professor Thomas Sejersen explains how ensuring continuous high-quality care during transition from paediatric to adult care teams must be a priority. Read here: rarerevolutionmagazine.com/transitioning-successfully-fro…
-
PTC Therapeutics
@PTCBio
We asked Luke Millington, our own PTC employee and wheelchair football player, why he is passionate about the sport. Watch the video to learn why Luke has been playing for almost 12 years to date.
-
PTC Therapeutics
@PTCBio
PTC leaders will provide a company overview at 1:35 p.m. EDT on Monday, Sept. 11 from the Morgan Stanley 21st Annual Global Healthcare Conference 2023. Listen here: ir.ptcbio.com/events/event-details/morgan-stanley-global-… #ptct
-
PTC Therapeutics
@PTCBio
This #wdad2023, we're thrilled to announce our 2023 #striveawards recipients. Congrats to the organizations whose projects will provide incredible support to the #duchenne communities in Australia and Brazil. @SaveOurSons Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
"The newborn screening system is foundational to the early detection of newborns with treatable, rare conditions but needs reform to accommodate innovative diagnostics and treatments,” says Judit Illes, Director of Government Affairs & Public Policy and white paper contributor.
EveryLife Foundation
@EveryLifeOrg
We're thrilled to unveil a new white paper: Pioneering the New Era of #newbornscreening with help from over 100 #nbs stakeholders. Together, we've charted a roadmap for a more comprehensive, efficient, and inclusive screening process.
Read Here: www.rareadvocates.org/nbs-white-paper/ -
PTC Therapeutics
@PTCBio
Register today for our our free webinar on September 13: ptcwebinars.com/dmd/q3/
HCPs are invited to attend, “Navigating the changing disease landscape: Continuity of care in nonsense mutation Duchenne muscular dystrophy," a one-hour webinar beginning at 12:00 EDT. -
PTC Therapeutics
@PTCBio
Join us for a company overview at 9:40 a.m. EDT on Wednesday, Sept. 6 at the Citi 2023 18th Annual BioPharma Conference. Listen here: ir.ptcbio.com/events/event-details/citi-2023-18th-annual-… #ptct
-
PTC Therapeutics
@PTCBio
In honor of World Duchenne Awareness Day, we invite you to join us for a daily quiz beginning Monday to learn more about #duchenne muscular dystrophy. Answers will be shared on Friday, Sept. 8. Follow us on LinkedIn to participate: www.linkedin.com/company/ptc-therapeutics/ #wdad2023
-
PTC Therapeutics
@PTCBio
“Just hang tight.”
This is Linda’s advice to the younger generation with #pku. Hear why she is so excited about the research being done for PKU in our Insightful Moments™ My VIBE podcast Episode 6, “Living with PKU, with Linda and Kendall.” Listen here: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an… -
PTC Therapeutics
@PTCBio
Last week, Jennifer Roan, PTC’s VP and GM of U.S. Neurology, joined @CenterForwardUS' Innovation Conference to discuss the unique challenges of #raredisease drug development and the impacts recent legislative actions have had on innovation with bipartisan Congressional staff.
-
PTC Therapeutics
@PTCBio
Join us September 7 at @HelpCureHD's 3rd annual event! “Innovators in Neurology and Fertility: Hope, Resilience, and an Eye on the Future,” will take place 8 a.m.-1 p.m. CDT at the C. Baldwin hotel in Houston. Admission is free for the #hd community and students.
-
PTC Therapeutics
@PTCBio
PTC leaders will present a company overview at these upcoming investor conferences: Citi 2023 18th Annual BioPharma Conference, Morgan Stanley 21st Annual Global Healthcare Conference 2023 and 2023 Cantor Global Healthcare Conference. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
The Global Patient Engagement team at PTC has impacted #raredisease communities around the world through the passion and care they have for the patients they serve. Read more about the PE team’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-supporting-and…
-
PTC Therapeutics
@PTCBio
Proud to partner with Roche and the SMA Foundation to get this important treatment to babies living with SMA.
Roche
@Roche
#media The European Commission has approved our treatment for spinal muscular atrophy for those aged under two months, bringing another therapeutic option to even the youngest of babies living with #sma.
Read more: www.roche.com/media/releases/med-cor-2023-08-29
$ROG $RHHBY -
PTC Therapeutics
@PTCBio
If you are an HCP attending the Society of Inborn Errors of Metabolism (#ssiem) 2023 Symposium, please join us tomorrow for our symposium discussing aromatic L-amino acid decarboxylase deficiency (#aadcdefieciency #aadcd). We invite you to also stop by booth A09 to meet our team!
-
PTC Therapeutics
@PTCBio
This morning we shared that PTC would present data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023. Learn more about our oral presentation, poster and symposium in our press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #pku @SSIEM2023
-
PTC Therapeutics
@PTCBio
Congratulations to our Board of Directors member Mary Smith! She was recently sworn in as the President of the @ABAesq - the first Native American woman to hold this role. Big smiles all around with friend and colleague Mark Boulding, EVP and Chief Legal Officer. @ABAPresident
-
PTC Therapeutics
@PTCBio
Karina Lambertini and Pat Clougherty had the privilege to attend a “Camp Day” organized by The Ronnie Sherrill Project. More than 150 people from the neuromuscular community enjoyed a day of fun activities, music, food and friends. To learn more, visit www.trsp.org.
-
PTC Therapeutics
@PTCBio
“No one said it would be easy,” says Dr. Welch, who has been tackling #duchenne in the lab for more than 25 years. In this extended #takeonduchenne episode, she speaks about the advancements in #dmd and how science is forging new pathways for patients. www.ptcbio.com/podcast-take-on-duchenne-north-america/
-
PTC Therapeutics
@PTCBio
Join Annie Tulkin and Adrienne Frumberg, M.A, Founder of Lighthouse Guidance for “Transitioning to College with a Physical Disability or Chronic Health Condition.” This free webinar will begin at 7 p.m. EDT next Wednesday, Aug. 30. Register today: ptcbio.zoom.us/webinar/register/WN_GdGcc_Q6SvuditC1pKXHow
-
PTC Therapeutics
@PTCBio
For Everette Brown, Executive Director, Global Talent Acquisition, the #culture at PTC is the “Secret Sauce” that attracts top talent. Read more about Everette’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-a-sustaining-t…
-
PTC Therapeutics
@PTCBio
PTC’s podcast My VIBE gives #raredisease patients, caregivers, families and friends a forum to share their story and journey living with a rare disease. Learn more: www.ptcbio.com/posts/my-vibe-every-story-deserves-to-be-t…
-
PTC Therapeutics
@PTCBio
PTC leaders recently discussed our Q2 2023 financial results and provided a corporate update and business outlook. #icymi, you can listen to the recording here: ir.ptcbio.com #ptct
-
PTC Therapeutics
@PTCBio
Healthcare professionals are invited to attend our webinar, “Navigating the changing disease landscape: Continuity of care in nonsense mutation Duchenne muscular dystrophy” on September 13. Register today: ptcwebinars.com/dmd/q3/ #duchenne
-
PTC Therapeutics
@PTCBio
If you're attending the RNA Assay Development & Screening Summit, Aug. 23-24 in Boston, join Wencheng's session, "High-Throughput RNA Sequencing Screening to Accelerate Disease Target and Small Molecule Hit Identification." There's still time to register: ter.li/8ixa42
-
PTC Therapeutics
@PTCBio
Ten nations and 80 world-class athletes will prove this #fipfaworldcup2023 that anything is possible. As a premier sponsor, we're excited to see these players achieve incredible things. Get to know the teams here: www.fipfawc2023.org. #powerchairfootball
-
PTC Therapeutics
@PTCBio
Join us as we congratulate our Chief Information Officer Linda Montella-Carter for her recognition as a #technology leader and finalist in the Large Corporate Category of the 2023 Philadelphia ORBIE® Awards. #phillycio #orbie @InspireCIO
Congratulations to all finalists! -
PTC Therapeutics
@PTCBio
Learn more about natural history studies and why they are so important in the study of #rarediseases and development of potential therapies: www.ptcbio.com/posts/what-are-natural-history-studies-and…
-
PTC Therapeutics
@PTCBio
There are many ways that people living with #rarediseases and their loved ones can be advocates! Learn more about advocating on behalf of a patient advocacy organization: www.ptcbio.com/posts/advocacy-in-action-patient-advocacy-…
-
PTC Therapeutics
@PTCBio
Thank you for your dedication toward this very important initiative. #duchenne #newbornscreening
Parent Project Muscular Dystrophy (PPMD)
@ParentProjectMD
PPMD’s nomination package to add Duchenne to the RUSP passed the ACHDNC Nomination and Prioritization vote today! This decision marks another exciting step towards having Duchenne added to newborn screening programs across the country. www.parentprojectmd.org/ppmds-rusp-nomination-package-for…
-
PTC Therapeutics
@PTCBio
Thank you to California @SenJoshBecker for stopping by our Mountain View office yesterday to witness #raredisease research firsthand. (L-R) John Valencia, Russ Rahimtoola, Ted Piper, Senator Josh Becker, Jeff Trimmer
-
PTC Therapeutics
@PTCBio
There is so much to love about powerchair football! Did you know it is one of the most diverse sport arts on the planet? Players of diverse age groups, genders and abilities can participate. Watch this video to learn more. #powerchairfootball #fipfaworldcup2023
-
PTC Therapeutics
@PTCBio
There are many ways that people living with #rarediseases and their loved ones can be advocates. Learn more about advocating on behalf of legislation with Leah Svoboda, Director, Government Affairs and Public Policy at PTC: www.ptcbio.com/posts/advocacy-in-action-legislation/
-
PTC Therapeutics
@PTCBio
The National Leiomyosarcoma Foundation (NLMSF) will hold an education symposium for patients, families and caregivers from 11 a.m.-1 p.m. MDT on August 18 at the University of Colorado Health Science Center. Join us for “Facing Sarcoma/LMS Together." docs.google.com/forms/d/e/1FAIpQLSeTLiff42FxvMiyH4jH55pzb…
-
PTC Therapeutics
@PTCBio
We're counting down to October 15. Can't wait! #powerchairfootball #fipfaworldcup2023
FIPFA
@OfficialFIPFA
Practice makes perfect! 🤩💥
Will Team USA rise to the occasion and reclaim their World Champions status in Sydney? 🏆🇺🇸
📸: @USsoccer_ENT
#powerchairfootball #fipfaworldcup2023 -
PTC Therapeutics
@PTCBio
Arya Singh has made an impact in the #raredisease community by working to ensure the patient voice is part of the clinical trial process – something she knows about first-hand. Read more about Arya’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-if-theres-a-wi…
-
PTC Therapeutics
@PTCBio
Saturday will be here before you know it! Join us at the @Help4HDI HIPE event. Learn more and register today: www.help4hd.org/events-1/help-4-hd-international-hipe-det… #hdevents #huntingtonsdisease #help4hdhipe2023
-
PTC Therapeutics reposted
Rafael
@_RafaelSierra
Many thanks to Prof Paul Hwu & Dr Nancy Chien (@NTU_Hospital) and Richard & Judy Poulin ( @edu4rare) for presenting at PTC’s #aadcdeficiency symposia. #aoccn2023 #raredisease
-
PTC Therapeutics
@PTCBio
We enjoyed sharing plans for our new headquarters in Warren this week with @CongressmaKean. The visit included a great discussion with @BioNJ CEO Debbie Hart about how policies can impact #raredisease drug development and the state’s #lifescience ecosystem.
-
PTC Therapeutics
@PTCBio
We're excited to sponsor and attend @Help4HDI HIPE on August 12 in Detroit. Please stop by our booth and say hello! #huntingtonsdisease #help4hdhipe2023
Help4HD
@Help4HDI
See all thats happening at Help 4 HD HIPE August 12th in Detroit, MI! #detroitmi #help4hdhipe2023
Register here: www.help4hd.org/events-1/help-4-hd-international-hipe-det… -
PTC Therapeutics
@PTCBio
Jonathan Blaize, PhD, Medical Science Liaison, Medical Affairs, PTC shares insights and learnings on the behavioral and psychological considerations for improved #duchenne patient care. Read more: www.ptcbio.com/posts/navigating-behavioral-health-in-duch…
-
PTC Therapeutics
@PTCBio
This afternoon, we shared a corporate update and reported second quarter financial results. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
Mark your calendars for August 30 for the next free webinar in the Accessible College Series. Topics will include considerations for students for college housing, personal care attendants, medication management and more. Register today: ptcbio.zoom.us/webinar/register/WN_GdGcc_Q6SvuditC1pKXHow
-
PTC Therapeutics
@PTCBio
Join us tomorrow for a conference call as our leaders discuss second quarter 2023 financial results and provide an update on the company’s business and outlook. Learn more and register today: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
The Emerging Leaders program was created specifically for future leaders of PTC – and the impact of the program, and its participants, can already be felt across the organization. Read more about the Remarkable Emerging Leaders story: www.ptcbio.com/posts/25-remarkable-stories-continuum-of-d…
-
PTC Therapeutics
@PTCBio
Action Duchenne hosted a residential weekend in late May where young adults with #duchenne participated in abseiling, canoeing and team building with plenty of time to socialize with the help of the 2022 PTC STRIVE award. Read more: www.ptcbio.com/posts/united-kingdom-based-action-duchenne…
-
PTC Therapeutics
@PTCBio
While the 10 competing teams are preparing for the #fipfaworldcup2023, let's explore #powerchairfootball and the rules of the game. Watch the video and read more: www.fipfawc2023.org/the-event/what-is-powerchair-football/
-
PTC Therapeutics
@PTCBio
Here are a few reasons @_RafaelSierra is looking forward to moderating our sponsored symposium on #aadcdeficiency with Prof. Hwu, Dr. Chien and the Poulin family. Join us on August 5 in Bangkok, Thailand. #aoccn2023 #aadcd
-
PTC Therapeutics
@PTCBio
We can't wait! #powerchairfootball #fipfaworldcup2023
FIPFA
@OfficialFIPFA
When you realise it's only 79 days until the start of the @2023FIPFAPFWC 🤩🌍
📸: Scot Goodman
#powerchairfootball #fipfaworldcup2023 -
PTC Therapeutics
@PTCBio
Our teammates were excited to attend two events in Puerto Rico recently with the @MDAorg and @TheAkarifoundat. These events provided #duchenne families time to connect, have fun, learn about our Spanish resources and more! Link to Momentos de Claridad: www.ptcbio.com/momentos-de-claridad/
-
PTC Therapeutics
@PTCBio
Congratulations to PTC Italy for winning two prestigious awards for #raredisease innovation, leadership and patient-centricity! Read more about the awards: www.ptcbio.com/2023/07/27/ptc-italy-wins-two-prestigious-…
-
PTC Therapeutics
@PTCBio
We wish the Tabors an epic journey along their road trip from Wyoming to New Jersey. It was a privilege to meet Autumn and her mother Londen last month at the @HDSA Convention.
thewyomingtruth
@thewyomingtruth
Gillette Teen Gears Up for Trip of a Lifetime
Read the article at the link below! wyomingtruth.org/gillette-teen-gears-up-for-trip-of-a-lif… -
PTC Therapeutics
@PTCBio
Martin Rexroad, Chief Culture & Community Officer, is known as the “Chief Storyteller” at PTC and has made a great impact on the company’s culture. Read more in Martin’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-chief-storytel…
-
PTC Therapeutics
@PTCBio
Does your brother or sister have a #raredisease? Join us at 7 p.m. EDT tomorrow, July 26, as we spotlight your important role. This webinar will be held entirely in Spanish. To register, please visit: ptcbio.zoom.us/webinar/register/WN_UQUBl0LETpakrsw2TMcbgg
-
PTC Therapeutics
@PTCBio
With the STRIVE grant, @mdahellas is producing a short film on sexuality in Duchenne and giving young adults with #duchenne a chance to speak out about an issue that is often uncomfortable to discuss. Read more: www.ptcbio.com/2023/07/25/greeces-mda-hellas-uses-the-str…
-
PTC Therapeutics
@PTCBio
The #fipfaworldcup2023 competition schedule has been confirmed and we are counting down to the first match. Let's get the ball rolling and learn more about this dynamic and fast-paced sport! #powerchairfootball
-
PTC Therapeutics
@PTCBio
This morning we shared that the CHMP adopted a positive opinion for the extension of the Evrysdi® (risdiplam) marketing authorization to include infants under two months of age with spinal muscular atrophy in the European Union. Read more: ir.ptcbio.com/news-releases/news-release-details/chmp-rec…
-
PTC Therapeutics
@PTCBio
Today we were excited to host Assemblymember Marc Berman. @AsmMarcBerman toured our facilities in Mountain View with Ted Piper of State Government Affairs (L), Jeff Trimmer, VP and Site Head (R) and others. Thank you, Assemblyman, for your interest in #raredisease research!
-
PTC Therapeutics
@PTCBio
The tremendous, positive impact made by the Friedreich's Ataxia Research Alliance (FARA) and co-founder Ron Bartek on the FA community is staggering. Read more about Ron’s Remarkable Story: www.ptcbio.com/2023/07/19/25-remarkable-stories-because-o…
-
PTC Therapeutics
@PTCBio
Gain insights on diagnosis and the impact of #aadcdeficiency from experts and caregivers at our symposium on August 5 at the 16th Asian Oceanian Congress of Child Neurology (AOCCN). #aadcd #aoccn2023
-
PTC Therapeutics
@PTCBio
Join us on Thursday, Aug. 3 as PTC leaders report our second quarter 2023 financial results and provide a company update. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
Congratulations to our co-founder Allan Jacobson, Ph.D. on receiving the 2023 Gruber Genetics Prize in recognition of his pioneering work in nonsense-mediated mRNA decay. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We’re proud to be featured in a recent article from @NatureBiotech. “Unprecedented blood biomarker enables ALS drug approval” includes PTC’s approach to #als, highlights the ongoing CARDINALS trial and shares insights from our CEO Dr. Matthew Klein.
Nature Biotechnology
@NatureBiotech
The disease biology of amyotrophic lateral sclerosis is complex and varied, but the field's understanding is growing — and a biomarker of neuronal damage is a useful trial endpoint to aim at www.nature.com/articles/s41587-023-01862-0
-
PTC Therapeutics
@PTCBio
With the 2022 STRIVE Grant Award, ACDM is continuing its work on Project Facilitate to help students with #duchenne. The project aims to provide students with greater career prospects, academic success and more. Read more: www.ptcbio.com/2023/07/18/brazils-acdm-continues-work-to-…
-
PTC Therapeutics
@PTCBio
Thank you to Lauren Bejcek and to all panelists for participating in the Career Connection Series and sharing your insights with future #stem leaders!
Students 2 Science
@S2S_Org
In the 1st session of our new Career Connection Series, designed to build students’ knowledge of STEM careers, dynamic professionals from the pharma industry engaed in conversation with our summer interns. A huge thank you to all participants!
#stemeducation #stemcareers -
PTC Therapeutics
@PTCBio
Today, we announced the appointment of experienced healthcare strategist Pierre Gravier to the role of Chief Financial Officer. Read more about the announcement: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #ptct
-
PTC Therapeutics
@PTCBio
Our dedicated #leiomyosarcoma (LMS) team is committed to helping patients living with this rare cancer. Meet the team and hear from patients and caregivers about their experiences living with LMS: www.ptcbio.com/posts/honoring-leiomyosarcoma-awareness-da…
#raredisease #oncology -
PTC Therapeutics
@PTCBio
PTC is working on an investigational product for the treatment of #leiomyosarcoma (LMS). Learn more about our clinical trial: short.url/aBcXyZ #raredisease #oncology
-
PTC Therapeutics
@PTCBio
Join us for our sibling program for #raredisease brothers and sisters of a rare sibling at 7:00pm EDT on July 26, 2023. Momentos de Claridad™ Sibling Program – Supporting Siblings with rare conditions will be held entirely in Spanish. Register today! ptcbio.zoom.us/webinar/register/WN_UQUBl0LETpakrsw2TMcbgg
-
PTC Therapeutics
@PTCBio
You could feel the impact Kyle Bryant made on the PTC community when he shared his story of living with #friedreichataxia. His story inspires us every day. Read more about Kyle’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-riding-through…
-
PTC Therapeutics
@PTCBio
On July 19th we are hosting a virtual presentation on #phenylketonuria (#pku) including discussion of the current therapeutic and commercial landscape with an expert KOL. Learn more and register: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
We caught up with KASDER, 2022 STRIVE Grant recipient, and we’re excited that they’ve expanded their online psychological services to include victims of the February 6 Kahramanmaraş-centered earthquakes. Read more: www.ptcbio.com/posts/strive-grant-recipient-kasder-expand…
-
PTC Therapeutics
@PTCBio
Our team is heading to the European Network to Cure ALS (ENCALS) meeting in Barcelona, Spain where we are proud to contribute as a gold sponsor. Learn more about #als and our clinical trial recruitment: www.ptcbio.com/therapeutic-areas/amyotrophic-lateral-scle…
-
PTC Therapeutics
@PTCBio
We’re honored to receive the Supply Chain Achievement Award and be named a finalist in the Life Science Company of the Year SME category at the @LifeSciencesIRL last night in Ireland. Congrats to our team and to all nominees! #lifesciencesirl Read more: www.ptcbio.com/2023/07/07/ptc-wins-supply-chain-achieveme…
-
PTC Therapeutics
@PTCBio
Marcelo Sal, Florencia Bellora and Felipe Barilari, colleagues from the Cono Sur team, visited Paraguay for the first local event related to #hattr where Dr. Alejandro Rodriguez of Argentina presented the clinical characteristics of hATTR to local neurologists. #raredisease
-
PTC Therapeutics
@PTCBio
Our teammates like Bryan Passink, Courtney Cruz, Karina Lambertini, Rupert Evans and Patricia Brown have been all over the U.S. lately, including Iowa, Wisconsin and Georgia. They are having a blast making new friends and helping facilitate activities at @MDAorg summer camps.
-
PTC Therapeutics
@PTCBio
The impact Neil Smith, Global PKU Project Leader, PTC, has made on the company’s work in #pku is unmatched, driven by science and his mission to help the PKU community. Read more about Neil’s Remarkable Story: www.ptcbio.com/2023/06/28/25-remarkable-stories-improving…
-
PTC Therapeutics
@PTCBio
Today, on #internationalpkuday, we’re thinking of Linda and the ~58,000 people with phenylketonuria globally. In episode 6, we learn that Linda is the youngest of four children, three of which have PKU, herself included. To hear more, visit www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an….
-
PTC Therapeutics
@PTCBio
Our team is heading to Dallas for the Parent Project Muscular Dystrophy Annual Conference. Please stop by our booth and say hello. The PPMD Annual Conference is focused entirely on #duchenne and Becker muscular dystrophy. To learn more, visit www.parentprojectmd.org/events/ppmds-2023-annual-conference/.
-
PTC Therapeutics
@PTCBio
Monday was an exciting day for our #oneptc team as we celebrated our 25th anniversary and 10th anniversary of our Initial Public Offering in Times Square. Learn more: www.ptcbio.com/posts/ptc-hosts-nasdaq-opening-bell-ceremony/
-
PTC Therapeutics
@PTCBio
Count down to today’s stock market opening with us! CEO Matthew Klein and others were in Times Square this morning to celebrate our 25th anniversary and 10th year as a public company.
Video credit: @NasdaqExchange -
PTC Therapeutics
@PTCBio
Thank you to the @NasdaqExchange team for an exciting morning! Our CEO Matthew Klein and other colleagues had the opportunity to open the stock market in celebration of our 10th year as a public company.
Nasdaq Exchange
@NasdaqExchange
🔬 @PTCBio is translating science to transform lives for patients.
$PTCT is a science-driven, patient-centered biopharmaceutical company focused on discovering best-in-class treatments & commercializing medicine for patients with rare disease. #nasdaqlisted -
PTC Therapeutics
@PTCBio
Our teammates are in Times Square this morning to ring the @NasdaqExchange opening bell in celebration of PTC's 10th anniversary as a public company. Join our CEO Matthew B. Klein, M.D., M.S., FACS and others in the livestream beginning at 9 a.m. EDT: livestream.com/accounts/27896496/events/10862181
-
PTC Therapeutics
@PTCBio
Loren Eng didn’t set out to run a non-profit, but the SMA Foundation has made a remarkable impact in the #spinalmuscularatrophy (SMA) community since it was founded. Read more about Loren’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-it-takes-many-…
-
PTC Therapeutics
@PTCBio
Join Maribel Hernandez, PA-C, VP, Clinical Operations & Special Projects and other industry experts in a panel at #dia2023 to cover topics like genetic testing, partnerships with patient advocacy groups and KOLs, and access to investigational treatments. www.diaglobal.org/en/flagship/dia-2023/about/conference
-
PTC Therapeutics
@PTCBio
Learn more about #genetherapy and the policy updates needed to ensure access on June 26 at the @gene_therapies Capitol Hill briefing. Register today for Realizing the Promise of Gene Therapy: Ensuring Access! docs.google.com/forms/d/e/1FAIpQLSeLMnvQyFCBkHGwsTj6CUXq4…
-
PTC Therapeutics
@PTCBio
.@ThomasBols, Head of Government Affairs and Patient Engagement EMEA & AP, joined #gamechangersbyfti recently to discuss how the #eupharmapackage may impact ongoing efforts to find cures and treatments for people with #rarediseases.
FTI Consulting EU
@FTIconsultingEU
Recently, @ThomasBols, Head of Government Affairs and Patient Engagement EMEA & AP at @PTCBio, joined us at #gamechangersbyfti to talk about how the #eupharmapackage may impact ongoing efforts to find cures and solutions for people with #rarediseases vimeo.com/837941362
-
PTC Therapeutics
@PTCBio
This morning, we shared positive interim data from the 12-week portion of the PIVOT-HD Phase 2 study of PTC518 in Huntington’s disease (HD) patients. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #huntingtonsdisease
-
PTC Therapeutics
@PTCBio
Cindy Salgado, another road warrior from our Patient Engagement team, traveled to Denver last week to spend time with 14 campers at Muscular Dystrophy Association summer camp. The campsite was beautiful, and even more importantly, completely wheelchair accessible!
-
PTC Therapeutics
@PTCBio
The #fipfaworldcup2023 is coming to Sydney, Australia this October and we're proud to support this event. World-class athletes from 10 nations will compete for the 2023 trophy. #powerchairfootball Learn more: www.ptcbio.com/posts/ptc-partners-with-fipfa-to-support-p…
-
PTC Therapeutics
@PTCBio
Thank you for taking the time to share your knowledge on such an important day, Coach!
Lynnette KhalfaniCox
@themoneycoach
Happy Juneteenth! Thanks to @PTCBio for having me speak to your Black Empowerment Council about financial wellness! #happyjuneteenth
-
PTC Therapeutics
@PTCBio
It was a clear and sunny day in Chicago for the Akari Foundation’s family workshop. Aurora Flores, Cindy Salgado and Paula Orandash spent quality time with the families and shared our Spanish educational resources, Momentos de Claridad™. theakarifoundation.org
-
PTC Therapeutics
@PTCBio
The European Conference on Rare Diseases recently published our abstract about cross border healthcare for those with #rarediseases in the Orphanet Journal of Rare Diseases. We're proud to support patients' access to therapy.: idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.….
-
PTC Therapeutics
@PTCBio
We’re looking forward to #epns2023 to help advance research and knowledge of rare neurological conditions like #duchenne muscular dystrophy, #aadcdeficiency and mitochondrial disease. PTC has a number of activities planned, including two symposia, two booths and numerous posters.
-
PTC Therapeutics
@PTCBio
Listen to the recording of the Goldman Sachs 44th Annual Global Healthcare Conference to hear a business update from our CEO Matthew B. Klein and CCO Kylie O’Keefe: ir.ptcbio.com/events/event-details/goldman-sachs-44th-ann…
-
PTC Therapeutics
@PTCBio
We’re proud of Leah Svoboda and Malisa Rust for supporting the “We the Patients” Second Annual Fly-in. Patients from across the country traveled to our nation’s capital to advocate for access, affordability and transparency. To learn more, visit patientsrisingnow.org.
-
PTC Therapeutics
@PTCBio
The Green Team Committee at PTC has made an impact not just on their local office and community, but on the entire company, too, through a commitment to sustainability. Read more about the Green Team’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-commitment-to-…
-
PTC Therapeutics
@PTCBio
We’re proud of our Hopewell Community Environmental Team for volunteering! The group planted ~25 bayberry saplings and maintained an area with other native trees and shrubs. Learn more about our efforts to care for the environment: www.ptcbio.com/about-ptc/our-responsibility/
-
PTC Therapeutics
@PTCBio
Our live webinar on recognizing the early symptoms of #duchenne muscular dystrophy will be held at 18:00 CEST (12:00 p.m. EDT) on Monday, June 26. “The BIG role of physiotherapists in early diagnosis” is for health care professionals only. Register today! ptcwebinars.com/dmd/q2/
-
PTC Therapeutics
@PTCBio
ICYMI: Our CEO Matthew B. Klein and CCO Kylie O’Keefe recently presented at the Jefferies Healthcare Conference. Watch the recording: ir.ptcbio.com/events-presentations
We will also present Wednesday at the Goldman Sachs 44th Annual Global Healthcare Conference. Please join us! -
PTC Therapeutics
@PTCBio
PTC had the privilege to serve at a @MDAorg summer camp in Southern California. Camp is available to children who have been diagnosed with a type of neuromuscular disease at no cost to their families, thanks to MDA supporters. Learn more: www.mda.org/summer-camp
-
PTC Therapeutics
@PTCBio
Please join us on June 21 for “Momentos de Claridad™ Sibling Program - A Message for Parents: The impact of rare conditions on siblings," which will be held entirely in Spanish. #raredisease
NPKUA
@NPKUA_Info
Join PTC Therapeutics on Wednesday, June 21 at 7pm EST for their webinar, "Momentos de Claridad" Spanish Program. Register at this link: ptcbio.zoom.us/webinar/register/WN_Z8kDAVl7QnuDxafLis8_9w
-
PTC Therapeutics
@PTCBio
Learn new strategies to make the most of #hr opportunities in #lifesciences at @BioNJ_Org's Annual HR Conference on June 13. PTC's Martin Rexroad and Eddy Tufford will see you there! bionj.org/event/bionj-hr-conference/
-
PTC Therapeutics
@PTCBio
Join us tomorrow at the 4th Annual Gene Therapy for Neurological Disorders Europe where Thomas Bols will present “Accessing cross-border healthcare for ATMPs: a treatment route for people living with a rare disease" #raredisease #genetherapy genetherapy-neurological-europe.com
-
PTC Therapeutics
@PTCBio
We've obtained the marketing authorization for TRANSLARNA in Uruguay, a milestone for patients with #duchenne muscular dystrophy and PTC. This highlights the LATAM team's dedication and shows our commitment to advancing medical innovation and addressing healthcare challenges.
-
PTC Therapeutics
@PTCBio
For three days, Mocotó SQF offered a tasting menu tailored for people with familial chylomicronemia syndrome (FCS) so they could eat without fear. Read more about the Remarkable Story of Mocotó SQF: www.ptcbio.com/2023/06/07/25-remarkable-stories-eat-witho…
-
PTC Therapeutics
@PTCBio
Emily McNulty, Toon van Gool and Paula Orandash enjoyed their time in New Orleans this weekend at the #hdsaconvention. @HDSA #huntingtonsdisease
-
PTC Therapeutics
@PTCBio
Join us for two upcoming investor conferences: the @Jefferies Healthcare Conference on June 7 and the Goldman Sachs 44th Annual Global Healthcare Conference on June 14. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
On #lougehrigday, we’re honoring his legacy and raising awareness for #als and related #neuromuscular diseases by sharing some of our favorite @MLB teams. Learn more about this #raredisease and our enrolling CARDINALS clinical trial: www.ptcbio.com/therapeutic-areas/amyotrophic-lateral-scle…
-
PTC Therapeutics
@PTCBio
Did you know we have two investigational therapies in development for rare cancers? We'll be onsite at #asco23 to help advance knowledge, understanding and research about leiomyosarcoma (LMS) and diffuse intrinsic pontine glioma (DIPG). Learn more: www.ptcbio.com/therapeutic-areas/
-
PTC Therapeutics
@PTCBio
As a silver sponsor, PTC is excited to support clinicians and scientists at the 5th Toronto International Sarcoma Symposium, May 31-June 1, in Toronto, Canada. Learn more about our ongoing SUNRISELMS clinical trial for leiomyosarcoma (LMS): clinicaltrials.ptcbio.com/results?id=PTC596-ONC-008-LMS
-
PTC Therapeutics
@PTCBio
Learn about 6 examples of topics aimed at breaking down barriers in the #duchenne community – the theme to World Duchenne Awareness Day 2023 on September 7.
World Duchenne Organization
@worldduchenne
This year's World Duchenne Awareness Day theme is "Duchenne: Breaking Barriers."
Together, let's raise awareness and empower the Duchenne community worldwide. 🌟
Want to learn more? Check out the press release with detailed information. #wdad2023
www.worldduchenneday.org/2023-duchenne-breaking-barriers/ -
PTC Therapeutics
@PTCBio
Visit PTC at our @HDSA Convention booth on the 3rd floor, June 1-3, in New Orleans. We will also be recording podcasts where patients and families can share their experiences with #huntingtonsdisease. Check out episodes 1-10 (episodes 8-10 are in Spanish): www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
-
PTC Therapeutics
@PTCBio
This afternoon, we shared topline results from our Vatiquinone MOVE-FA registration-directed trial in patients with Friedreich ataxia. We will hold a conference call at 5:00 p.m. EDT today to discuss this news. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Marla Weetall, SVP, Pharmacology & Biomarkers, is fascinated by the science and motivated by the potential for developing innovative treatments for rare and neglected diseases like #als. Learn more about how PTC is working to treat ALS: www.ptcbio.com/therapeutic-areas/amyotrophic-lateral-scle…
-
PTC Therapeutics
@PTCBio
Working with #raredisease patients, families and non-profit groups helps our team to better understand the patient experience. #ptccsr2022 #committedtodoingourpart www.ptcbio.com/posts/committed-to-doing-our-part-2022-cor…
-
PTC Therapeutics
@PTCBio
Don’t miss the activities and projects coming up for @cure_mito! In the May newsletter, the foundation shares an article in @WebMD, ongoing work on a new #leighsyndrome website, an upcoming conference date and more! #mitochondrialdisease #raredisease
CureMITO
@cure_mito
Our May Newsletter is available!
Please find it at: mailchi.mp/d9c41986cdd3/cure-mito-foundation-news-9328449
#curemito #leighsyndrome #mitochondrialdisese #hope #research #mito -
PTC Therapeutics
@PTCBio
By participating in a clinical trial, you are taking an active role in the development and approval of new medicines and treatments. Learn more this #clinicaltrialsday about how to navigate clinical trials: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
With employees across 20 countries, we are proud to have a diverse workforce. Jesse Sibarium, Head of EMEA, shares how he fosters inclusive leadership across the region: www.ptcbio.com/posts/the-importance-of-inclusive-leadersh…
#eudiversitymonth
#unitedindiversity
#unionofequality -
PTC Therapeutics
@PTCBio
LIVE from #asgct23! Our team is thrilled to be at ASGCT's 26th Annual Meeting. Swing by booth 655 to talk #genetherapy with us and click to learn more about our Gene Therapy Technical Center of Excellence: www.ptcbio.com/about-ptc/gene-therapy-center-of-excellence/
-
PTC Therapeutics
@PTCBio
Jonathan and Christine Piacentino’s advocacy efforts for the #duchenne community are extraordinary and impactful. Read more about Jonathan and Christine’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-tenacious-fero…
-
PTC Therapeutics
@PTCBio
Join us in less than 4 hours!
NPKUA
@NPKUA_Info
TONIGHT! Join PTC Therapeutics for their upcoming Insightful Moments webinar "Accessible College: Developing Independent Living and Executive Function Skills”, that will be taking place on Wednesday, May 17th at 7pm Eastern. Link to register: ptcbio.zoom.us/webinar/register/WN_389270yZSyeOP_KKYlpgWA
-
PTC Therapeutics
@PTCBio
We're at #asgct23! Stop by booth 655 to learn more about our innovative #genetherapy platform and manufacturing abilities at our Hopewell, NJ Gene Therapy Technical Center of Excellence.
-
PTC Therapeutics
@PTCBio
We are proud to announce that our Phase 3 clinical trial for our treatment for phenylketonuria (#pku) achieved its primary endpoint. Read more about the news: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Our team is heading to the DIPG/DMG (Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma) Symposium, May 18-21. Join us on May 19 for presentations by our colleagues Emily McNulty and Marla Weetall.
-
PTC Therapeutics
@PTCBio
We are busy preparing for the ASGCT 26th Annual Meeting and looking forward to attending! So, what is #genetherapy, and how does it work to treat genetic diseases? Watch as Zhijian Wu, Vice President, Gene Therapy Research, explains. #asgct23
-
PTC Therapeutics
@PTCBio
Alexis Krolick and Zach Carr will present the exhibitor showcase “Pioneering in Targeted Gene Delivery to the Brain,” 8:15-8:45 a.m. PDT, on May 17 at the @ASGCTherapy Annual Meeting. Join us to learn about PTC’s focus on #genetherapy for #rarediseases and much more.
-
PTC Therapeutics
@PTCBio
Read as Christian Werner, Executive Director, Global Medical Affairs, Global DMD Lead, PTC, shares his perspective on the “totality of evidence” in understanding of the impact of a novel treatment: www.ptcbio.com/posts/why-we-must-consider-the-totality-of…
-
PTC Therapeutics
@PTCBio
“When you hear the term ‘rare disease,’ you think of very small numbers; however, there is a big network of rare disease families, and together we can make a much larger number,” says Richard Poulin. #aadcdeficiency #aadcd #raredisease themighty.com/topic/rare-disease/how-our-family-supports-…
-
PTC Therapeutics
@PTCBio
For Brian Beers, Global Project Leader, PTC, working on the #huntingtonsdisease program at PTC means being a potential beacon of hope for people living with HD and their families. Learn more about how PTC is working to treat HD: www.ptcbio.com/therapeutic-areas/huntingtons-disease/ #letstalkabouthd
-
PTC Therapeutics
@PTCBio
As a candidate for the @GalienFdn’s “Best Pharmaceutical Product,” we were honored to join other #prixgalien UK award finalists in London last night. Congratulations to all nominees and winners on this distinguished recognition and commitment to patients!
-
PTC Therapeutics
@PTCBio
Congrats to our publication and medical teams for their recent publication in the Journal of Neurology. The 2022 STRIDE manuscript is the first and largest real-world study of nonsense mutation #duchenne muscular dystrophy patients in clinical practice. idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.…
-
PTC Therapeutics
@PTCBio
After her daughter was the fourth person diagnosed in the world with #aadcdeficiency, Kelly Heger became a pioneering advocate. We are continually inspired by her and the impact she has made on this community. #aadcd #raredisease www.ptcbio.com/2023/05/10/25-remarkable-stories-a-pioneer…
-
PTC Therapeutics
@PTCBio
Five posters and abstracts from our team were displayed at ISPOR, the Professional Society for Health Economics and Outcomes Research, May 7-10, in Boston. #heor #ispor2023 #isporannual
-
PTC Therapeutics
@PTCBio
We’re looking forward to supporting and attending the SPAGN Annual Conference, May 11-13, to connect with patient advocacy organizations and help bring the patient voice to our work. #spagn2023
Read about our efforts to support those living with LMS: www.ptcbio.com/therapeutic-areas/leiomyosarcoma/ -
PTC Therapeutics
@PTCBio
The #huntingtonsdisease community has given Jenna Woodard many new friends and mentors. Feeling lost after her diagnosis, Jenna is now thriving as an advocacy chair, a youth mentor and an ambassador for the @HDYOFeed. www.ptcbio.com/posts/jenna-woodard-the-hd-community-has-h…
-
PTC Therapeutics
@PTCBio
Finding personal connection through meditation and visualization is a powerful way to reduce stress, especially when living with or supporting someone with a #raredisease. Watch to find out how.
This media couldn't be displayed. See it on the original post.
PTC Therapeutics
@PTCBio
Thanks for sharing, @AwarenessHD!
-
PTC Therapeutics
@PTCBio
As a founding member of the National Center for Advancing Translational Sciences Alliance, we’re dedicated to advancing scientific breakthroughs to detect and treat more diseases faster. Check out our fellow members and find out how you can join us: ncatsalliance.org
-
PTC Therapeutics
@PTCBio
#icymi, Last week, we published our 2022 Corporate Sustainability Report, “Committed to doing our part”. Check out some highlights from the report: www.ptcbio.com/posts/committed-to-doing-our-part-2022-cor…
-
PTC Therapeutics
@PTCBio
We're honored to be selected as a finalist in the 2023 Prix Galien UK Award for "Best Pharmaceutical Product." We look forward to joining colleagues and other finalists at the award ceremony on May 11 in London. Read more: www.prnewswire.com/news-releases/the-galien-foundation-an…
-
PTC Therapeutics
@PTCBio
We are inspired every day by #raredisease patients and their families. Thank you for sharing @Elijahjstacy's story. He certainly is the embodiment of what CAN be achieved while living with #duchenne.
RARE Revolution Magazine®
@RareRevolutionM
The global movement, #duchennecan, has drawn inspiration from witnessing what people living with Duchenne CAN achieve. Each #duchennecan story is a testament to the determination and positive can-do attitude of those affected by a disabling rare disease
edition.pagesuite-professional.co.uk/cookie_check.aspx?pu… -
PTC Therapeutics
@PTCBio
In this @PharmaReview article, our Chief Technical Operations Officer Neil Almstead, Ph.D. takes us inside PTC’s Gene Therapy Center of Excellence and covers the top 4 ways the industry can collaborate toward reaching this goal. #genetherapy (Guest login available.)
European Pharmaceutical Review
@PharmaReview
Neil Almstead of @PTCBio discusses what gene therapy manufacturers can gain from collaboration. Read it here...
www.europeanpharmaceuticalreview.com/article/181719/what-…
#genetherapy
#manufacturing -
PTC Therapeutics
@PTCBio
To date, the Sandra K. Russell (SKR) Derby Day event has raised $1.5M+ to help seriously ill patients and their families. The 14th annual SKR Benefit for Mito starts at 5 p.m. this Saturday. Reserve your tickets today: give.mitoaction.org/event/2023-derby-day/e454126
MitoAction
@MitoAction
We would like to express our gratitude to PTC Therapeutics for their support of this year’s Sandra K. Russell Derby Day Benefit for Mito. This event wouldn’t be possible without the generosity of our sponsors.
Visit: give.mitoaction.org/event/2023-derby-day/e454126 -
PTC Therapeutics
@PTCBio
We’re thrilled to share the full 2022 Corporate Sustainability Report! “Committed to doing our part” is a comprehensive look at support for our patient communities, efforts to help the environment and much more! ir.ptcbio.com/static-files/7ab286c3-83bf-4531-aca8-ef7ec8… #ptccsr2022 #committedtodoingourpart
-
PTC Therapeutics
@PTCBio
This afternoon, PTC provided Q1 financial results and a corporate update. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
For PTC, 2022 was a milestone-reaching, patient-supporting, award-winning, employee-engaging, community-driven year. We’re proud of what we accomplished, and we’re looking forward to continuing this momentum in 2023. Read PTC’s annual report: ir.ptcbio.com/static-files/1cd85e59-37b6-4b76-b6d8-5d57f8…
-
PTC Therapeutics
@PTCBio
Are you heading to Brussels for the The Economist Impact Cell and Gene Therapy Summit? If so, please join Rafael Sierra, PhD, 15:00-15:15 CET, on Monday, April 24, for “Gene therapy: an innovative approach for rare diseases.” #econcellgenetherapysummit #genetherapy #raredisease
PTC Therapeutics
@PTCBio
Live from Brussels! #econcellgenetherapysummit #genetherapy #raredisease
-
PTC Therapeutics
@PTCBio
CureDuchenne FUTURES 2023 is in full swing! You can find Malisa Rust, Karina Lambertini and Aurora Flores in Booth 25 and Pat Cusick in the e-gaming room today until 6 p.m. PDT. @CureDuchenne #futures2023 #duchenne
-
PTC Therapeutics
@PTCBio
Stress from living with or supporting someone with a #raredisease is natural, but revisiting things that brought you joy or inspiration as a child can be a great way to help reduce stress. Watch to find out how.
This media couldn't be displayed. See it on the original post. -
PTC Therapeutics
@PTCBio
We’re looking forward to sharing our 2022 Corporate Sustainability Report! “Committed to doing our part" will illustrate our 5 key focus areas: patients, people, community, values and the environment. #raredisease #ptccsr2022 #committedtodoingourpart
-
PTC Therapeutics
@PTCBio
Ever since Luke Millington joined the #oneptc team, he has made an incredible impact on how we engage with people living with #rarediseases. Read more about Luke’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-where-experien…
-
PTC Therapeutics
@PTCBio
Read more about the Emerging Leaders program at PTC and why Hege Sollie-Zetlmayer, SVP, Human Resources, is passionate about enriching PTC’s pipeline of diverse leaders: www.ptcbio.com/posts/building-a-pool-of-diverse-leaders/
-
PTC Therapeutics
@PTCBio
Thank you, Elijah Stacy, for sharing your story in the latest edition of @RareRevolutionM released today. You are a wonderful example of what people with #duchennecan do. Read more on pg. 84: edition.pagesuite-professional.co.uk/cookie_check.aspx?pu…
-
PTC Therapeutics
@PTCBio
Join Rafael Sierra, PhD, Executive Director, Global Medical Affairs, Global Gene Therapy Lead, and other speakers at the inaugural #econcellgenetherapysummit, an event to discuss market access, policy, delivery and more. Learn more and register here: events.economistenterprise.com
Economist Enterprise events
@EconomistEvents
Gene therapy is an innovative approach for rare diseases. Join us on April 24-25th to discuss this and more. Featured speaker, PTCTherapeutics, Rafael Sierra, executive director, global medical affairs, global gene therapy lead. events.economistenterprise.com
#econcellgenetherapysummit -
PTC Therapeutics
@PTCBio
Our PTC colleagues are looking forward to connecting with the #duchenne community at the #cureduchenne #2023futures National Conference, April 20-23. Stop by booth 25 to meet our team and watch for presentations by Christian Werner and Karyn Koladicz. #raredisease
-
PTC Therapeutics
@PTCBio
Join @ThomasBols on April 18 for "Successful Strategies and Business Model For Companies Bringing Their Orphan Drug To Market." us06web.zoom.us/webinar/register/WN_LWxQTV9ZSoKgMw74mlHc0g
EuropaBio
@EuropaBio
📢 What potential impact the upcoming pharmaceutical and OMP legislation revisions have on company #innovation & #patient benefits?
Join our webinar & meet @ThomasBols who talks about opportunities & barriers for innovation within #orphandrug development: www.europabio.org/event/development-of-orphan-biologics-c… -
PTC Therapeutics
@PTCBio
Thanks for sharing our upcoming webinar details, @MitoAction. We hope you can join us on Tuesday!
MitoAction
@MitoAction
Join PTC Therapeutics for “Holistic Inspirations,” an upcoming Insightful Moments webinar on April 18th at 7:00pm EST. Click to learn more about the Holistic Inspirations roadmaps and additional educational programs.
Visit: www.ptcbio.com/insightful-moments/ -
PTC Therapeutics
@PTCBio
This morning, PTC shared it would host a webcast conference call at 4:30 p.m. ET on April 27 to report its first quarter 2023 financial results and provide a business update. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Learn about #aadcdeficiency, its symptoms, causes, diagnosis and more. #aadcd #raredisease
Teach RARE
@edu4rare
Aromatic L-Amino Acid Decarboxylase Deficiency,
AADC deficiency, is a #genetic neurotransmitter disorder. The AADC enzyme helps make serotonin and dopamine. People with this #raredisease don’t make enough AADC enzyme 📑 teachrare.org/rare-diseases/aadc-deficiency/ -
PTC Therapeutics
@PTCBio
PTC is proud to announce we’ve been named a winner of the 2023 Don Clifton Strengths-Based Culture Award. Learn more and read perspectives from PTC employees on their #cliftonstrengths results:
-
PTC Therapeutics
@PTCBio
Living with a #raredisease or supporting someone with a rare disease can be stressful. Watch to learn how to conquer stress through prioritizing personal space.
This media couldn't be displayed. See it on the original post. -
PTC Therapeutics
@PTCBio
We're happy to partner with you again, @UMDF! #mitomed2023
United Mitochondrial Disease Foundation
@UMDF
Welcome back, @PTCBio -- a returning symposium sponsor. We appreciate your long-time dedication to the mito community. For more information about sponsorship, visit www.umdf.org/symposium #mitomed2023
-
PTC Therapeutics
@PTCBio
PTC's Amy-Lee Bredlau presented "mRNA Splicing Platforms: Everything You Wanted to Know" at the @HDYOFeed Congress and it was a highlight for Riley from Canada. Check out the other favorite moments in this video. #huntingtonsdisease
HDYO
@HDYOFeed
We're still celebrating the success and impact of the HDYO Congress in Glasgow! But don't take it from us...hear the voices of some of our attendees on why these events matter. @TIC_conferences @EHDN_GRANTM @EuroHuntington @HDA_tweeting @HuntingtonSC
youtu.be/iVgXCMvM7IY -
PTC Therapeutics
@PTCBio
As the President and CEO of @BioNJ_Org, Debbie Hart has made a huge impact on the life sciences industry in New Jersey – and formed an incredible partnership with PTC along the way. Read more about Debbie’s Remarkable Story: www.ptcbio.com/posts/25-remarkable-stories-palpable-elect…
-
PTC Therapeutics
@PTCBio
We were happy to join the Akari Foundation at its family workshop in San Juan, Puerto Rico on Saturday. Families in attendance were thankful for access to resources in Spanish, their primary language. Learn more about PTC's Spanish resources: www.ptcbio.com/momentos-de-claridad/
-
PTC Therapeutics
@PTCBio
We’re kicking off a new series to commemorate our 25th anniversary as a publicly traded company: 25 Remarkable Stories. Learn more about the series and stay tuned for more: www.ptcbio.com/posts/introducing-25-remarkable-stories-ce…
-
PTC Therapeutics
@PTCBio
During the month of March, PTC employees were excited to be in-person again with #raredisease families. We were honored to offer lab tours in Hopewell and South Plainfield, NJ to patients and family members who have been impacted by Angelman Syndrome and Friedreich Ataxia.
-
PTC Therapeutics
@PTCBio
Living with a #raredisease is like being in a constant storm at sea. Practicing mindfulness and taking care of emotional wellbeing is an important part of the journey. Learn more about discovering wellness: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
Navigating the balancing act of raising a child with a #raredisease in addition to other children is difficult. Click here to check out tips from our Parent Roadmap on how you can support yourself and your children: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
PTC's Paula Orandash and Emily McNulty attended the first rideATAXIA for 2023 in Gainesville, FL. They are pictured with Kyle Bryant (R), who started rideATAXIA, a nationwide program to raise funds for @CureFA_org's mission to treat and cure Friedreich’s ataxia through research.
-
PTC Therapeutics
@PTCBio
Register to join tomorrow's live webinar on the importance of #genetictesting for the diagnosis of #duchenne muscular dystrophy: ptcwebinars.com/dmd/q1/
-
PTC Therapeutics
@PTCBio
This morning, PTC shared that Stuart Peltz, Ph.D., a #raredisease pioneer, will retire as Chief Executive Officer. A conference call will be held today, March 24, at 8:30 a.m. ET. Read more: ir.ptcbio.com/news-releases/news-release-details/stuart-p…
-
PTC Therapeutics
@PTCBio
Genentech shared new long-term data for Evrysdi® (risdiplam) in a broad range of people aged 2-25 years with spinal muscular atrophy (SMA) at the #mdaconference. Evrysdi is a product of the SMA collaboration between PTC, the SMA Foundation, and Genentech.
Genentech
@genentech
ICYMI: During #mdaconference we presented new data evaluating the long-term efficacy and safety of our medicine for spinal muscular atrophy (SMA) in people with Type 2 and non-ambulant Type 3 #sma. Learn more: www.gene.com/media/press-releases/14985/2023-03-19/new-fo…
-
PTC Therapeutics
@PTCBio
Being a sibling of someone with a #raredisease can bring up a lot of different emotions. Click here to check out our sibling roadmap, created to help siblings on their journey: www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
We’re looking forward to staffing a booth at the 38th Annual #hdsaconvention and recording #raredisease family stories for Insightful Moments My VIBE. Listen to previous recordings here: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
HDSA
@HDSA
Thank you @PTCBio for being a Bronze Sponsor at the 38th Annual #hdsaconvention!
To learn more about Sponsorship, Exhibitor and Registration information, please visit hdsa.org/convention
#letstalkabouthd #huntingtonsdisease #hdsafamily #neworleans #nola -
PTC Therapeutics
@PTCBio
Five fair neuromuscular #raredisease registries now provide joint answers to questions from researchers or patients
World Duchenne Organization
@worldduchenne
🤝 Due to the joint work of ERN @euro_nmd and the FAIRification team at @radboudumc, it is now possible to conduct queries related to neuromuscular diseases in multiple, independent registries simultaneously without exposing sensitive patient details.
www.worldduchenne.org/news/five-fair-neuromuscular-rare-d… -
PTC Therapeutics
@PTCBio
Rare Topic for a Rare Disease: 2023 Education Conference for HD Families is a free in-person and virtual series. Join us March 25 in Raleigh, NC. Register today! conference.hdreach.org
-
PTC Therapeutics
@PTCBio
Join experts on March 28 as they discuss the role of #genetictesting in #duchenne muscular dystrophy and share best practices in how to reach an accurate diagnosis. Register today! ptcwebinars.com/dmd/q1/
-
PTC Therapeutics
@PTCBio
ICYMI: Listen to archived webcasts from March, including the Raymond James 44th Annual Institutional Investor Conference, the Cowen 43rd Annual Health Care Conference and Barclays Global Healthcare Conference. ir.ptcbio.com/events-presentations
-
PTC Therapeutics
@PTCBio
Swing by Booth 620 at the 2023 MDA Clinical & Scientific Conference until 5 p.m. today to chat with PTC's Edward Ward, Margaret McCloskey and Kyle Raventos. #mdaconference
-
PTC Therapeutics
@PTCBio
Join PTC tomorrow at 7 a.m. CDT for a sponsored Industry Forum for #healthcare professionals at the 2023 MDA Clinical & Scientific Conference, discussing treatment in #duchenne muscular dystrophy. Registered in-person and virtual conference delegates may click to RSVP.
-
PTC Therapeutics
@PTCBio
As an educational grant sponsor, we’re looking forward to the ESMO Sarcoma and Rare Cancers Congress 2023 and to continue developing treatments for LMS patients. Learn more about our ongoing Phase 2/3 SUNRISELMS Trial and our efforts in oncology: www.ptcbio.com/therapeutic-areas/leiomyosarcoma/
-
PTC Therapeutics
@PTCBio
Excitement beats out jet lag today for Day 1 of the HDYO International Young Adults Congress in Glasgow, Scotland #hdyoglasgow2023 #hdyocongress #huntingtonsdisease @HDYOFeed
-
PTC Therapeutics
@PTCBio
Attending #simd2023? Meet the PTC Team at Booth 108 and learn about a rare neurometabolic disorder #aadcdeficiency. #neurometabolicdisorders #metabolicdisorders #aadcd #rarediseases
-
PTC Therapeutics
@PTCBio
We’re proud to sponsor the Diagnostic Challenges evening on March 17 from 5:30-7 p.m. at #acmg2023. The event will feature interactive sessions, which will allow genetics professionals to present cases of rare knowns and unknowns, as well as share best practices. #rarediseases
-
PTC Therapeutics
@PTCBio
NEW RELEASE: Cardiomyopathy associated with #dmd in our latest #takeonduchenne podcast with Dr. Linda Cripe. Tune in to an in-depth conversation about navigating cardiovascular care for manifesting carriers. #duchenne #raredisease www.ptcbio.com/posts/take-on-duchenne-podcast-cardiomyopa…
-
PTC Therapeutics
@PTCBio
Our CEO Stuart Peltz was among the 7 experts interviewed for this @Labiotech_eu piece, "5 reasons why collaboration is important in research." www.labiotech.eu/expert-advice/importance-of-research-col…
-
PTC Therapeutics
@PTCBio
We’re excited to sponsor the Sarcoma Conference 2023 and to continue developing treatments for leiomyosarcoma (LMS) patients. Learn more about our ongoing Phase 2/3 SUNRISELMS Trial and how PTC is working to treat advanced LMS: www.ptcbio.com/therapeutic-areas/leiomyosarcoma/
-
PTC Therapeutics
@PTCBio
Are you attending #acmg2023? Visit our team at Booth 508 to learn about #ptcpinpoint, a no-charge #genetictesting program to help support patients with suspected neurotransmitter disorders or Cerebral Palsy with unknown etiology. #aadcdeficiency #aadcd
-
PTC Therapeutics
@PTCBio
Christian Werner, global medical affairs lead for #duchenne at PTC, shares his thoughts on the importance of looking at the totality of evidence to improve #patientaccess to treatments. #raredisease www.linkedin.com/posts/christian-werner-661b1013_clinical…
-
PTC Therapeutics
@PTCBio
Attending #acmg2023? Stop by Booth 506 and meet Ryan Miller, a certified genetic counselor, to discuss the diagnostic challenges of #aadcd (Aromatic L-amino decarboxylase deficiency). #aadcdeficiency #raredisease #genechat
-
PTC Therapeutics
@PTCBio
Join us for a discussion on the treatment of #duchenne muscular dystrophy, along with breakfast, on March 20 at the 2023 MDA Clinical and Scientific Conference. PTC is excited to sponsor this event for #healthcare professionals. Learn more and RSVP: www.ptcif2023.com
-
PTC Therapeutics
@PTCBio
Join us at 8:00 a.m. EDT tomorrow, March 14, for our live webcast at Barclays Global Healthcare Conference. Register and listen here: event.webcasts.com/starthere.jsp?ei=1599090&tp_key=420bfd…
-
PTC Therapeutics
@PTCBio
Here's the opportunity to be recognized for the amazing work you’re doing to support people living with #duchenne. There is one week left to apply for the 2023 STRIVE grant award. Head to www.ptcbio.com/grants-and-donations/strive-awards-program/ to submit your application today!
-
PTC Therapeutics
@PTCBio
.@HDYOFeed's Young Adults Congress is the first opportunity to meet the international community of young people, families and professionals impacted by #huntingtonsdisease, and we wouldn't miss it! We are proud to participate at the event sponsorship level and also to present.
-
PTC Therapeutics
@PTCBio
We’re proud to support @worldduchenne and its “Help has no borders” launch. This video shows how families with children and young people with #duchenne and Becker muscular dystrophy find support in emergencies. #raredisease #dmdemergencyprogram
World Duchenne Organization
@worldduchenne
Exciting news! 📢 The documentary 'Help has no borders' is now out. The documentary showcases the work of the DMD Emergency Program, providing support to families living with Duchenne & Becker MD affected by disasters.
#dmdemergencyprogram #rarediseaseday
worldduchenne.org/news/help-has-no-borders-the-dmd-emerge… -
PTC Therapeutics
@PTCBio
We’re excited to present at 12:50 p.m. EST tomorrow, March 7, at the Cowen 43rd Annual Health Care Conference. Register and join us here: wsw.com/webcast/cowen132/register.aspx?conf=cowen132&page…
-
PTC Therapeutics
@PTCBio
We’re presenting at 8:05 a.m. EST tomorrow, March 6, at the Raymond James 44th Annual Institutional Investor Conference. Register and listen to the webcast here: wsw.com/webcast/rj127/register.aspx?conf=rj127&page=ptct&…
-
PTC Therapeutics
@PTCBio
We are excited to be included in the @Labiotech_eu list of biotech companies making a difference in rare diseases #raredisease #rarediseaseday www.labiotech.eu/best-biotech/10-biotech-companies-rare-d…
-
PTC Therapeutics
@PTCBio
PTC congratulates Dr. Allan Jacobson, co-founder of PTC and member of the board of directors, on his award of the 2023 Gruber Genetics Prize. Read more: gruber.yale.edu/search/node. Congrats, @ajplanetearth!
-
PTC Therapeutics
@PTCBio
PTC employees are excited to celebrate #rarediseaseday by highlighting some of the patient advocacy organizations we support. Thank you all for your commitment to #raredisese patients, families and caregivers!
-
PTC Therapeutics
@PTCBio
#rarediseaseday is quickly approaching! Here are 5 ways PTC employees are honoring this important day. www.ptcbio.com/posts/pioneering-treatments-for-rare-disea…
-
PTC Therapeutics
@PTCBio
Jillian Heger was the fourth child in the world to be diagnosed with #aadcdeficiency. Learn about her journey and #raredisease through the words of her Mom and caregiver Kelly: themighty.com
-
PTC Therapeutics
@PTCBio
The Journal of Clinical Pharmacology’s supplement on #rarediseases includes “Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein,” written by PTC Clinical Pharmacology teammates. accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2172
-
PTC Therapeutics
@PTCBio
The #eurordisawards2023 concluded with a celebration of achievements and commitment by individuals, organizations and companies dedicated to making a difference for the #raredisease community. Our PTC team was proud to be present and receive the Company Award for Innovation 2023.
-
PTC Therapeutics
@PTCBio
This afternoon, PTC announced a corporate update and financial results for the fourth quarter and full year ending December 31, 2022. Learn why Stuart Peltz, Ph.D., Chief Executive Officer says 2023 will be a very exciting year at PTC: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
PTC announced this morning that the company will present at three investor conferences in March: Raymond James 44th Annual Institutional Investor Conference, Cowen 43rd Annual Health Care Conference and Barclays Global Healthcare Conference. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Thank you for hosting us, @defeatduchenne!
Defeat Duchenne Canada
@defeatduchenne
We were thrilled to host @PTCBio for a visit earlier this month and hear about their programs, services, and drug development for our #duchenne #musculardystrophy community. Thank you, PTC Therapeutics, for joining Defeat Duchenne Canada as a Platinum Education Partner for 2023!
-
PTC Therapeutics
@PTCBio
There is one month left to apply for a 2023 STRIVE grant! Continue your advocacy work to support people living with #duchenne in your community. Head to www.ptcbio.com/grants-and-donations/strive-awards-program/ to apply today.
-
PTC Therapeutics
@PTCBio
Huge thanks to Dr. @DelegateDonna for helping PTC employees learn about #raredisease in the Black community, healthcare disparities, the importance of education and trust, diversity in clinical trials and much more during today’s webinar in recognition of #blackhistorymonth.
Institute for Gene Therapies
@gene_therapies
Thank you @PTCBio for including @DelegateDonna in this morning’s webinar “Rare Disease in the Black Community” in celebration of #blackhistorymonth.
-
PTC Therapeutics
@PTCBio
ICYMI: PTC leaders shared a business update at @SVB Securities' 2023 Global Biopharma Conference earlier this week. Watch the ~30 min. fireside chat (registration required): wsw.com/webcast/svb8/register.aspx?conf=svb8&page=ptct&ur…
-
PTC Therapeutics
@PTCBio
PTC will join the Angelman Syndrome community to recognize International #angelmansyndrome Day on February 15, 2023. Read more about this rare genetic disorder that mainly affects the nervous system: www.ptcbio.com/therapeutic-areas/angelman-syndrome/ #raredisease
-
PTC Therapeutics
@PTCBio
We believe every story in the #raredisease community deserves to be told. Thanks for sharing, @AmazeMediaLabs! Listen here: www.ptcbio.com/my-vibe-my-voice-is-inspirational-brave-an…
Amaze Media Labs
@AmazeMediaLabs
February 13-18 is National Duchenne Muscular Dystrophy Awareness Week! 💪
Take some time to listen to the first 4 episode of #insightfulmoments: My VIBE from @PTCBio & hear all about the experience of living with DMD - straight from patients, family members, and caregivers! -
PTC Therapeutics
@PTCBio
PTC is honored to continue to serve on @BioNJ_Org's Board of Directors to support New Jersey's life science community, improve patient access to medicine and protect medical innovation. njbmagazine.com/njb-news-now/bionj-elects-board-chair-off…
-
PTC Therapeutics
@PTCBio
What’s so special about 2023 for PTC? Read more to learn about this meaningful, unique, and thrilling year: www.ptcbio.com/2023/02/09/whats-so-special-about-2023/
-
PTC Therapeutics
@PTCBio
PTC announced this afternoon that the company will host a call to report its fourth quarter and full year 2022 financial results and provide an update on the company's business and outlook at 4:30 p.m. ET on Tuesday, Feb. 21. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Join @Hege_Sollie on Tuesday, Feb. 21 at the LEAP HR: Life Sciences Europe Summit. For more information, visit leaphr-lifesciences-europe.com.
Hege Sollie-Zetlmayer
@Hege_Sollie
I am so honoured to be speaking at this year's LEAP HR: Life Sciences Europe Summit! It's set to be a fantastic event, and I hope to see you there! #hr #employeewellbeing #belonging
-
PTC Therapeutics
@PTCBio
PTC is honored to receive this award. Thank you, @eurordis, for recognizing our continued commitment to serving the #raredisease community. #eurordisawards2023
EURORDIS-Rare Diseases Europe
@eurordis
This year’s EURORDIS Company Award for Innovation recognises @PTCBio’s breakthrough, novel therapies and continued research commitment to underserved disease areas.
Learn more: www.eurordis.org/black-pearl-awards/awardees/
#eurordisawards2023 -
PTC Therapeutics
@PTCBio
This morning, PTC shared that the company has been named the winner of the 2023 @EURORDIS Black Pearl Company Award for Innovation. This is especially meaningful as PTC employees celebrate the company’s 25 years of serving the #raredisease community. ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
This afternoon, PTC announced that the company will present a company overview at the SVB Securities Global Biopharma Conference at 9:20 a.m. EST on Tuesday, Feb. 14. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics reposted
ALS Advocacy
@alsadvocacy
Utreloxastat, an investigational therapy for ALS, was safe and displayed promising pharmacological properties in study of healthy people. alsnewstoday.com/news/als-study-results-clear-way-test-ut…
-
PTC Therapeutics reposted
VJ Neurology
@VJNeurology
💊The PIVOT-HD trial: splicing modification
@DrBredlau, Lee Golden and Brian Beers (@PTCBio) introduce a promising HTT-lowering candidate for the treatment of #huntingtonsdisease
➡️www.vjneurology.com/video/ib3hz-gvfla-phase-ii-piovt-hd-t…
@EHDN_News #ehdn2022 #neurotwitter #neurology -
PTC Therapeutics
@PTCBio
Thank you, @NPKUA_Info, for helping spread the word about next Wednesday's webinar to discuss the impact of #raredisease on siblings.
NPKUA
@NPKUA_Info
PTC Therapeutics will be hosting a virtual speaker event, with Emily McNulty M.S. CCLS titled, "The Impact of Rare Disease on Siblings," on Wednesday January 18 at 7pm ET. Click the link to register: ptcbio.zoom.us/webinar/register/5516697705986/WN_wfjcI9Ci…
PTC Therapeutics
@PTCBio
The Insightful Moments sibling program webinar recording is now available on our website in the Sibling Support section. We are planning to hold this program for parents on March 29 and to present a program in Spanish this June. www.ptcbio.com/insightful-moments/
-
PTC Therapeutics
@PTCBio
Thank you to @AADCFamilyNtwk for sharing your inspiring #aadcdeficiency story with @PharmaTimes. #aadcd #raredisease magazine.pharmatimes.com
-
PTC Therapeutics
@PTCBio
#aadcdeficiency is a rare genetic disorder which is frequently misdiagnosed. Thank you @edu4rare for sharing your journey. #aadcd #raredisease
AP Health & Science
@APHealthScience
Scientists say a new way of delivering gene therapy -- directly to the brain -- holds promise for treating a host of brain disorders. It was recently approved in Europe and the U.K. for a rare genetic disease. apne.ws/jDVdcgx
-
PTC Therapeutics
@PTCBio
PTC is proud to be a part of the @cure_mito Foundation’s newly launched Corporate Advisory Council to accelerate the development and delivery of treatments.
CureMITO
@cure_mito
In collaboration with five of the industry’s prominent rare disease companies @PTCBio @AstellasUS Saol Therapeutics, Standigm, and Abliva, we announce the launch of a unique Corporate Advisory Council (CAC).
www.eurekalert.org/news-releases/976914
#leighsyndrome #mitochondrialdisese #mito -
PTC Therapeutics
@PTCBio
The BBC recently released an interview with the Poulin family and Dr. Hwu, which covers life for the family both pre- and post- #genetherapy, an overview of #aadcd, a description from Dr. Hwu on how gene therapy is delivered and more. Listen here: www.bbc.co.uk/sounds/play/w3ct32xl
-
PTC Therapeutics
@PTCBio
This week’s @neurology_live Brain Games is focused on #aadcdeficiency. Test your knowledge!
NeurologyLive®
@neurology_live
Test your neurology knowledge today with #braingames! This week's questions (which include a fourth bonus question) have the theme of genetic neurological disorders, specifically AADC deficiency disorder, submitted by @PTCBio.
👉 Check it out here: www.neurologylive.com/view/neurologylive-brain-games-janu… -
PTC Therapeutics
@PTCBio
Conor and his teammates took home the AIB GAA Football All-Ireland Senior Club Championship. Pictured below with his mother, aunty, uncle, cousins and friends. Conor is a Senior Financial Analyst at PTC and we couldn’t be more proud!
Kilmacud Crokes GAA
@KCrokesGAAClub
Saint Conor Ferris #passionliveshere
-
PTC Therapeutics
@PTCBio
Now it its 9th year, the PTC STRIVE Awards Program helps address the needs of people living with #duchenne. Support your advocacy project and help the Duchenne community across the world by submitting an application here: www.ptcbio.com/grants-and-donations/strive-awards-program/
-
PTC Therapeutics reposted
NICE
@NICEComms
Today we’ve published final draft guidance which now recommends ataluren for routine NHS funding for treating Duchenne muscular dystrophy caused by a nonsense mutation. You can read the draft guidance here: www.nice.org.uk/guidance/gid-hst10044/documents/html-cont…
-
PTC Therapeutics
@PTCBio
This morning, PTC announced that the National Institute for Health and Care Excellence has issued a Final Evaluation Document recommending Translarna™ (ataluren) for reimbursement and use across the National Health Service in England and Wales. Read more: ir.ptcbio.com/news-releases/news-release-details/nice-rec…
-
PTC Therapeutics
@PTCBio
Thanks to @BioNJ_Org for sharing our #jobopportunities. Join PTC as we celebrate our 25th year in #raredisease!
BioNJ
@BioNJ_Org
PTC Therapeutics is #hiring! Take a look at their new job postings along with many other career opportunities and #apply today! Visit #bionj’s Career Portal often, new jobs posted daily. www.bionjtalentnetwork.org/company/ptc-therapeutics-6100
-
PTC Therapeutics
@PTCBio
For 25 years, PTC has remained committed to supporting #raredisease families. This morning, we launched the ninth annual STRIVE™ awards program to help people living with #duchenne around the world. Read more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
This week’s @neurology_live Brain Games is focused on #duchenne muscular dystrophy. Test your knowledge!
NeurologyLive®
@neurology_live
Test your neurology knowledge today with #braingames! This week's topic is neuromuscular disorders, specifically Duchenne muscular dystrophy, submitted by PTC Therapeutics.
👉 Check it out here: www.neurologylive.com/view/neurologylive-brain-games-janu… -
PTC Therapeutics
@PTCBio
PTC will provide an update on commercial progress and R&D pipeline at the 41st Annual J.P. Morgan Healthcare Conference this morning. #jpm23 Read the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
This afternoon, PTC announced its participation in the upcoming J.P. Morgan Healthcare Conference. PTC will present a company overview at 7:30 a.m. PST/10:30 a.m. EST on Monday, Jan. 9. Read the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Happy Holidays to our valued @Screen4Care partners and #raredisease community. We look forward to continuing our work together in 2023 to shorten the path to rare disease diagnosis.
Screen4Care
@Screen4Care
What a year it's been! Presentations at various events, comms activities and of course tireless research—with some of the first results published 💫
After a short break, we'll keep working just as actively on shortening the path to rare disease diagnosis next year! #screen4care -
PTC Therapeutics
@PTCBio
For PTC, 2022 was a milestone-reaching, patient-supporting, award-winning, employee-engaging, community-driven year. Learn more about moments we’re most proud of: www.ptcbio.com/posts/2022-a-year-of-many-firsts/
-
PTC Therapeutics reposted
BioNJ
@BioNJ_Org
In a new BioNJ guest blog, Dr. Ellen Welch of @PTCBio shares her perspective on the importance of protecting medical #innovation to better the lives of Patients with rare diseases. Learn more here: bionj.org/protect-medical-innovation/guest-blog/hear-from…
-
PTC Therapeutics
@PTCBio
Thanks to @BioNJ_Org for taking the time to sit down with our Chief Scientific Officer, Dr. Ellen Welch. Check out this short video about why medical innovation is critical to bringing new treatments to patients.
BioNJ
@BioNJ_Org
Emerging threats to medical #innovation could leave Patients with a rare disease with fewer, or perhaps even no, treatment options. Hear from @PTCBio’s Dr. Ellen Welch on the importance of protecting innovation in her recent conversation with BioNJ: bionj.org/protect-medical-innovation/guest-blog/hear-from…
-
PTC Therapeutics
@PTCBio
Congratulations to our HR team in Ireland and to all finalists!
CIPD Ireland
@cipdireland
Many thanks to @McCannFitz for their support in sponsoring the #cipdhrawards 2023 People team of the year category!
Well done to all the finalists👏🎉
Book your ceremony ticket: www.eventbrite.ie/e/cipd-ireland-hr-awards-2023-recognisi…
#hr #peopleteam #peopleprofession #awards -
PTC Therapeutics
@PTCBio
Elijah is such an inspiration to us. Thank you for sharing his story!
RARE Revolution Magazine®
@RareRevolutionM
The global movement, #duchennecan, has drawn inspiration from witnessing what people living with #duchenne CAN achieve. From graduating as genetic scientists to winning #olympicgoldmedals… everything is possible.
rarerevolutionmagazine.com/duchennecan-celebrating-what-p… -
PTC Therapeutics
@PTCBio
#takeonduchenne North America podcast recently launched episode dedicated to Women in Duchenne. Tune in to hear three incredible women discuss unique challenges and experiences in the world of Duchenne: www.ptcbio.com/2021/12/21/podcast-take-on-duchenne/
-
PTC Therapeutics
@PTCBio
Congratulations to all finalists and winners in @Reuter’s Pharma Awards USA 2022. We are proud of our #duchenne Muscular Dystrophy Case Player, which was recognized as a finalist in the Most Valuable HCP Initiative Award category. patientcaseplayer.com/DMDCaseplayer/v2/app_offline.htm
-
PTC Therapeutics
@PTCBio
Today we announced our treatment for familial partial lipodystrophy (FPL) was approved by ANVISA, the regulatory authority in Brazil. This is the first ever approval for treatment for FPL. Read more about the news: ir.ptcbio.com/news-releases/news-release-details/brazilia…
-
PTC Therapeutics
@PTCBio
Join experts on December 6 for a live webinar on the latest data in DMD management across the disease continuum. Live Portuguese and Spanish translations available.
For HCPs only. Product-related information will be discussed. Register today: ptcwebinars.com/dmd/q4/ -
PTC Therapeutics
@PTCBio
Today, PTC announced that Upstaza™ was granted marketing authorization by the Medicines and Healthcare Products Regulatory Agency in Great Britain for treatment for AADC deficiency in patients 18 months and older. Read the press release: ir.ptcbio.com/news-releases/news-release-details/upstazat…
-
PTC Therapeutics reposted
EUCOPE
@EUCOPE
#wodc - @ThomasBols from our member @PTCBio discussing the importance and power of cross-border healthcare as a tool to enable timely patient access. #atmps @orphan_drugs
-
PTC Therapeutics
@PTCBio
We were thrilled to attend last week's Pharma Industry Awards 2022 ceremony in Ireland. PTC was represented in two categories alongside remarkable finalists in Ireland’s pharma industry. #pharmaawardsirl Read more in our newsroom: www.ptcbio.com/posts/ptc-is-a-finalist-in-two-pharma-indu…
-
PTC Therapeutics
@PTCBio
Thomas Bols will share his perspective on cross-border healthcare as a powerful tool to enable timely patient access on Nov. 17 at the World Orphan Drug Congress. Learn more and register here: www.terrapinn.com/conference/world-orphan-drug-congress/i… #wodc
-
PTC Therapeutics
@PTCBio
Our colleagues are pleased to be with distinguished experts at the 7th Annual @SPNSKSA conference. They're looking forward to Saturday’s presentation on #duchenne muscular dystrophy, PTC's talk on #genetherapy, and many more exchanges to advance patient outcomes.
-
PTC Therapeutics
@PTCBio
It is encouraging to see the tremendous progress toward accelerating #raredisease diagnosis. PTC is looking forward to continued collaboration with our 36 international partners on screen4care.eu, now available in German, Italian and French.
Screen4Care
@Screen4Care
💫Today, all #screen4care partners are coming together for the #annualmeeting, which marks one year activity!
As we look to the future, we’re reviewing all the work done until now—here is a small taste 👇
And now back to work to shorten the path to #raredisease diagnosis! -
PTC Therapeutics
@PTCBio
Last week in Switzerland, our team made a contribution to reforestation by planting trees in partnership with @onetreeplanted and Almighty Tree. Kudos to our teammates for delivering on PTC's commitment to the environment. Read more: www.ptcbio.com/posts/ptc-planting-trees-for-the-future/
-
PTC Therapeutics reposted
EUCOPE
@EUCOPE
🔦In our latest #memberspotlight, we spoke with Adrian Haigh of @PTCBio about the biggest challenges facing #atmps and the key pieces of legislation to watch out for in the future.
Full Q&A ➡️ www.eucope.org/eucope-member-spotlight-qa-with-ptc-therap…
#membershipmatters #rarediseases -
PTC Therapeutics
@PTCBio
Thomas Bols shares his perspective on how preparing Europe for a new generation of innovative therapies has the potential to transform the lives of #patients. Read more: www.ptcbio.com/posts/preparing-europe-for-a-new-generatio…
-
PTC Therapeutics
@PTCBio
Today, we announced our third quarter 2022 financial results and an update on our business outlook. Read more in the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, we shared our third quarter 2022 financial results and an update on our business outlook. Check out some of the highlights.
-
PTC Therapeutics
@PTCBio
Join us today at 4:30 p.m. ET for our third quarter 2022 financial results webcast. Register here: ir.ptcbio.com/events/event-details/ptc-3rd-quarter-2022-f…
-
PTC Therapeutics
@PTCBio
Today, the @AADCFamilyNtwk will host a Facebook Live event at 11 a.m. ET in honor of AADC Deficiency Awareness Day on Sunday with special guests from the community. Learn more about the AADC Family Network and founder Kelly Heger’s story here: www.insider.com/nurse-mom-genetic-condition-care-trained-…
-
PTC Therapeutics
@PTCBio
We’re proud to support the @AADCFamilyNtwk’s informative Facebook event for the AADC community on Friday, Oct. 21at 11 a.m. ET in honor of #aadcdeficiency Awareness Day. This special program will include guests from the AADC community. We hope to see you there!
-
PTC Therapeutics
@PTCBio
For the third year, PTC will join the AADC deficiency community to celebrate and honor AADC Deficiency Awareness Day on Oct. 23. Read more about the history of this milestone and the organizations involved: www.ptcbio.com/posts/honoring-aadc-deficiency-awareness-d…
-
PTC Therapeutics
@PTCBio
Join PTC today at 5:30PM ET for a sponsored educational symposium for #healthcare professionals attending the 51st #cns Annual Meeting. The symposium will review #aadcdeficiency & discuss experience with an investigational treatment for this #raredisease web.cvent.com/event/0da5b916-dd22-43f3-bc65-c23d8503d2cb/…
-
PTC Therapeutics
@PTCBio
Congratulations to our #striveaward recipient, @ActionDuchenne! Their initiative will establish training courses to support young people with #duchenne in the UK as they transition into adulthood. Find out more: www.ptcbio.com/posts/2022-strive-award-recipient-action-d…
-
PTC Therapeutics
@PTCBio
Join PTC on 10/13 for a sponsored educational symposium for #healthcare professionals attending the 51st #cns Annual Meeting. The program will review #aadcdeficiency & discuss experience with an investigational treatment for this neurological #raredisease. web.cvent.com/event/0da5b916-dd22-43f3-bc65-c23d8503d2cb/…
-
PTC Therapeutics
@PTCBio
We are pleased to be attending the #wms2022 Congress this week and present our latest clinical and real-world data for #duchenne. Find out more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther… #wms2022
-
PTC Therapeutics
@PTCBio
This week, we’re looking forward to attending the 29th European Society of Gene & Cell Therapy Congress and participating in important discussions on our #aadcdeficiency program. We hope to see you there. #esgct2022
-
PTC Therapeutics
@PTCBio
PTC’s Matthew Klein, MD, Chief Operating Officer, is presenting at the 2022 Cell & Gene Meeting on the Mesa as part of a plenary session on #genetherapy. Learn more about the conference and register here: meetingonthemesa.com/registration/ #cgmesa22
-
PTC Therapeutics
@PTCBio
MDA Hellas, one of this year’s #striveaward recipients, will be producing a short film focused on sexuality with #duchenne, a topic which has long been viewed as taboo! Well done @mdahellas – and congratulations! Find out more: www.ptcbio.com/posts/2022-strive-award-recipient-mda-hellas/
-
PTC Therapeutics
@PTCBio
This week at the 17th International Child Neurology Conference, we're looking forward to participating in important discussions and sharing updates on our #duchenne muscular dystrophy and #aadcdeficiency programs. Learn more: icnapedia.org/congress/icnc2022 #icnc2022
-
PTC Therapeutics
@PTCBio
Thank you Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC for sharing your thoughts on the future of innovation and the potential of EU’s growth in healthcare biotechnology excellence. Watch the video from EuropaBio below:
EuropaBio
@EuropaBio
#innovation #investment #excellence
.@ThomasBols, @PTCBio shares his thoughts on why a revision of #eu #pharmaceutical legislation and Orphan regulation is a perfect opportunity to make #europe the world's most innovative #biotech region.🚀
🎥Listen www.youtube.com/watch?v=7eJWYzM9drk&t=3s -
PTC Therapeutics
@PTCBio
As a second-time recipient following their award in 2018, @KasDernek will use this year’s #striveaward grant to expand their online psychological support programme for people with #duchenne in Turkey. Congratulations! Find out more about KASDER: www.ptcbio.com/posts/2022-strive-award-recipient-neuromus…
-
PTC Therapeutics
@PTCBio
We're delighted to announce that we've been shortlisted for two awards at the upcoming Pharma Industry Awards 2022 for Biotech Company of the Year and Supply Chain Achievement Award! We look forward to the awards ceremony on the 10 Nov! #pharmaawardsirl
-
PTC Therapeutics
@PTCBio
Congratulations to Associacao Cearense de Distrofias Musculares (ACDM), one of this year’s #striveaward recipients! Their initiative will ensure no student with #duchenne is left behind in Brazil. Find out more about ACDM: www.ptcbio.com/posts/2022-strive-award-recipient-acdm/
-
PTC Therapeutics
@PTCBio
This #mitoawarenessweek, join us virtually today for the @Cure_Mito Virtual Symposium! Matthew Klein, MD, Chief Operating Officer, PTC, will be sharing an overview of PTC’s #mitochondrialdisease programs. Register here: www.curemito.org/news-updates/
-
PTC Therapeutics
@PTCBio
We are proud to announce the launch of Insightful Moments My VIBE! We believe every story in the #raredisease community deserves to be told. Check out the trailer below and stay tuned for more episodes: insightful-moments-my-vibe.simplecast.com/episodes/welcom…
-
PTC Therapeutics
@PTCBio
Today, PTC’s Paula Orandash, Patient Engagement Liaison, will be speaking at the @GlobalGenes 2022 RARE Patient Advocacy Summit in San Diego on industry’s commitment to patient education & community resources. We hope to see you there! #ggsummit22
-
PTC Therapeutics
@PTCBio
Today, we’re presenting at the Morgan Stanley Global Healthcare Conference in New York. Click here to watch the webcast: ir.ptcbio.com/events/event-details/morgan-stanley-20th-an…
-
PTC Therapeutics
@PTCBio
Members of PTC’s Patient Engagement team will be attending the @GlobalGenes 2022 RARE Patient Advocacy Summit in San Diego. Meet the team at the PTC Insightful Moments booth # 404. #ggsummit22
-
PTC Therapeutics
@PTCBio
We’re at #esmo22! Tomorrow, we look forward to presenting an overview of SUNRISELMS, our ongoing phase II/III study evaluating the efficacy and safety of unesbulin in advanced #leiomyosarcoma, at the Sarcoma Poster Session.
-
PTC Therapeutics
@PTCBio
Today, we’re presenting at the Wells Fargo Healthcare Conference. Click here to watch the webcast: ir.ptcbio.com/events/event-details/wells-fargo-17th-annua…
-
PTC Therapeutics
@PTCBio
To honor #worldduchenneawareness Day, we’re highlighting and celebrating inspiring women in the Duchenne community. Read their incredible stories: www.ptcbio.com/posts/world-duchenne-awareness-day-celebra…
-
PTC Therapeutics
@PTCBio
This #worldduchenneawarenessday, we are thrilled to announce our 2022 #striveawards recipients. Congratulations to all the recipients whose projects will provide incredible support to the #duchenne communities in Greece, Brazil, Turkey and the UK.
#duchennemusculardystrophy -
PTC Therapeutics
@PTCBio
In 2021, @PathfindersNMA received the #striveaward to create information resources helping young people living with #duchenne transition into adulthood. Find out what they’ve achieved this year: www.ptcbio.com/posts/strive-living-full-lives-achieving-y…
#duchennemusculardystrophy -
PTC Therapeutics
@PTCBio
2021 #striveaward recipient AGADIM used their grant to create the ‘Duchenne Fraternity House’ project to improve the quality of life of adults living with #duchenne in Brazil. Click to watch the video to learn more about their journey so far www.ptcbio.com/posts/strive-republica-duchenne/
-
PTC Therapeutics
@PTCBio
This week at #ssiem2022, we are looking forward to contributing to scientific exchange and sharing data and real-world experience about our recently approved #genetherapy for a rare genetic disorder. For HCPs laventanasteakhouse.com/contact/
-
PTC Therapeutics
@PTCBio
2021 #striveaward recipient @ASCADIM was facing many challenges in getting their clinic ready for #duchenne patients. Watch to learn how they have used their grant to overcome the challenges and become stronger for the Brazilian #duchennecommunity. www.ptcbio.com/posts/ascadim-creating-a-safe-space-for-th…
-
PTC Therapeutics
@PTCBio
Today, we announced our second quarter 2022 financial results and an update on our business outlook. Read more in the press release: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Today, we shared our second quarter 2022 financial results and an update on our business outlook. Check out some of the highlights.
-
PTC Therapeutics
@PTCBio
As a partner of @ThinkGenetic, we are thrilled by this announced partnership between ThinkGenetic and Guardian Research Network. We’re hopeful this partnership will help shorten the diagnostic journey for patients, their families, and healthcare providers.
ThinkGenetic, Inc.
@ThinkGenetic
We are thrilled to announce a collaborative partnership with @The_GRN to accelerate the diagnosis and treatment options for undiagnosed patients with genetic diseases and inherited predisposition to cancer. Read more at news.thinkgenetic.com/2022/07/28/guardian-research-networ… #raredisease #digitalhealth
-
PTC Therapeutics
@PTCBio
Alethia Young was recently appointed to PTC’s Board of Directors. Read more about the journey that brought her here, what she’s most looking forward to in her new role, and her advice for women looking to pursue a career in #stem: www.ptcbio.com/posts/ptc-welcomes-alethia-young-to-the-bo…
-
PTC Therapeutics
@PTCBio
PTC is committed to, and passionate about, bringing #genetherapy to patients with devastating rare diseases that have limited or no treatment options, such as #aadcdeficiency. Find out more about our technologies here: www.ptcbio.com/our-science/expertise/gene-therapy/?sf1682…
-
PTC Therapeutics
@PTCBio
The first and only treatment for #aadcdeficiency, a rare genetic disease impacting children, is now approved in Europe.
Read more about this significant milestone at ir.ptcbio.com/news-releases/news-release-details/upstazat…
#aadcdeficiency #genetherapy -
PTC Therapeutics
@PTCBio
We’re pleased to announce a unique partnership with @Screen4Care that aims to accelerate diagnosis for #raredisease patients. We look forward to contributing to this innovative research approach. Learn more: www.ptcbio.com/posts/ptc-joins-screen4care-to-shorten-the…
-
PTC Therapeutics
@PTCBio
PTC’s Martin Rexroad, Chief Culture & Community Officer, and Everette Brown, Executive Director, Global Talent Acquisition, are speaking at LEAP HR: Life Sciences East 2022 on meeting employee needs and innovation in talent acquisition. Register to attend: leap-hr-lifesciences-east.com/register/?sf167714852=1
-
PTC Therapeutics
@PTCBio
Thank you, @Screen4Care. We look forward to collaborating to shorten the diagnosis journey for people living with rare diseases.
Screen4Care
@Screen4Care
The Screen4Care consortium has grown! We welcome PTC Therapeutics (@PTCBio) as new partner in our consortium! Looking forward to shortening the path to #raredisease diagnosis together💪. Read more in our News: screen4care.eu/news/new-partner-brings-valuable-expertise…
-
PTC Therapeutics
@PTCBio
Join us at the World Orphan Drug Congress 2022 in Boston! Today at 1:20 pm ET, Matthew Klein, MD, Chief Operating Officer is presenting on pioneering #genetherapies for rare disorders. We hope to see you there!
-
PTC Therapeutics
@PTCBio
We are excited to announce that PTC’s Gene Therapy Center of Excellence in Hopewell, NJ was named a winner in the New Good Neighbor Awards by the @NJBIA. Read more in NJ Business Magazine: editions.mydigitalpublication.com/publication/?m=18790&i=…
-
PTC Therapeutics
@PTCBio
We are proud to support the 2022 @NPKUA_Info Conference: Challenging the Summit this week. If you’re onsite in Vancouver, be sure to check out our booth and participate in our story-sharing program: My VIBE: My Voice is Inspirational, Brave and Empowering! #pku #phenylketonuria
-
PTC Therapeutics reposted
NPKUA
@NPKUA_Info
PTC Therapeutics is a proud supporter of the 2022 NPKUA Conference. Meet the PTC team in-person this week in Vancouver and online at their virtual booth. Check out- My VIBE: My Voice is Inspirational, Brave and Empowering! Learn more about PTC: www.ptcbio.com
-
PTC Therapeutics
@PTCBio
Tune in to the latest #takeonduchenne North America episode featuring Dr. Chet Villa, Pediatric Cardiologist at Cincinnati Children’s Hospital. Dr. Villa shares his knowledge and experience on the continuum of the disease with a focus on Cardiopathology www.ptcbio.com/posts/dmd-continuum-of-disease-and-importa…
-
PTC Therapeutics reposted
Parent Project Muscular Dystrophy (PPMD)
@ParentProjectMD
PPMD’s Duchenne Newborn Screening efforts have reached an incredible milestone! Today, PPMD submitted a nomination package to add #duchenne to the RUSP, requesting Duchenne be a condition recommended for nationwide Newborn Screening. www.parentprojectmd.org/ppmd-submits-rusp-nomination-pack…
-
PTC Therapeutics
@PTCBio
PTC Therapeutics is committed to improving the lives of those living with Duchenne muscular dystrophy (DMD). Learn more by joining Dr Christian Werner, Prof Luca Bello and Prof Ros Quinlivan at the PTC Therapeutics industry-sponsored symposium on 6 July 2022. #icnmd2022 #dmd
-
PTC Therapeutics
@PTCBio
We’re looking forward to participating in the 11th European Conference on Rare Diseases and Orphan Products and presenting on the needs and pathways for patients with #rarediseases to access cross-border healthcare #ecrd2022
-
PTC Therapeutics
@PTCBio
Today, Matthew Klein, MD, Chief Operating Officer, will present an update on our treatment for nonsense mutation #duchenne muscular dystrophy at the @ParentProjectMD 2022 Annual Conference. Join us onsite at 12:10 PM PT or watch the presentation virtually: www.parentprojectmd.org?sf166495095=1
-
PTC Therapeutics
@PTCBio
We look forward to participating in the 8th #ean2022 Congress this weekend. Visit our booth and learn how we are making a difference in the lives of those living with rare diseases like #duchenne muscular dystrophy. Register here: www.ean.org/congress2022?sf166494892=1
-
PTC Therapeutics
@PTCBio
We are pleased to share topline results from Study 041 in patients with nonsense mutation #duchenne muscular dystrophy. Watch the webcast to learn more: ir.ptcbio.com/events-presentations?sf166429273=1
-
PTC Therapeutics
@PTCBio
Join us at 8:00 AM ET today as we review topline results from Study 041 in patients with nonsense mutation #duchenne muscular dystrophy. Learn more and access the webcast: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Tomorrow, June 21, at 8:00 AM ET we are hosting a call to review topline results from Study 041 in patients with nonsense mutation #duchenne muscular dystrophy. Learn more: ir.ptcbio.com/news-releases/news-release-details/ptc-ther…
-
PTC Therapeutics
@PTCBio
Introducing Shelley, Caregiver of the Year from UK! Shelley’s advocacy work has positively impacted not only her son but also those in the wider rare disease and disability communities. Learn more about her impactful work www.ptcbio.com/posts/caregiver-of-the-year-in-uk-can-pain…
-
PTC Therapeutics
@PTCBio
Check out our newest #takeonduchenne North America podcast episode with Dr. Oscar H. Mayer, Director of the Pulmonary Function Lab at Children’s Hospital of Philadelphia where he shares his insights on the continuum of this disease and its importance to the continuation of care.
-
PTC Therapeutics
@PTCBio
We estimate that 20,000 people globally are living with mitochondrial disease associated seizures. There are no approved treatment options, but PTC is conducting a clinical trial for a potential treatment. Read more about our clinical trial.
-
PTC Therapeutics
@PTCBio
We recently issued our 2021 Corporate Sustainability Report, outlining our efforts and impact in five key areas: our patients, our people, our community, our values, and our environment. Check out the report highlights: www.ptcbio.com/posts/ptc-issues-2021-corporate-sustainabi…
-
PTC Therapeutics
@PTCBio
Today, we’re presenting at the William Blair & Company 42nd Annual Growth Stock Conference in Chicago. Click here to watch the webcast: ir.ptcbio.com/events/event-details/william-blair-42nd-ann…
-
PTC Therapeutics
@PTCBio
We are proud to announce the latest addition to our Board of Directors. Please join us in welcoming Alethia Young. Read more about the announcement: ir.ptcbio.com/news-releases/news-release-details/biotech-…
-
PTC Therapeutics
@PTCBio
The theme of #worldenvironmentday 2022 is #onlyoneearth, calling for collective, transformative action to celebrate, protect and restore our planet. Check out our 2021 Corporate Sustainability Report to learn more about our environmental sustainability efforts and impact:
-
PTC Therapeutics
@PTCBio
#leiomyosarcoma (LMS) is a rare and aggressive cancer found in smooth muscle tissue, and one of the more aggressive sarcoma subtypes. Learn more about LMS and our research efforts: www.ptcbio.com/our-science/therapeutic-areas/about-leiomy…
#asco22 -
PTC Therapeutics
@PTCBio
Don’t forget to check out our recent episodes of the #takeonduchenne North America podcast. Our guests offer deep insights sparking meaningful conversations which tackle key topics related to care and management of #duchenne muscular dystrophy (#dmd).
-
PTC Therapeutics
@PTCBio
Today we announced results of a phase 1b study of our investigational treatment for #leiomyosarcoma (LMS), a rare and aggressive cancer found in smooth muscle tissue. Read more about the news. #asco22
-
PTC Therapeutics
@PTCBio
We recently issued our 2021 Corporate Sustainability Report, outlining our efforts and impact in five key areas: our patients, our people, our community, our values, and our environment. Read the full report: ir.ptcbio.com/static-files/fd644622-875f-4869-b58c-53e00c…
-
PTC Therapeutics
@PTCBio
Meet Philip, the first ever Paralympic gold medalist with #duchenne! Find out about his journey to beating a Paralympic record at Tokyo 2020 and his plans for the next Paralympics. #duchennecan
-
PTC Therapeutics
@PTCBio
Thank you @yourcpf for raising awareness about the importance of genetic testing. We offer a no-cost program to families that may help identify an underlying cause, such as AADC deficiency which is often misdiagnosed and mimics CP. Learn more. www.ptcpinpoint.com
Cerebral Palsy Foundation
@yourcpf
New research is showing that up to 30% of CP cases may have a genetic cause. Some of these genetic conditions may have life changing treatments for the first time.
Learn more at cpresource.org/topic/assessments-and-testing/can-genetic-… -
PTC Therapeutics
@PTCBio
Gaming is a huge deal, so we’re going big for the @CureDuchenne 2022 FUTURES National Conference. Don’t miss the Game Face Picture Station to get a photo taken. Be sure to join the conversation with #seemygameface.
-
PTC Therapeutics
@PTCBio
Meet Philip, the first ever Paralympic gold medalist with #duchenne! Find out about his journey to beating a Paralympic record at Tokyo 2020 and his plans for the next Paralympics. #duchennecan
-
PTC Therapeutics
@PTCBio
PTC is at the forefront of #genetherapy, an exciting and transformative area. We are committed to bringing life-changing therapies to patients who have limited or no treatment options, like those living with #aadcdeficiency.
-
PTC Therapeutics
@PTCBio
We are thrilled to be taking one step closer to providing treatment for patients living with rare genetic disorders. Read more in @endpts
Endpoints News
@endpts
To date, there have been no treatments approved for AADC deficiency, which has been identified in less than 150 patients. But now, New Jersey biotech PTC Therapeutics is one step closer to getting its gene therapy approved in the EU.
endpts.com/ahead-of-fda-ema-recommends-authorizing-new-ge… -
PTC Therapeutics
@PTCBio
Our scientists are exploring the possibilities of #genetherapy and the opportunities it may offer to patients living with rare genetic disorders, such as #aadcdeficiency.
-
PTC Therapeutics
@PTCBio
We are proud to announce that we have received a positive CHMP opinion for the first #genetherapy to treat #aadcdeficiency, a rare genetic disorder.
-
PTC Therapeutics
@PTCBio
#huntingtonsdiseaseawarenessmonth is a time to educate and learn about this progressive #raredisease that affects the brain and is caused by a defective gene.
-
PTC Therapeutics
@PTCBio
PTC is at the forefront of a new and transformative era of #genetherapy, with one of the most advanced gene therapy pipelines for rare neurological disorders.
-
PTC Therapeutics
@PTCBio
Thank you to everyone who joined our ASGCT 25th Annual Meeting sponsored exhibitor showcase on PTC’s gene therapy pipeline, and for stopping by our booth!
-
PTC Therapeutics
@PTCBio
Today, we’re presenting at the 2022 RBC Capital Markets Global Healthcare Conference.
-
PTC Therapeutics
@PTCBio
Join us today at the @ASGCTherapy 25th Annual Meeting for an exhibitor showcase to learn more about PTC’s advanced #genetherapy pipeline for rare neurological disorders. #asgct22 attendees, please stop by our booth 512.
-
PTC Therapeutics
@PTCBio
What is #genetherapy and what kind of promise does it hold for the future of healthcare? Discover the science behind gene therapy and how it could contribute to advancing transformative treatment options for patients living with rare genetic diseases.
-
PTC Therapeutics
@PTCBio
Inspiring stories like this are why we’re dedicated to researching therapies for ultra-rare diseases such as #aadc.
TODAY
@TODAYshow
When Jillian was born she experienced some health crisis and it took a long time for doctors to understand why. on.today.com/3L8y2wN
-
PTC Therapeutics
@PTCBio
Today, we’re presenting at the Bank of America 2022 Healthcare Conference.
-
PTC Therapeutics
@PTCBio
We celebrate moms like Kelly and their amazing capacity to nurture and protect. When her daughter was diagnosed with AADCd, an ultra rare disease, she became an RN to better care for her. Read her incredible story: www.today.com/health/essay/daughters-rare-disease-diagnos…
-
PTC Therapeutics
@PTCBio
Join us on May 16 for an exhibitor showcase at the @ASGCTherapy 25th Annual Meeting, where we’ll discuss PTC’s robust #genetherapy pipeline for central nervous system disorders. For those attending #asgct22 in person please stop by our booth 512.
-
PTC Therapeutics
@PTCBio
PTC is proud to support the @MassBio 2022 State of Possible Conference. Join us for a day of networking, discussions, and keynotes with #lifesciences leaders.
MassBio
@MassBio
MassBio’s #stateofpossible Conference takes place on May 5, and you're invited to join us as we celebrate how the #lifesciences make the impossible possible and discuss the Massachusetts biopharma ecosystem in the post-COVID era. Register today: www.massbio.org/events/listing/2022-state-of-possible-con…
-
PTC Therapeutics
@PTCBio
Please join us today for our latest webinar ‘Diagnosing neurotransmitter-related disorders: Understanding the caregiver and clinician experience’. Sign up to explore the broad phenotypic spectrum of neurotransmitter-related disorders. For HCPs only. #neurotransmitterdisorders
-
PTC Therapeutics
@PTCBio
Join us tomorrow May 5 for our live webinar, where we’ll be taking a closer look at the diagnostic journey and phenotypic spectrum of neurotransmitter-related disorders. For HCPs only. #neurotransmitterdisorders #ntds #aadcdeficiency
-
PTC Therapeutics
@PTCBio
Today, we shared our first quarter 2022 financial results and an update on our business outlook. Check out some of the highlights.
-
PTC Therapeutics
@PTCBio
Today, we’re announcing our first quarter 2022 financial results and an update on our business outlook. Join us today to learn more.
-
PTC Therapeutics reposted
Institute for Gene Therapies
@gene_therapies
April is #nationalminorityhealthmonth. We are proud to partner with leaders in innovation who prioritize addressing unmet medical needs & health equity. Check out our newest blog by our Scientific, Academic, & Medical Advisory Council Chair @DelegateDonna. www.gene-therapies.org/post/prioritizing-minority-health
-
PTC Therapeutics
@PTCBio
Meet Laura, an important member of our patient engagement team in Argentina. Find out how she is using her personal experience of #duchenne to help others affected by the condition. #duchennecan
-
PTC Therapeutics
@PTCBio
People with #duchenne CAN dream big! Click the link below to learn about the incredible individuals who pursued their talents and ambitions to make their dreams a reality. #duchennecan
-
PTC Therapeutics
@PTCBio
PTC Pinpoint, a no-cost genetic testing program initiated from the comfort of home, aims to deliver insights to those experiencing symptoms of diseases such as Cerebral Palsy or AADC deficiency.
-
PTC Therapeutics
@PTCBio
Gabriela wrote ‘Timothy’s Magic Wheelchair’ to teach children that people with disabilities, including #duchenne, CAN be the hero of their own stories! At just 17 she was empowered to make a difference and help create new role models. #duchennecan #icbd2022
-
PTC Therapeutics
@PTCBio
Join PTC today at 12:45 pm ET at the 2022 SIMD Annual Meeting for a sponsored interactive symposium for #healthcare professionals on advancing the diagnosis and management of #aadc deficiency. Meeting attendees may click to RSVP.
-
PTC Therapeutics
@PTCBio
This August is the IWAS Powerchair Hockey World Cup in Switzerland! We’re proud to be a sponsor and look forward to this incredible event. Stay tuned for updates and learn more here.
-
PTC Therapeutics
@PTCBio
On April 12, join PTC at the 2022 SIMD Annual Meeting for a sponsored interactive symposium for #healthcare professionals on advancing the diagnosis and management of #aadc deficiency. Meeting attendees may click to RSVP.
-
PTC Therapeutics
@PTCBio
Listen to the latest podcast episode from @Biotech2050Pod featuring PTC Founder & CEO Stuart Peltz on RNA-driven treatments in rare diseases.
Biotech2050 Podcast
@Biotech2050Pod
Thanks Stuart Peltz, Founder & CEO @PTCBio for joining us!
From @RWJMS - to industry leader in #rna #biology - he has guided PTC from a #research organization to a publicly-traded, global commercial organization!
soundcloud.com/user-306573075/95-rna-driven-treatments-in…
$PTCT #raredisease #stem #genetherapy -
PTC Therapeutics
@PTCBio
Join us on April 12 at the 2022 SIMD Annual Meeting for a PTC-sponsored interactive symposium for #healthcare professionals on advancing the diagnosis and management of #aadc deficiency. Meeting attendees may click to RSVP.
-
PTC Therapeutics
@PTCBio
We are excited to announce the official opening of our PTC Japan office in Tokyo! Our new office adds to PTC’s growing global footprint and extends our reach to support people living with #rarediseases around the globe.
-
PTC Therapeutics
@PTCBio
Today, we announced the initiation of a Phase 2 clinical trial evaluating our therapy in patients with #huntingtonsdisease.
-
PTC Therapeutics
@PTCBio
Register for our webinar this Wednesday where we will review the @economistimpact report, ‘Rare paediatric neurological diseases: A focus on Europe.’ Thank you @EuropaBio for sharing!
EuropaBio
@EuropaBio
To highlight #priorities for improving #care & #lifequality of people dealing w/rare #paediatric #neurological conditions, @economistimpact & @PTCBio undertook a project to better understand how these #disorders affect the lives of #patients & families:
👉www.europabio.org/event/rare-paediatric-neurological-dise… -
PTC Therapeutics
@PTCBio
Today, we’re presenting at the 2022 #barchealthcare Conference at 8 a.m. ET. Watch the webcast here: ir.ptcbio.com/events/event-details/barclays-global-health…
-
PTC Therapeutics
@PTCBio
What is #genetherapy and what kind of promise does it hold for the future of healthcare? Discover the science behind gene therapy and how it could contribute to advancing transformative treatment options for patients living with rare genetic diseases.
-
PTC Therapeutics
@PTCBio
Join PTC today at 12 pm CDT for a sponsored Industry Forum for #healthcare professionals at the 2022 MDA Clinical & Scientific Conference, discussing treatment in #duchenne muscular dystrophy. Registered in-person and virtual conference delegates may click to RSVP.
-
PTC Therapeutics
@PTCBio
Come and join us in our webinar where we will review the findings of the @economistimpact report ‘Rare paediatric neurological diseases: A focus on Europe’ and discuss how different stakeholders can collaborate to improve care and outcomes.
-
PTC Therapeutics
@PTCBio
ONE week left to apply for the STRIVE Award. The award seeks to recognize programs dedicated to addressing the unmet needs of the Duchenne community. Submit your application.
-
PTC Therapeutics
@PTCBio
Join us on March 15 for a PTC-sponsored Industry Forum for #healthcare professionals at the 2022 MDA Clinical and Scientific Conference, discussing treatment in #duchenne muscular dystrophy. Registered in-person and virtual conference delegates may click to RSVP.
-
PTC Therapeutics
@PTCBio
Join #duchennecan this March as we celebrate #internationalwomensday! Each week we will be highlighting inspiring women who have dedicated their lives to supporting boys and their families affected by #duchenne.
-
PTC Therapeutics
@PTCBio
We’re presenting at the 42nd Annual #cowenhealthcare Conference today at 1:30 p.m. ET. Tune into the webcast here: ir.ptcbio.com/events/event-details/cowen-virtual-42nd-ann…
-
PTC Therapeutics
@PTCBio
There’s still time to submit your application for the 2022 STRIVE Awards. Don’t miss out on the opportunity to be recognized for the amazing work you’re doing to support people living with the #raredisease #duchenne in your local community. www.ptcbio.com/our-company/grants-and-donations/strive/
-
PTC Therapeutics
@PTCBio
Our new Insightful Moments educational series was created to help support and empower #raredisease patients and their families on every step of their journey. Read more about the new program: www.ptcbio.com/posts/introducing-insightful-moments-a-rar… #rarediseaseday
-
PTC Therapeutics
@PTCBio
This #rarediseaseday we’d like to highlight a new report by @economistimpact outlining policies for improving care, patient outcomes and quality of life of patients in #eu with rare neurological diseases. Learn about the priorities insights.economistenterprise.com/health-society/rare-paed…
-
PTC Therapeutics
@PTCBio
We are proud to support #rarediseaseday and partner with @economistimpact to launch a new report highlighting the need to address the challenges of patients and children in #eu with rare paediatric neurological diseases. Read the report insights.economistenterprise.com/health-society/rare-paed…
-
PTC Therapeutics
@PTCBio
We’re announcing our fourth quarter, year-end 2021 financial results and an update on our business outlook. Join us on February 22 to learn more.
-
PTC Therapeutics
@PTCBio
Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations at PTC, shared her thoughts with @PharmaVoice on the importance of patient input in #raredisease R&D and what advocacy in rare disease looks like. Read more: www.pharmavoice.com/news/ptcs-vice-president-of-patient-r…
-
PTC Therapeutics
@PTCBio
As we open the Talent Pipeline Program application period for our second “class,” we checked in with a few TPP alumni, who are now full-time PTC employees. Read more about their experiences: www.ptcbio.com/2022/02/11/a-transformative-experience-tal…
-
PTC Therapeutics
@PTCBio
For #internationalangelmanday, join us in raising awareness of this rare neuro-genetic disorder. We’re proud to support this incredible community!
-
PTC Therapeutics
@PTCBio
This #internationalepilepsyday, we recognize and support those impacted by #epilepsy and reaffirm our commitment to addressing the unmet medical needs of patients living with neurological disorders.
-
PTC Therapeutics
@PTCBio
Today, on International Day of Women and Girls in Science, we recognize and celebrate the many women who have shaped the future of science. Thank you to the #womeninscience who have made significant strides and achievements in #stem.
-
PTC Therapeutics
@PTCBio
Starting today, the application program for our Talent Pipeline Program is officially open! This 1-year, global initiative is designed to provide recent college graduates with high-quality, real-world work experience. Learn more and apply here: www.ptcbio.com/careers/talent-pipeline-program-fellowship/
-
PTC Therapeutics
@PTCBio
We are at the International Symposium on #paediatric Movement Disorders to share findings of #raredisease #aadc deficiency www.paedmovdissymposium.com?sf159856241=1
-
PTC Therapeutics
@PTCBio
Applications for the 2022 STRIVE Awards for #duchenne muscular dystrophy are closing soon. Click here to apply www.ptcstriveawards.com.
-
PTC Therapeutics
@PTCBio
Tune in to our latest #takeonduchenne North America episode. We speak with Sarah Stoney, licensed social worker at the Children’s Hospital of Philadelphia about the transition to adult care in DMD from a social perspective.
-
PTC Therapeutics
@PTCBio
Our innovative gene therapy platform has the potential to treat patients with #rarediseases that were once considered untreatable. Read more about these scientific advancements in our @FortuneMagazine piece.
-
PTC Therapeutics
@PTCBio
Long-term follow-up results from three clinical trials of gene therapy in patients with #aadc deficiency published in the February issue @MolTherapy #aadcd
Molecular Therapy Family of Journals
@MolTherapy
The February issue of @moltherapy is out now! On the cover: Aromatic l-amino acid decarboxylase deficiency (#aadcd) results in decreased neurotransmitter levels and severe motor dysfunction. www.cell.com/ymthe/issue?pii=S1525001621X00068
-
PTC Therapeutics
@PTCBio
Huntington’s disease (HD), a rare, genetic disorder of the central nervous system, can cause a range of debilitating symptoms that affect a person’s motor, cognitive, and behavioral abilities.
-
PTC Therapeutics
@PTCBio
We are excited to support the @findacurefoundation International Rare Disease showcase this week and look forward to joining fellow advocates on the path to accelerate change in rare disease. #rareshowcase22 #rarediseaseday
-
PTC Therapeutics reposted
World BI
@WorldBI_Uk
@WorldBI_Uk BI Welcomes Marla Weetall Sr. Vice President, Pharmacology and Biomarkers @PTCBio at the #16thdrugdiscoveryinnovationprogramme Taking Place on 17-18 May 2022 in Boston, MA
Register Now www.worldbigroup.com
#drugdiscovery #innovation #inpersonevents -
PTC Therapeutics
@PTCBio
Laura McLinn and her son Jordan are determined to make a difference for those living with Duchenne and the people who love and care for them. Learn more about their mission and the @BestDayEver513 Foundation. #duchennecan #dmd
-
PTC Therapeutics
@PTCBio
Happy New Year from #duchennecan! We are back and looking forward to sharing more stories and raising the voices of the #duchenne community in 2022. If you have an inspirational DuchenneCan story to share, write to us. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w…
-
PTC Therapeutics
@PTCBio
Applications for the 2022 PTC STRIVE Awards for Duchenne muscular dystrophy are now open! Find out how to apply for funding to support innovative #raredisease advocacy projects that are making a difference to people living with #duchenne across the world. www.ptcbio.com/our-company/grants-and-donations/strive/
-
PTC Therapeutics
@PTCBio
We are pleased to share the recent publication by @ODExpertGroup highlighting recommendations on how to improve the rare disease environment in Europe. Click below to read the publication in @FrontPharmacol.
@ODExpertGroup
@odexpertgroup
Did you miss it?
The recommendations of the OD Expert Group to improve the rare disease environment in Europe were published in @FrontPharmacol
4 principles for policy change
14 Recommendations
26 Rare disease experts
📜www.frontiersin.org/journals/pharmacology/articles/10.338… -
PTC Therapeutics
@PTCBio
Neil Smith, PharmD, MBA, Global Project Leader at PTC, has worked on PTC923 since its earliest stages of development. Read more about his work on this therapy in development.
-
PTC Therapeutics
@PTCBio
Dr. Matthew Klein has been promoted to Chief Operating Officer, and will continue to oversee PTC's Development organization in his new role. Read more about the update here.
-
PTC Therapeutics
@PTCBio
Managing the care of a child with any rare disease requires significant medical support and expertise. In #aadcd the size and breadth of the multidisciplinary team required is only increased due to the complex symptoms and care needs. #neurologist #aadcdeficiency
-
PTC Therapeutics
@PTCBio
At #isporeurope we presented new burden of disease #data on #aadcdeficiency. Our session included the most common symptoms seen by physicians treating this #raredisease. Here’s a recap of some of the signs of #aadcd #neurologists
-
PTC Therapeutics
@PTCBio
Caring for a child with #aadcdeficiency not only has a significant emotional and physical burden on caregivers, but also a financial one. At #isporeurope we presented the first data to look into the financial impact of this #raredisease #aadcd
-
PTC Therapeutics
@PTCBio
We’re reflecting on our symposia at #isporeurope, the new #data presented on the burden of #aadcd #aadc #aadcdeficiency and how this shapes our collective understanding of this devastating disease. #raredisease #education
-
PTC Therapeutics
@PTCBio
We’re excited to announce that the novel treatment Waylivra™ (volanesorsen) has successfully received Category 1 pricing from CMED (Drug Market Regulation Chamber) in Brazil, which will allow more patients to have access to treatment. Learn more: ir.ptcbio.com/news-releases/news-release-details/waylivra…
-
PTC Therapeutics
@PTCBio
We had so much good news in 2021, it was hard to choose the highlights to include in our wrap up. Read more about them.
-
PTC Therapeutics
@PTCBio
We are speaking with Dr. Lauren Elman, adult neurologist at the University of Pennsylvania about ‘Transition to adulthood’ for patients living with #duchenne muscular dystrophy (#dmd). Tune in to #takeonduchenne North America podcast to learn more.
-
PTC Therapeutics
@PTCBio
A new study published in @NatureComms demonstrates that our innovative small molecule splicing platform effectively reduces huntingtin (HTT) mRNA and protein levels in cells and animal models with #huntingtonsdisease (HD). Learn more: go.nature.com/3e7M4R0
-
PTC Therapeutics
@PTCBio
We hope you’ve enjoyed seeing some of our favorite #duchennecan moments from 2021 as much as we have. We’d like to end today’s #celebration by saying #thankyou to everyone involved! www.ptcbio.com/posts/duchennecan-celebrates-individuals-w… #inspiration #reflection
-
PTC Therapeutics
@PTCBio
Our PTC teams share a true passion for helping to make a change and improve the lives of those with Duchenne. That’s why we go the extra mile to create opportunities and add more moments to families lives. Like and share to celebrate them. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w… #duchennecan
-
PTC Therapeutics
@PTCBio
The Duchenne community would not be the same without dedicated families, #caregivers, #advocates and #healthcare professionals #hcps working hard every day to improve the future for those living with #duchenne. Like or share to show your appreciation www.ptcbio.com/posts/duchennecan-celebrates-individuals-w…
-
PTC Therapeutics
@PTCBio
More and more boys, young men and adults living with #duchenne are defying the odds and living vibrant lives. We’ve had the pleasure to meet some of them and today we are celebrating them. Like and share to show your support. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w… #duchennecan #dmd #rolemodels
-
PTC Therapeutics
@PTCBio
#duchennecan has allowed us to meet some of the most amazing people from the global #duchenne community. Their stories have touched our hearts and have reached many others around the world. Like if you feel the same #inspiration. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w…
-
PTC Therapeutics
@PTCBio
It’s been an amazing year of DuchenneCan…so many #remarkable Duchenne individuals, so many powerful stories…so many shared moments… Join our #duchennecan party today for 2021 highlights that just deserve to be #celebrated. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w… #duchenne #makingadifference
-
PTC Therapeutics
@PTCBio
SAVE THE DATE!! PTC will be hosting a #duchennecan party tomorrow, #celebrating #inspirational people from the Duchenne community around the world. JOIN the conversation and help us spread some positive cheer for Duchenne. www.ptcbio.com/posts/duchennecan-celebrates-individuals-w…
-
PTC Therapeutics
@PTCBio
Last week we attended the @AmEpilepsySoc annual meeting. We were proud to join industry leaders in important discussions around gene therapy and AADC deficiency. Read more about #aes2021: aesnet.org/2021-annual-meeting?sf156657940=1
-
PTC Therapeutics
@PTCBio
Today, Philippe Moyen, PTC Chief of Staff to the CTOO, Gene Therapy and Small Molecules, presented at the annual Gene Therapy for Neurological Disorders conference, where he spoke about PTC’s gene therapy program and pipeline.
-
PTC Therapeutics
@PTCBio
Guðjón is a geneticist from Iceland who is living with #duchenne. He is determined to use his expertise and experience to advance science and help others living with genetic disorders. Read more about his research www.ptcbio.com/posts/gudjon-can-contribute-to-science-res… #duchennecan #dmd #raredisease
-
PTC Therapeutics
@PTCBio
PTC is delighted to present an on-demand educational symposium for #healthcare professionals who attended the 50th @ChildNeuroSoc (#cns) Annual Meeting. Review advances in the care of #aadc deficiency, a debilitating neurological #raredisease. #neurology #rwe
-
PTC Therapeutics
@PTCBio
As we continue the #duchennecan journey, we want to stop and reflect on 18 amazing and inspirational stories of courage, determination, and strength which have inspires us. Do you have an inspirational story to share?
-
PTC Therapeutics
@PTCBio
Don’t miss our first #takeonduchenne North America podcast episode with Dr. Diana Castro, a leading pediatric neurologist, discussing evolving care in #duchenne muscular dystrophy (#dmd).
-
PTC Therapeutics
@PTCBio
JUST LAUNCHED: #takeonduchenne North America podcast series in conversation with medical and scientific leaders in the #duchenne muscular dystrophy (#dmd) community. Learn more about evolving care in DMD with leading pediatric neurologist Dr. Diana Castro.
-
PTC Therapeutics
@PTCBio
With thousands of #rarediseases identified and so few therapies approved, #clinicaltrials are essential to the process of developing safe and effective treatments. Learn how PTC is working to improve the patient #clinicaltrial experience.
-
PTC Therapeutics
@PTCBio
Proud of the work our partner @genentech is doing to amplify the voices of the Spinal Muscular Atrophy (SMA) community. A powerful celebration of the talents and achievements of those living with a disability. Together we can make a difference.
Genentech
@genentech
The song & music video, SPACES, is now available! The song aims to highlight the talents and humanity of people with disabilities, who are often misrepresented in the media. Watch the music video, and learn more about the making of SPACES here: www.gene.com/stories/the-song-youre-gonna-sing
-
PTC Therapeutics
@PTCBio
PTC is pleased to launch the #takeonduchenne North America podcast series dedicated to #duchenne muscular dystrophy (#dmd). In our first episode, leading pediatric neurologist Dr. Diana Castro discusses evolving care in DMD.
-
PTC Therapeutics
@PTCBio
Andrea studied graphic design as a way to channel his creativity. He was keen to give back and support the #duchenne community and now works at @Parent_Project Italy - proof that people with #duchennecan turn their #passion into a career. Watch his story. www.ptcbio.com/posts/andrea-can-find-a-reason-to-smile/
-
PTC Therapeutics
@PTCBio
“Patients are the most important stakeholders in our work.” Read more from PTC SVP Corporate & Patient Relations Mary Frances Harmon.
Merge Communications
@MergeComm
When it concerns groundbreaking drug research, it is essential to listen to patients as they go through trials. Mary Frances Harmon of PTC Therapeutics shares three lessons she learned about the importance of valuing patient experiences.
www.clinicalleader.com/doc/incorporating-patient-voice-in… -
PTC Therapeutics
@PTCBio
Join $PTCT for a virtual #investor conference company overview presentation at the @CreditSuisse 30th Annual Healthcare Conference at 8:00 a.m. ET today. You can access the live webcast on our website.
-
PTC Therapeutics
@PTCBio
PTC scientists are working on #genetherapy treatments for rare genetic disorders. If you’ve ever wondered what gene therapy is and how it might be able to help treat #raredisease, our Gene Therapy 101 video is for you.
-
PTC Therapeutics
@PTCBio
#congratulations and thank you to PTC Biologist Anu Bhattacharyya, Ph.D. for presenting at the @huntingtonSG #hsg2021: Unmasking HD virtual meeting. Learn more about the “first and largest” clinical research network focused exclusively on #huntingtonsdisease (#hd).
-
PTC Therapeutics
@PTCBio
Congratulations to our team as they demo the Mission Duchenne™ online escape game from PTC at @Jesses_Journey’s #defeatduchenne Family Forum to demonstrate the value of online #gaming for people with physical disabilities. #raredisease #inclusion #duchenne #dmd
-
PTC Therapeutics
@PTCBio
PTC is proud to partner with @parentprojectMD, @sarepta, @perkinelmer, @solidbioDMD and @pfizer on a pilot program to screen newborn babies for #duchenne muscular dystrophy. #dmd
Muscular Dystrophy News Today
@mdnewstoday_
Parent Project Muscular Dystrophy's pilot program identified four babies in New York with Duchenne or Becker; goals are for national program. musculardystrophynews.com/2021/10/26/36000-newborns-scree…
#musculardystrophy #md #mdnewstoday #livingwithmd #mdresearch #treatingmd #mdtreatments #duchennebabies -
PTC Therapeutics
@PTCBio
Please join $PTCT at 4:30 p.m. ET on October 28 for a webcast conference call to report our third quarter 2021 financial results and provide an update on our business outlook. #investors
-
PTC Therapeutics
@PTCBio
PTC is offering #healthcare professionals a no-cost neurotransmitter-related disorders webinar, in two parts. Part B will cover dopamine β-hydroxylase and #aadc deficiency, as well as steps to improve diagnosis. Learn more and register online.
-
PTC Therapeutics
@PTCBio
PTC is excited to partner with the Loulou Foundation et al. to collaborate on a clinical study for the potential treatment of #cdkl5deficiencydisorder. $PTCT #raredisease #cdkl5 #cdd
-
PTC Therapeutics
@PTCBio
PTC has news for patients aged 2 to 5 years old with nonsense mutation #duchenne muscular dystrophy (#dmd) – and their caregivers – in Brazil. $PTCT #raredisease
-
PTC Therapeutics
@PTCBio
PTC is pleased to sponsor the @IAmBiotech 2021 Patient & Health Advocacy Digital Summit. Check out the PTC newsroom to learn from our Director, Government Affairs & Public Policy Leah Svoboda why supporting this event is critical to our #raredisease mission.
-
PTC Therapeutics
@PTCBio
Thank you, @RepGregMurphy and @RepStephenLynch, for your support! #aadc #aadcdeficiency #raredisease #esg
Congressman Greg Murphy, M.D.
@RepGregMurphy
I’m excited to support #aadc Deficiency Awareness Day 2021 with @AADCFamilyNtwk, @ClearPointNeuro and @ptcbio on October 22. Join us in spreading the word! Learn more about AADC Deficiency: www.aadcfamilynetwork.org
-
PTC Therapeutics
@PTCBio
Thanks to an amazing team! #aadcdeficiency Awareness Day 2021 #aadc
Bob Coughlin
@BobCoughlin
I’m pumped to kick off #aadc Awareness Day at the @MassBio Hub. Thank you @PTCBio for all you do for patients! Join us at 11!! @AADCFamilyNtwk #patientdriven @joeboncore @KendalleOC @JLL @RepStephenLynch
-
PTC Therapeutics
@PTCBio
We’re celebrating our second AADC Deficiency Awareness Day today! Meet patients, caregivers and experts as they share information about AADC deficiency, patient advocacy and gene therapy. Read more about this important day on our website.
-
PTC Therapeutics
@PTCBio
PTC is working on an investigational gene therapy using adenovirus vectors to introduce normal dopa decarboxylase (DDC) genes into people with AADC deficiency. We’re hosting a virtual AADC Deficiency Awareness Day on 10/22.
-
PTC Therapeutics
@PTCBio
PTC is offering #healthcare professionals a no-cost neurotransmitter-related disorders webinar, in two parts. Part A will cover non-ketotic hyperglycinemia (#nkh) and sepiapterin reductase deficiency. Learn more and register online.
-
PTC Therapeutics
@PTCBio
Aromatic l-amino acid decarboxylase (AADC) deficiency is sometimes mistaken for cerebral palsy or epilepsy. We’re celebrating AADC Deficiency Awareness Day on 10.22.
-
PTC Therapeutics
@PTCBio
There is currently no approved cure for aromatic l-amino acid decarboxylase (AADC) deficiency. Help us spread awareness for this rare disease.
-
PTC Therapeutics
@PTCBio
Congratulations and thank you to PTC Director, Market Access Axel Boehnke on his role as a chairperson of the 10th European Pricing Platform Life Sciences Pricing Forum. @pricingplatform has a mission to support pricing professionals to improve revenue and profitability.
-
PTC Therapeutics
@PTCBio
PTC is delighted to sponsor the 2021 @ESGCT Congress as well as a scientific symposium featuring Chief Scientific Officer Ellen Welch, Ph.D. and Chief Development Officer Matthew Klein, MD, MS, FACS. Will contain product information and is intended for #healthcare professionals.
-
PTC Therapeutics
@PTCBio
Thank you to PTC SVP Commercial and Corporate Strategy Kylie O’Keefe for sharing awareness on the #aadc caregiver experience. #raredisease
CheckRare
@CheckRare
Kylie O’Keefe of PTC Therapeutics discusses the results of a study on the impact of caring for an individual with aromatic L-amino acid decarboxylase (AADC) deficiency. @PTCBio PTC Therapeutics, Inc. #aadc
checkrare.com/survey-showcases-the-overwhelming-burden-th… -
PTC Therapeutics
@PTCBio
People with aromatic l-amino acid decarboxylase (AADC) deficiency often exhibit poor muscle tone, body movement disorders and involuntary eye movements. Read about our upcoming FB Premiere in honor of AADC Deficiency Awareness Day.
-
PTC Therapeutics
@PTCBio
Congratulations to our #oneptc team in Brazil on a recent commercial milestone! PTC is working hard to help patients with hereditary transthyretin (#hattr) amyloidosis – a progressive, systemic and fatal inherited #raredisease that affects approximately 50,000 people worldwide.
-
PTC Therapeutics
@PTCBio
Aromatic l-amino acid decarboxylase (AADC) deficiency interferes with the way the cells in the nervous system talk to each other through neurotransmitters. We’re raising awareness for AADC during our virtual AADC Deficiency Awareness Day on 10/22.
-
PTC Therapeutics
@PTCBio
Most parents of a child with a #raredisease have questions about #clinicaltrials. Check out our latest interview with a PTC clinical development leader to learn more about our approach to safety and quality in clinical trials.
-
PTC Therapeutics
@PTCBio
Aromatic l-amino acid decarboxylase (AADC) deficiency interferes with the way the cells in the nervous system talk to each other through neurotransmitters. We’re celebrating AADC Deficiency Awareness Day on 10/22.
-
PTC Therapeutics
@PTCBio
PTC is offering #healthcare professionals a no-cost neurotransmitter-related disorders webinar, in two parts. Participants will learn the early signs and symptoms of neurotransmitter disorders, as well as current best practices in management options for patients.
-
PTC Therapeutics
@PTCBio
Common symptoms of aromatic l-amino acid decarboxylase (AADC) deficiency include excessive sweating, hypersalivation, delayed development and more.
-
PTC Therapeutics
@PTCBio
At PTC, we have a collaborative approach to developing #genetherapy treatments for patients with #rarediseases. We listen to patients and caregivers at all stages of the research and development journey, from the earliest stages of discovery to clinical trials and beyond.
-
PTC Therapeutics
@PTCBio
Aromatic l-amino acid decarboxylase (AADC) deficiency is an extremely rare disease and is difficult to diagnose. Read about our virtual AADC Deficiency Awareness Day on October 22.
-
PTC Therapeutics
@PTCBio
PTC is delighted to host a LIVE online streaming of the ribbon-cutting ceremony at our new #genetherapy manufacturing center in Hopewell, New Jersey on October 14, 2021 at 4 p.m. ET.
-
PTC Therapeutics
@PTCBio
A child with aromatic l-amino acid decarboxylase (AADC) deficiency can sometimes benefit from treatments targeting its symptoms. Join us for our AADC Deficiency Awareness Day Facebook Premiere on 10/22!
-
PTC Therapeutics
@PTCBio
For the second year in a row, Bob Coughlin will co-host #aadc Deficiency Awareness Day – LIVE on Facebook at 11 am ET on October 22. As a “dadvocate” for his own child with a #raredisease, Bob is a courageous partner in our efforts to develop treatments for rare diseases.
-
PTC Therapeutics
@PTCBio
Elijah founded @destroydisease when he was just 15 and is on a mission to #completethecure for #duchenne. Learn more about his work and other incredible accomplishments at www.ptcbio.com/posts/elijah-can-destroy-duchenne-duchenne…. #duchennecan #inspiration #makingadifference
-
PTC Therapeutics
@PTCBio
PTC is pleased to sponsor an important event featuring our Board Member Mary Smith in honor of the Native American children who were removed from their homes and forced to attend boarding schools. #indigenouspeoplesday #ipd2021
-
PTC Therapeutics
@PTCBio
PTC presents Reconoce DMD, a radio segment in Spanish about #duchenne and its symptoms, especially helpful for new patient families - through 12/14. On Tuesdays, tune in to El Desayuno in Miami at 5:30 am on 107.5 Amor, or El Palo Con Coco in New York at 3 pm on X 96.3 FM. #dmd
-
PTC Therapeutics
@PTCBio
PTC is proud to sponsor the @MassBio Patient Advocacy Summit – bringing together the patient advocacy community to showcase best practices and cutting-edge examples of how we can more fully incorporate the patient voice into the work we do. #raredisease
-
PTC Therapeutics
@PTCBio
Let the games begin! Meet Hawken Miller, Adrien Quintero and Chris Younkin, panelists and gamers in this year’s #duchenne United Gaming (DUG) Rocket League tournament on October 9 from 6-8 p.m. CDT. Learn more about this rare disease in support of Duchenne muscular dystrophy.
-
PTC Therapeutics
@PTCBio
PTC was delighted to welcome the amazing Quiara Alegria Hudes as a guest speaker for #oneptc global team members, in honor of #nationalhispanicheritagemonth. Quiara was joined by members of our Hispanic and Latino employee resource group for a panel discussion on #diversity.
-
PTC Therapeutics
@PTCBio
Join PTC today for a live webinar to discuss the symptoms and progressive milestones of #duchenne muscular dystrophy. This webinar is provided at no-cost for #healthcare professionals in Germany, Austria, Brazil, Israel, Bulgaria and Chile. #dmd
-
PTC Therapeutics
@PTCBio
PTC acknowledges #rarecancerday 2021 on September 30th, along with @rarediseases (NORD) and patients with rare cancers such as #acutemyeloidleukemia (#aml), #leiomyosarcoma (#lms), #diffuseintrinsicpontineglioma (#dipg) and others. #oncology
-
PTC Therapeutics
@PTCBio
PTC is presenting an educational symposium for #healthcare professionals attending the 50th @ChildNeuroSoc (#cns) Annual Meeting. This symposium will review #aadc deficiency & discuss experience with treating this debilitating neurological #raredisease. www.childneurologysociety.org/colleagues/network/cns-annu…
-
PTC Therapeutics
@PTCBio
PTC Head of Gene Therapy Biologics Norm Stoffregen will present at @BioNJ_org’s Manufacturing Briefing today on “Addressing Talent Challenges in Manufacturing.”
-
PTC Therapeutics
@PTCBio
PTC is heading to the @ChildNeuroSoc 50th annual meeting to share new data from our clinical program for the devastating condition #aadc deficiency. Learn more about AADC at aadcinsights.com. #cns #cnsam #neurology #raredisease
-
PTC Therapeutics
@PTCBio
Join PTC Patient Engagement Liaison Anne Bruns on September 28 for a presentation on patient engagement in #clinicaltrials at the #ggsummit from @globalgenes – one of the world’s largest gatherings of #raredisease patients, caregivers, advocates and others.
-
PTC Therapeutics
@PTCBio
Join $PTCT today – Monday, September 27 at 3:30pm ET – for the Cantor Virtual Global Healthcare Conference. Our leaders will present a company overview and business update. You can access the presentation via live webcast on our website. #investors
-
PTC Therapeutics
@PTCBio
Congratulations to @ASCADIM, one of this year’s STRIVE Award recipients! ASCADIM plans to structure its clinic to provide more patients with muscular dystrophies free basic care such as physical therapy. Learn more at: www.ptcbio.com/posts/structuring-the-clinic-for-basic-car…. #duchenne #inspiration
-
PTC Therapeutics
@PTCBio
Healthcare professionals registered for @GeneticCouns’s 40th Annual Conference can access our sponsored morning session today! Learn more about #genetictesting for the diagnosis of #cerebralpalsy. #neurology #nsgc21
-
PTC Therapeutics
@PTCBio
PTC is delighted to be a sponsor of @GeneticCouns’s 40th Annual Conference. Registered healthcare professional attendees can access our sponsored morning session to learn more about #genetictesting for the diagnosis of #cerebralpalsy. #neurology #nsgc21
-
PTC Therapeutics
@PTCBio
Meet Brent, Chloe and Suzette. Chloe was diagnosed with #leighsyndrome - a rare genetic neurometabolic disorder (and a type of #mitochondrialdisease). Find #inspiration in this family’s story, and learn how they found community support through @UMDF.
-
PTC Therapeutics
@PTCBio
PTC is proud to share that our #edi leader Pamela Zapata is a featured presenter at @DynamicGlobalEv’s 7th Advancing Women’s Leadership Skills and Opportunities in Pharma & Healthcare online livestream. #womenleaders #womeninleadership
-
PTC Therapeutics
@PTCBio
Luca was 2 years old when he was diagnosed with #duchenne muscular dystrophy. His father, Filippo, spoke to PTC about what his son’s diagnosis meant for him as a parent, and about supporting Luca through his journey to adulthood. Watch the full video at: www.ptcbio.com/posts/duchenne-diagnosis-reflections-of-a-….
-
PTC Therapeutics
@PTCBio
PTC is a proud sponsor of @ASGCTherapy’s 2021 #policysummit in Washington, D.C. and online. This event will cover topics related to #genetherapy and how regulatory, legislative and payment policies for diagnosis and treatment intersect. #esg
-
PTC Therapeutics
@PTCBio
Thank you to PTC Chief Culture & Community Officer Martin Rexroad and Director, Global Equality, Diversity & Inclusion Pamela Zapata for representing PTC at LEAP HR Life Sciences 2021. Our Culture & Community team is driving #oneptc employee engagement. leaphr-life-sciences-fall.com?sf151517211=1
-
PTC Therapeutics
@PTCBio
PTC was excited to sponsor @GAP_PKU’s 2021 Global PKU Patient Conference, and even more excited to hear from the conference Chairwoman, Monique Cooper (pictured with her son Charlie). This #pku #caregiver is working to make the world a better place for #raredisease #patients.
-
PTC Therapeutics
@PTCBio
In honor of this past World Duchenne Awareness Day, we invite you to listen to a podcast with three inspiring young men about adult life and #duchenne. Click to listen: www.ptcbio.com/posts/adult-life-and-duchenne-podcast-duch…. #wdad2021 #duchennecan
-
PTC Therapeutics
@PTCBio
PTC will host a conference call to discuss our PTC518 study for the potential treatment of #huntingtonsdisease (#hd) on September 23 at 8 a.m. ET. #raredisease $PTCT
-
PTC Therapeutics
@PTCBio
PTC is pleased to observe World Mitochondrial Disease Awareness Week. Our team is hard at work on the PTC743 (vatiquinone) #clinicaltrial for the potential treatment of mitochondrial #epilepsy. #mitoawarenessweek
-
PTC Therapeutics
@PTCBio
PTC is proud to be presenting at #wms2021, exploring the value of real-world evidence in rare diseases, such as #duchenne. Learn more about the importance of #rwe at www.ptcbio.com/posts/first-and-largest-real-world-study-o….
-
PTC Therapeutics
@PTCBio
Join PTC and Professors Tracey Willis and Thomas Sejersen for a live webinar to the discuss the signs and progressive milestones of #duchenne muscular dystrophy. This is provided at no-cost to #healthcare professionals in Germany, Austria, Brazil, Israel, Bulgaria and Chile.
-
PTC Therapeutics
@PTCBio
When their son was diagnosed with #duchenne, Aida and her husband founded the Lebanese Association for Neuromuscular Disease (L.A.N.D.). It's a #raredisease community that feels just like a #family. Learn more at: www.ptcbio.com/posts/for-l-a-n-d-community-can-feel-like-…. #duchennecan #dmd
-
PTC Therapeutics
@PTCBio
Congratulations to @PathfindersNMA, one of three recipients of this year’s STRIVE Awards! Its initiative will develop resources addressing key questions from young people with #duchenne in the UK as they transition into adulthood. Read more: www.ptcbio.com/posts/living-full-lives-achieving-your-aim….
-
PTC Therapeutics
@PTCBio
When it comes to #clinicaltrials, PTC puts our patients first. We listen and we learn. Read more from our Senior Vice President of Corporate and Patient Relations, Mary Frances Harmon. #raredisease
-
PTC Therapeutics
@PTCBio
Join PTC Patient Engagement Liaison Anne Bruns today at 3 p.m. CET (9 a.m. ET) for “ELEVATE: Taking patient engagement in clinical trials to a new level” at the Clinical Trials in Rare Diseases Conference. #raredisease
-
PTC Therapeutics
@PTCBio
PTC is proud to sponsor the National Latino Leadership Conference from @NDC_Diversity, featuring three amazing #oneptc speakers: Karina Lambertini, Marie Muniz and Manny Torres. #diversity #equity #inclusion #leadership #ndc #clwe #hispanicheritagemonth
-
PTC Therapeutics
@PTCBio
PTC is proud to announce that Chief Culture & Community Officer Martin Rexroad will moderate a @bionj_org panel discussion on the obstacles faced by workplaces during the continuing pandemic – and their solutions!
-
PTC Therapeutics
@PTCBio
Join $PTCT today – Friday, September 10 at 11 a.m. ET – for the @morganstanley Virtual 19th Annual Global Healthcare Conference. Our leaders will present a company overview and business update. You can access the presentation via live webcast on our website. #investors
-
PTC Therapeutics
@PTCBio
PTC is delighted to sponsor @GAP_PKU’s 2021 Global PKU Patient Conference. #phenylketonuria (#pku) is caused by a defective gene and can lead to developmental delays, tremors and other disabling symptoms if left untreated. #gpkuc
-
PTC Therapeutics
@PTCBio
Congratulations to AGADIM, one of three recipients of this year’s STRIVE Awards! AGADIM will use its STRIVE Award to launch its “Duchenne Community” project – creating a safe and empowering residential space for adults living with #duchenne. Learn more: www.ptcbio.com/posts/republica-duchenne/
-
PTC Therapeutics
@PTCBio
Join PTC Founder & CEO Stuart Peltz, Ph.D. for the @wuxi_apptec webinar “DMD: Charting the Path for New Therapeutics and Better Care.” Stu will be a featured panelist at 12:30 p.m. ET on September 9, 2021. #dmd #duchenne #raredisease #neurology
-
PTC Therapeutics
@PTCBio
Thank you, @KarinaLamberti1! It has been fun to chat with you. Please spread the word today on #wdad2021 that people with #duchennecan live life to the fullest! If you need #inspiration, visit duchennecan.com. #adultingwithmax Follow me at @MaxMaximizer13.
-
PTC Therapeutics
@PTCBio
I’m looking forward to my career – graduate school or law school. I’m really excited to see where it will take me and the kinds of people I will meet. Novel experiences. Meeting new people. Dating. Traveling. All the stuff you look forward to and that you can do. #adultingwithmax
-
PTC Therapeutics
@PTCBio
Absolutely! If given the chance, I would love to go to space. Stephen Hawking did zero gravity and loved feeling weightless. It’s why I love swimming. #adultingwithmax www.newscientist.com/article/dn11730-stephen-hawking-gets…
-
PTC Therapeutics
@PTCBio
I loved visiting the town Dungarvan in Ireland where my mom was born. It’s quaint and quiet. #accessibility was pretty good when I traveled in Ireland. Easy-to-use handicapped bathrooms. Plus, I was surrounded by cousins and extended family. #adultingwithmax
-
PTC Therapeutics
@PTCBio
I used to be shy but I really came out of my shell when I started college. Like with dating, sometimes I’m nervous; but I remind myself that we’re all just people. As people, we all have our struggles. #adultingwithmax
-
PTC Therapeutics
@PTCBio
The #accessibility features at school are pretty good. There are elevators. And the restaurants nearby are pretty accessible. My friends are usually there to help me. And sometimes I have relied on the #kindness of strangers. #adultingwithmax
-
PTC Therapeutics
@PTCBio
Gaming has been a big part of my social life, especially during COVID. I like the cooperative aspect of doing missions together. With games for all ages, it’s neat to see how good some of these players get the more you play. We also play a lot of online #chess. #adultingwithmax
-
PTC Therapeutics
@PTCBio
It can be hard having to rely on others, but also rewarding when people do nice things. Sometimes, I’ve found help and support from total strangers. #bekind #adultingwithmax
-
PTC Therapeutics
@PTCBio
Public transportation can be hard. You have to know in advance if there’s an elevator. I have been in situations with friends where we’ve gotten stuck and they’ve helped me get myself and my wheelchair up the stairs. Remember: Think one step ahead. #adultingwithmax
-
PTC Therapeutics
@PTCBio
There’s a hospital near me that does an adaptive driving class. Hopefully, I’ll be driving myself around really soon. #adultingwithmax
-
PTC Therapeutics
@PTCBio
My #friends have been very understanding. They have admitted to me sometimes that they forget I’m disabled. I’m thankful we can have open conversations with sensitivity. #disability #adultingwithmax
-
PTC Therapeutics
@PTCBio
During the height of COVID, we did a lot of video chatting and hanging out outside with masks. I stuck with one group to be safe. I’d love to hear how other people have managed to socialize during the pandemic. Use the hashtag #adultingwithmax.
-
PTC Therapeutics
@PTCBio
It’s a combination of being together at home and hanging out in public. My friend has a pool and he’s really strong so it’s nice to go swimming. He can lift me in and out of the pool. I like feeling weightless in the water. #adultingwithmax
-
PTC Therapeutics
@PTCBio
I like to watch movies with friends. Now that I’m 22, I like to get drinks and hang out at the bar. I like hanging out at our houses, online gaming, dining out. My favorite restaurant is a ramen place. We also love trivia night every Wednesday at a local bar. #adultingwithmax
-
PTC Therapeutics
@PTCBio
Still, sometimes my mom jumps in. She means well. I think the most important thing is to assert yourself, but also be sensitive. My parents want the best for me and I always want to be respectful of that. Anyone having trouble asserting yourself? #adultingwithmax
-
PTC Therapeutics
@PTCBio
My mom still helps me out with appointments, but now it’s my contact information at the doctor’s office, not my mom’s. It happened naturally when I turned 21 because I shifted to “adult” status. I had to see an adult doctor rather than a pediatrician. #adultingwithmax
-
PTC Therapeutics
@PTCBio
What I’m most proud about is that, despite having some physical limitations, I still do all the things adults get to do – go on dates, have adventures, start a career, travel. Nothing has really stopped me. #adultingwithmax
-
PTC Therapeutics
@PTCBio
When I have a job interview, I call ahead to make sure I’ll be able to access the site using my wheelchair. But I’m a smart person and I’ve learned to think strategically about living my life so I get the most out of it. Anyone else do this, too? #adultingwithmax
-
PTC Therapeutics
@PTCBio
Growing up with #duchenne, you accept there are certain things that will challenge you. There are certain places I have trouble going because of #accessibility limitations. I always have to think one step ahead. When I go on a date, I choose a place with ramps. #adultingwithmax
-
PTC Therapeutics
@PTCBio
I’m a really open person and I’m happy to answer questions and really listen to what others have to say about living with #duchenne. If I can help just one person, that will be awesome! So many people have helped me along the way. #kindness #adultingwithmax
-
PTC Therapeutics
@PTCBio
That’s awesome, @KarinaLamberti1! Fire away. I can tell you one of my favorite parts about growing up (or “#adulting”) is that I get to do this #twittertakeover to help bring awareness to #duchenne on #wdad2021. #dmd #raredisease #adultingwithmax
-
PTC Therapeutics
@PTCBio
I love to #travel and I’ve been to Belgium, France, Spain, the U.K. and Ireland. Someday, I hope to travel to Italy, Japan and beyond. I also work at a radio station and am applying for jobs in psychology. #adultingwithmax
-
PTC Therapeutics
@PTCBio
Let me start by telling you a little about me. I’m a student at @fordhamNYC and I study computer science and psychology. I was adopted as a baby from Moldova and I’m working on learning Russian. #adultingwithmax
-
PTC Therapeutics
@PTCBio
Hi, everyone! I’m Max and I’m doing a #wdad2021 #twittertakeover of PTC’s channel. Got questions about how I have been able to travel, learn, work, date and grow up with #duchenne? I’m here until 12 p.m. ET with answers.
-
PTC Therapeutics
@PTCBio
It's today! #wdad2021 #adultingwithmax #dmd #duchenne #twittertakeover #wdad #inspiration
PTC Therapeutics
@PTCBio
Join PTC on Tuesday, September 7th – #wdad2021 – for a #twittertakeover at 11 a.m. ET. Max Fernandez will answer questions LIVE about adult life with #duchenne. Follow us on Twitter and use the hashtag #adultingwithmax to engage. #dmd
-
PTC Therapeutics
@PTCBio
PTC is thrilled to announce the recipients of our 2021 STRIVE Awards. Congratulations to @PathfindersNMA, @ASCADIM and AGADIM. Their incredible initiatives will provide vital support to their local Duchenne communities. Learn more at www.ptcstriveawards.com. #raredisease #dm.
-
PTC Therapeutics
@PTCBio
Since receiving the 2020 #striveaward, @ADMArgentina has confronted many challenges; but this has made its team stronger. Watch to learn how it has used the #grant to support the #duchenne Community. Read more at www.ptcbio.com/posts/strive-awards-sponsor-hope-online/. #dmd #raredisease #inspiration
-
PTC Therapeutics
@PTCBio
2020 #striveaward recipient @GAOORDI from Russia used its #grant to realize the ‘Not alone’ project and improve the quality of life of people with #duchenne and their relatives. To read more, visit www.ptcbio.com/posts/counseling-duchenne-patients-in-russia/. #dmd #raredisease
-
PTC Therapeutics
@PTCBio
PTC is excited to be at the @ILAEWeb 34th International Epilepsy Congress sharing new data about #aadc deficiency and the impact of #oculogyriccrises (#ogc) – a common, devastating and distressing symptom. #neurology #raredisease #iec2021
-
PTC Therapeutics
@PTCBio
Join PTC on Tuesday, September 7th – #wdad2021 – for a #twittertakeover at 11 a.m. ET. Max Fernandez will answer questions LIVE about adult life with #duchenne. Follow us on Twitter and use the hashtag #adultingwithmax to engage. #dmd
-
PTC Therapeutics
@PTCBio
PTC is pleased to share the latest article discussing new #realworldevidence on a treatment option to consider in #duchenne muscular dystrophy (#dmd). This article contains product information and is intended for health care professionals. #neurology #realworlddata




























































































































































































































































































































































































































































































































